99 results on '"Muanza T"'
Search Results
2. OA07.06 Second Line Treatment Outcomes After Progression on Immunotherapy Plus Chemotherapy (IO-CT) In Advanced Non-small Cell Lung Cancer (aNSCLC)
- Author
-
Auclin, E., Benitez-Montanez, J., Gorria, T., Garcia-Campelo, R., Dempsey, N., Pinato, D.J., Reyes, R., Albarran, V., Dall'ollio, F., Soldato, D., Hendriks, L., Aboubakar, F., Tonneau, M., Lopez-Castro, R., Nadal, E., Katsandjian, S., Blanc-Durand, F., Fabre, E., Castro, N., Arasanz, H., Muanza, T., Rochand, A., Besse, B., Routy, B., and Mezquita, L.
- Published
- 2022
- Full Text
- View/download PDF
3. 1357P A deep radiomics approach to assess PD-L1 expression and clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A multicentric study
- Author
-
Tonneau, M., Phan, K., Kazandjian, S., Elkrief, A., Panasci, J., Richard, C., Nolin-Lapalme, A., El Sayed, R., Ding, L., Nair, T., Malo, J., Chandelier, F., Kafi, K., O'Brien, J., Di Jorio, L., Muanza, T., and Routy, B.
- Published
- 2021
- Full Text
- View/download PDF
4. Combining prostate cancer radiotherapy with therapies targeting the androgen receptor axis.
- Author
-
Ghashghaei, M., Kucharczyk, M., Elakshar, S., Muanza, T., and Niazi, T.
- Subjects
PROSTATE cancer ,ANDROGEN receptors ,CANCER radiotherapy ,CANCER treatment ,ABIRATERONE acetate ,CASTRATION-resistant prostate cancer - Abstract
Background Prostate cancer (PCA) is the most common non-dermatologic cancer and the 3rd leading cause of male cancer mortality in Canada. In patients with high-risk localized or recurrent PCA, management typically includes the combination of long-term androgen deprivation therapy (ADT) and radiotherapy (rt). New androgen-receptor-axis targeted therapies (ARATS), which await validation, offer an option to intensify therapy. Methods In this narrative review, we report the relevant history that has supported combining ADT with RT. The literature in PubMed was searched for studies involving PCA and novel ARATS (abiraterone acetate, enzalutamide, apalutamide, darolutamide) published between 1995 and 2019. Literature discussing clinical trials in which those modalities were combined was extracted and synthesized into a combined molecular and clinical discussion. Potential treatment intensification mechanisms and rationales are explored. Results Early results from three phase III trials demonstrated that concurrent abiraterone acetate, ADT, and rt is safe, improves the extent of chemical castration, and is associated with limited treatment failures. A single in vitro study implies synergy for radiosensitization beyond that facilitated by conventional ADT. Studies investigating the combination of other ARATS with RT are under way, including multiple phase iii trials, but short-term results are not yet available. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
5. Does the presence of emphysema increase the risk of radiation pneumonitis in lung cancer patients?
- Author
-
Kasymjanova, G., Jagoe, R. T., Pepe, C., Sakr, L., Cohen, V., Small, D., Muanza, T. M., and Agulnik, J. S.
- Subjects
LUNG cancer ,CANCER patients ,PNEUMONIA ,RADIATION ,COMPUTED tomography - Abstract
Introduction Radiotherapy (rt) plays an important role in the treatment of lung cancer. One of the most common comorbidities in patients with lung cancer is pulmonary emphysema. The literature offers conflicting data about whether emphysema increases the occurrence and severity of radiation pneumonitis (rp). As a result, whether high doses of rt (with curative intent) should be avoided in patients with emphysema is still unclear. Objective We measured the documented incidence of rp in patients with and without emphysema who received curative radiation treatment. Methods This retrospective cohort study considered patients in the lung cancer clinical database of the Peter Brojde Lung Cancer Centre. Data from the database has been used previously for research studies, including a recent publication about emphysema grading, based on the percentage of lung occupied by emphysema on computed tomography (ct) imaging. Results Using previously published methods, chest ct imaging for 498 patients with lung cancer was scored for the presence of emphysema. The analysis considered 114 patients who received at least 30 Gy radiation. Of those 114 patients, 64 (56%) had emphysema, with approximately 23% having severe or very severe disease. The incidence of rp was 34.4% in patients with emphysema (n = 22) and 32.0% in patients with no emphysema (n = 16, p = 0.48). No difference in the incidence of rp was evident between patients with various grades of emphysema (p = 0.96). Similarly, no difference in the incidence of rp was evident between the two treatment protocols--that is, definitive rt 17 (37%) and combined chemotherapy-rt 21 (31%, p = 0.5). Conclusions In our cohort, the presence of emphysema on chest ct imaging was not associated with an increased risk of rp. That finding suggests that patients with lung cancer and emphysema should be offered rt when clinically indicated. However, further prospective studies will be needed for confirmation. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
6. 1558P - A patient-centered approach to the re-development of supportive care services for oncology adolescent and young adult (AYA) patients (pt(s)) across McGill University hospitals (Rossy Cancer Network-RCN)
- Author
-
Kavan, P., Fox, R., Raskovic, G., Barrera, I., Sateren, W., Batist, G., Palumbo, M., Muanza, T., Johnson, N., Mamo, A., Alcindor, T., Turcotte, R., and Meguerditchian, A.
- Published
- 2017
- Full Text
- View/download PDF
7. Precision electroweak measurements on the Z resonance
- Author
-
Schael, S, Barate, R, Bruneliere, R, Buskulic, D, Bonis, De, Decamp, I, Ghez, D, Goy, P, Jezequel, C, Lees, S, Lucotte, Jp, Martin, A, Merle, F, Minard, E, Nief, Mn, Odier, Jy, Pietrzyk, P, Trocme, B, Bravo, B, Casado, S, Chmeissani, Mp, Comas, M, Crespo, P, Fernandez, Jm, E, Fernandez, Bosman, Garrido, M, Grauges, L, Juste, E, Martinez, A, Merino, M, Miquel, G, Mir, R, Orteu, Lm, Pacheco, S, Park, A, Perlas, Ic, Riu, J, Ruiz, I, Sanchez, H, Colaleo, F, Creanza, A, D, Filippis, De, N, Palma, De, Iaselli, M, Maggi, G, Nuzzo, M, Ranieri, S, Raso, A, Ruggieri, G, Selvaggi, F, Silvestris, G, Tempesta, L, Tricomi, P, Zito, A, Huang, G, Lin, X, Ouyang, J, Wang, Q, Xie, T, Xu, Y, Xue, R, Zhang, S, Zhang, J, Zhao, L, Abbaneo, W, Bazarko, D, Becker, A, Boix, U, Bird, G, Blucher, F, Bonvicini, E, B, Bright, Thomas, Barklow, P, Buchmuller, T, Cattaneo, O, Cerutti, M, Ciulli, F, Clerbaux, V, Drevermann, B, Forty, H, Frank, Rw, Greening, M, Hagelberg, Tc, Halley, R, Gianotti, Aw, Girone, F, Hansen, M, Harvey, Jb, Jacobsen, J, Hutchcroft, R, Janot, De, Jost, R, Knobloch, B, Kado, J, Lehraus, M, Lazeyras, I, Maley, P, Mato, R, May, P, Moutussi, J, A, Pepe, Altarelli, Ranjard, M, Rolandi, F, Schlatter, L, Schmitt, D, Schneider, B, Tejessy, O, Teubert, W, Tomalin, F, Tournefier, Ir, Veenhof, E, Valassi, R, Wiedenmann, A, Wright, W, Ajaltouni, Ae, Badaud, Z, Chazelle, F, Deschamps, G, Dessagne, O, Falvard, S, Ferdi, A, Fayolle, C, Gay, D, Guicheney, P, Henrard, C, Jousset, P, Michel, J, Monteil, B, Montret, S, Pallin, Jc, Pascolo, D, Perret, Jm, Podlyski, P, Bertelsen, F, Fernley, H, Hansen, T, Hansen, Jd, Hansen, Jr, Kraan, Ph, Lindahl, Ac, Mollerud, A, Nilsson, R, Rensch, Bs, Waananen, B, Daskalakis, A, Kyriakis, G, Markou, A, Simopoulou, C, Siotis, E, Vayaki, I, Zachariadou, A, Blondel, K, Bonneaud, A, Brient, G, Machefert, Jc, Rouge, E, Rumpf, A, Swynghedauw, M, Tanaka, M, Verderi, R, Videau, M, Focardi, H, Parrini, E, Corden, G, Georgiopoulos, M, Antonelli, C, Antonelli, A, Bencivenni, M, Bologna, G, Bossi, G, Campana, F, Capon, P, Chiarella, G, Felici, V, Laurelli, G, Mannocchi, P, Murtas, G, Passalacqua, Gp, Picchi, L, Colrain, P, P, Ten, Have, Hughes, I, Kennedy, Is, Knowles, J, Lynch, Ig, Morton, Jg, Negus, Wt, Oshea, P., Raine, V, Reeves, C, Scarr, P, Smith, Jm, Thompson, K., Turnbull, As, Wasserbaech, Rm, Cavanaugh, S, Dhamotharan, R, Geweniger, S, Hanke, C, Hansper, P, Hepp, G, Kluge, V, Putzer, Ee, Sommer, A, Stenzel, J, Tittel, H, Werner, K, Wunsch, W, Beuselinck, M, Binnie, R, Cameron, Dm, Davies, W, Dornan, G, Goodsir, Pj, Marinelli, S, Martin, N, Nash, Eb, Nowell, J, Rutherford, J, Sedgbeer, Sa, Thompson, Jk, White, Jc, Williams, R, Ghete, Md, Girtler, Vm, Kneringer, P, Kuhn, E, Rudolph, D, G, Bouhova, Thacker, Bowdery, E, Buck, Ck, Clarke, Pg, Ellis, Dp, Finch, G, Foster, Aj, Hughes, F, Jones, G, Rwl, Keemer, Pearson, Nr, Robertson, Mr, Sloan, Na, Smizanska, T, Snow, M, Williams, Sw, van der Aa, Delaere, O, Leibenguth, C, Lemaitre, G, Bauerdick, V, Lat, Blumenschein, U, Van, Gemmeren, Giehl, P, Holldorfer, I, Jakobs, F, Kasemann, K, Kayser, M, Kleinknecht, F, Muller, K, Quast, As, Renk, G, Rohne, B, Sander, E, Schmeling, Hg, Wachsmuth, S, Wanke, H, Zeitnitz, R, Ziegler, C, Aubert, T, Benchouk, Jj, Bonissent, C, Carr, A, Coyle, J, Curtil, P, Ealet, C, Etienne, A, Fouchez, F, Motsch, D, Payre, F, Rousseau, P, Tilquin, D, Talby, A, Thulasides, M, Aleppo, M, Ragusa, M, Buscher, F, David, V, Dietl, A, Ganis, H, Huttmann, G, Lutjens, K, Mannert, G, Manner, C, Moser, W, Settles, Hg, Seywerd, R, Villegas, H, Wolf, M, Azzurri, G, Boucrot, P, Callot, J, Chen, O, Cordier, S, Davier, A, Duflot, M, Grivaz, L, Heusse, Jf, Jacholkowska, P, Diberder, Le, Lefrancois, F, Mutz, J, Schune, Am, Serin, Mh, Veillet, L, Videau, Jj, Zerwas, I, Bagliesi, D, Bettarini, G, Boccali, S, Bozzi, T, Calderini, C, Dellorso, G, Fantechi, R, Ferrante, R, Fidecaro, I, Foa, F, Giammanco, L, Giassi, A, Gregorio, A, Ligabue, A, Lusiani, F, Marrocchesi, PIER SIMONE, Messineo, Ps, Palla, A, Rizzo, F, Sanguinetti, G, Sciaba, G, Sguazzoni, A, Spagnolo, G, Steinberger, P, Tenchini, J, Venturi, R, Vannini, A, Verdini, C, Awunor, Pg, Blair, O, Cowan, Ga, Garcia, Bellido, Green, A, Medcalf, Mg, Misiejuk, T, Strong, A, Teixeira, Dias, Botterill, P, Clifft, Dr, Edgecock, Rw, Edwards, Tr, Haywood, M, Norton, Sj, Ward, Pr, Bloch, Devaux, Boumediene, B, Colas, D, Emery, P, Fabbro, S, Kozanecki, B, Lancon, W, Lemaire, E, Locci, Mc, Perez, E, Rander, P, Renardy, J, Roussarie, Jf, Schuller, A, Schwindling, Jp, Tuchming, J, Vallage, B, Black, B, Dann, Sn, Kim, Jh, Konstantinidis, Hy, Litke, N, Mcneil, Am, Taylor, Ma, Booth, G, Cartwright, Cn, Combley, S, Hodgson, F, Lehto, Pn, Thompson, M, Affholderbach, Lf, Barberio, K, Bohrer, E, Brandt, A, Burkhardt, S, Feigl, H, Grupen, E, Hess, C, Lutters, J, Meinhard, G, H, Minguet, Rodriguez, Mirabito, J, Neugebauer, L, Ngac, E, Prange, A, Rivera, G, Saraiva, F, Schafer, P, Sieler, U, Smolik, U, Stephan, L, Trier, F, Apollonio, H, Borean, M, Bosisio, C, L, Della, Marina, Giannini, R, Gobbo, G, Musolino, B, Pitis, G, He, L, Kim, H, Putz, H, Rothberg, J, Armstrong, J, Bellantoni, Sr, Berkelman, L, Cinabro, K, Conway, D, Cranmer, Js, Elmer, K, Feng, P, Ferguson, Z, Dps, Gao, Gonzalez, Y, Grahl, S, Harton, J, Hayes, Jl, Hu, Oj, Jin, H, Johnson, S, Kile, Rp, Mcnamara, J, Nielsen, Pa, Orejudos, J, Pan, W, Saadi, Y, Scott, Y, Sharma, Ij, Walsh, V, Walsh, Am, Wear, J, J, von Wimmersperg Toeller, Wu, Jh, Wu, J, Wu, Sl, Yamartino, X, Zobernig, Jm, Dissertori, G, Abdallah, G, Abreu, J, Adam, P, Adye, W, Adzic, T, Ajinenko, P, Albrecht, I, Alderweireld, T, Alekseev, T, Alemany, Fernandez, Allmendinger, R, Allport, T, Almehed, Pp, Amaldi, S, Amapane, U, Amato, N, Anashkin, S, Anassontzis, E, Andersson, Eg, Andreazza, P, Andringa, A, Anjos, S, Antilous, N, Apel, P, Arnoud, Wd, Ask, Y, Asman, S, Augustin, B, Augustinus, Je, Baillon, A, Ballestrero, P, Bambade, A, Barao, P, Barbiellini, F, Barbier, G, Bardin, R, Barker, D, Baroncelli, G, Battaglia, A, Baubillier, M, Becks, M, Begalli, Kh, Behrmann, M, Beilliere, A, Belokopytov, P, Belous, Y, K, Ben, Haim, Benekos, E, Benvenuti, N, Berat, A, Berggren, C, Berntzon, M, Bertini, L, Bertrand, D, Besancon, D, Besson, M, Bianchi, N, Bigi, F, Bilenky, M, Bizouard, Ms, Bloch, Ma, Blom, D, Bluj, M, Bonesini, M, Bonivento, M, Boonekamp, W, Booth, M, Psl, Borgland, Borisov, Aw, Bosio, G, Botner, C, Boudinov, O, Bouquet, E, Bourdarios, B, Bowcock, C, Tjv, Boyko, Bozovic, I, Bozzo, I, Bracko, M, Branchini, M, Brenke, P, Brenner, T, Brodet, R, Bruckman, E, Brunet, P, Bugge, Jm, Buran, L, Burgsmueller, T, Buschbeck, T, Buschmann, B, Cabrera, P, Caccia, S, Calvi, M, Rozas, M, Ajc, Camporesi, Canale, T, Canepa, V, Carena, M, Carroll, F, Caso, L, Gimenez, C, Mvc, Castro, Cattai, N, Cavallo, A, Cerruti, F, Chabaud, C, Chapkin, V, Charpentier, M, Chaussard, P, Checchia, L, Chelkov, P, Chen, Ga, Chierici, M, Chliapnikov, R, Chochula, R, Chorowicz, P, Chudoba, V, Chung, J, Cieslik, Su, Collins, K, Colomer, P, Contri, M, Cortina, R, Cosme, E, Cossuti, G, Costa, F, Cowell, Mj, Crawley, Jh, Crennell, Hb, Crepe, D, Crosetti, S, Cuevas, G, Czellar, J, Dhondt, S, Dalmagne, J, Dalmau, B, Damgaard, J, Davenport, G, M, Silva, Da, T, Deghorain, W, Della, Ricca, Delpierre, G, Demaria, P, Angelis, De, Boer, De, W, Brabandere, De, S, Clercq, De, C, Lotto, De, Maria, De, Min, De, Paula, De, Dijkstra, L, Ciaccio, Di, Diodato, Di, Simone, Di, Djannati, A, Dolbeau, A, Doroba, J, Dracos, K, Drees, M, Drees, J, Dris, Ka, Duperrin, M, Durand, A, Ehret, Jd, Eigen, R, Ekelof, G, Ekspong, T, Ellert, G, Elsing, M, Engel, M, Erzen, Jp, Santo, B, Mce, Falk, Fanourakis, E, Fassouliotis, G, Fayot, D, Feindt, J, Fenyuk, M, Fernandez, A, Ferrari, J, Ferrer, P, Ferrer, Ribas, Ferro, E, Fichet, F, Firestone, S, Fischer, A, Flagmeyer, Pa, Foeth, U, Fokitis, H, Fontanelli, E, Franek, F, Frodesen, B, Fruhwirth, Ag, R, Fulda, Quenzer, Fuster, F, Galloni, J, Gamba, A, Gamblin, D, Gandelman, S, Garcia, M, Garcia, C, Gaspar, J, Gaspar, C, Gasparini, M, Gavillet, U, Gazis, P, Gele, E, Gerber, D, Gerdyukov, Jp, Ghodbane, L, Gil, N, Glege, I, Gokieli, F, Golob, R, Gomez, Ceballos, Goncalves, G, Caballero, P, Gopal, Ig, Gorn, G, Gorski, L, Gouz, M, Gracco, Y, Graziani, V, Green, E, Grefrath, C, Grimm, A, Gris, Hj, Grosdidier, P, Grzelak, G, Gunther, K, Guy, M, Haag, J, Hahn, C, Hahn, F, Hallgren, S, Hamacher, A, Hamilton, K, Hansen, K, Harris, J, Haug, Fj, Hauler, S, Hedberg, F, Heising, V, Hennecke, S, Henriques, M, Hernandez, R, Herquet, Jj, Herr, P, Hessing, H, Heuser, Tl, Higon, Jm, Hoffman, E, Holmgren, J, Holt, So, Holthuizen, Pj, Hoorelbeke, D, Houlden, S, Hrubec, Ma, Huber, J, Huet, M, Hughes, K, Hultqvist, Gj, Jackson, K, Jacobsson, Jn, Jalocha, R, Janik, P, Jarlskog, R, Jarlskog, C, Jarry, G, Jean, Marie, Jeans, B, Johansson, D, Johansson, Ek, Jonsson, Pd, Joram, P, Juillot, C, Jungermann, P, Kapusta, L, Karafasoulis, F, Katsanevas, K, Katsoufis, S, Keranen, E, Kernel, R, Kersevan, G, Kerzel, Bp, Khomenko, U, Khovanski, Ba, Kiiskinen, Nn, King, A, Kinvig, Bt, Kjaer, A, Klapp, Nj, Klein, O, Kluit, H, Knoblauch, P, Kokkinias, D, Konopliannikov, P, Koratzinos, A, Kostioukhine, M, Kourkoumelis, V, Kouznetsov, C, Krammer, O, Kreuter, M, Kriznic, C, Krstic, E, Krumstein, J, Kubinec, Z, Kucewicz, P, Kucharczyk, W, Kurowska, M, Kurvinen, J, Lamsa, K, Lanceri, J, Lane, L, Langefeld, Dw, Lapin, P, Laugier, V, Lauhakangas, Jp, Leder, R, Ledroit, G, Lefebure, F, Leinonen, V, Leisos, L, Leitner, A, Lemonne, R, Lenzen, J, Lepeltier, G, Lesiak, V, Lethuillier, T, Libby, M, Liebig, J, Liko, W, Lipniacka, D, Lippi, A, Loerstad, I, Lokajicek, B, Loken, M, Lopes, Jg, Lopez, Jh, Lopez, Femandez, Loukas, R, Lutz, D, Lyons, P, Macnaughton, L, Mahon, J, Maio, Jr, Malek, A, Malmgren, A, Tgm, Maltezos, Malychev, S, Mandl, V, Marco, F, Marco, J, Marechal, R, Margoni, B, Marin, M, Mariotti, Jc, Markou, C, Martinez, Rivero, Martinez, Vidal, Garcia, F, Smi, Masik, Mastroyiannopoulos, J, Matorras, N, Matteuzzi, F, Matthiae, C, Mazik, G, Mazzucato, J, Mazzucato, F, Mccubbin, M, Mckay, M, Mcnulty, R, Meroni, R, Meyer, C, Miagkov, Wt, Migliore, A, Mitaroff, E, Mjoernmark, W, Moa, U, Moch, T, Moeller, M, Moenig, R, Monge, K, Montenegro, R, Moraes, J, Moreau, D, Moreno, X, Morettini, S, Morton, P, Mueller, G, Muenich, U, Mulders, K, Mulet, Marquis, Mundim, C, Muresan, L, Murray, R, Muryn, W, Myatt, B, Myklebust, G, Naraghi, T, Nassiakou, F, Navarria, M, Navas, F, Nawrocki, S, Negri, K, Neufeld, P, Neumann, N, Neumeister, W, Nicolaidou, N, Nielsen, R, Nieuwenhuizen, Bs, Niezurawski, M, Nikolaenko, P, Nikolenko, V, Nomokonov, M, Normand, V, Nygren, A, Oblakowska, Mucha, Obraztsov, A, Olshevski, V, Onofre, A, Orava, A, Orazi, R, Osterberg, G, Ouraou, K, Oyanguren, A, Paganini, A, Paganoni, P, Paiano, M, Pain, S, Paiva, R, Palacios, R, Palka, Jp, Papadopoulou, H, Papageorgiou, Td, Pape, K, Parkes, L, Parodi, C., Parzefall, F, Passeri, U, Passon, A, Pavel, O, Pegoraro, T, Peralta, M, Perepelitsa, L, Pernicka, V, Perrotta, M, Petridou, A, Petrolini, C, Philips, A, Piana, Ht, Piedra, G, Pieri, J, Pierre, L, Pimenta, F, Piotto, M, Podobnik, E, Poireau, T, Pol, V, Polok, Me, Polycarpo, G, Poropat, E, Pozdniakov, P, Privitera, V, Pukhaeva, R, Pullia, N, Radojicic, A, Ragazzi, D, Rahmani, S, Rakoczy, H, Rames, D, Ramler, J, Ratoff, L, Read, Pn, Rebecchi, A, Redaelli, P, Regler, Ng, Rehn, M, Reid, J, Reinhardt, D, Renton, R, Resvanis, P, Richard, Lk, Ridky, F, Rinaudo, J, Ripp, Baudot, Rivero, I, Rodriguez, M, Rohne, D, Romero, O, Ronchese, A, Rosenberg, P, Rosinsky, Ei, Roudeau, P, Rovelli, R, Royon, T, Ruhlmann, Kleider, Ruiz, V, Ryabtchikov, A, Saarikko, D, Sacquin, H, Sadovsky, Y, Sajot, A, Salmi, G, Salt, L, Sampsonidis, J, Sannino, D, Savoy, Navarro, Scheidle, A, Schneider, T, Schwemling, H, Schwering, P, Schwickerath, B, Schyns, U, Mae, Scuri, Seager, F, Sedykh, P, Segar, Y, Seibert, A, Sekulin, N, Shellard, R, Sheridan, Rc, Siebel, A, Silvestre, M, Simard, R, Simonetto, L, Sisakian, F, Skaali, A, Smadja, Tb, Smirnov, G, Smirnova, N, Smith, O, Sokolov, Gr, Sopczak, A, Sosnowski, A, Spassov, R, Spiriti, T, Sponholz, E, Squarcia, P, Stampfer, S, Stanescu, D, Stanic, C, Stanitzki, S, Stapnes, M, Stevenson, S, Stocchi, K, Strauss, A, Strub, J, Stugu, R, Szczekowski, B, Szeptycka, M, Szumlak, M, Tabarelli, T, Taffard, T, Tegenfeldt, Ac, Terranova, F, Thomas, F, Timmermans, J, Tinti, J, Tkatchev, N, Tobin, L, Todorov, M, Todorovova, T, Toet, S, Tomaradze, Dz, Tome, A, Tonazzo, B, Tortora, A, Tortosa, L, Transtromer, P, Travnicek, G, Treille, P, Tristram, D, Trochimczuk, G, Trombini, M, Troncon, A, Tsirou, C, Turluer, A, Tyapkin, Ml, Tyapkin, Ia, Tzamarias, P, Ullaland, S, Uvarov, O, Valenti, V, Vallazza, G, Vander, Velde, Van, Apeldoorn, Van, Dam, Van den Boeck, Van, Doninck, Van, Eldik, Van, Lysebetten, Van, Remortel, Van, Vulpen, Vassilopoulos, I, Vegni, N, Velos, G, Ventura, F, Venus, L, Verbeure, W, Verdier, F, Verlato, P, Vertogradov, M, Verzi, Ls, Vilanova, V, Vitale, D, Vlasov, L, Vodopyanov, E, Vollmer, As, Voulgaris, C, Vrba, G, Wahlen, V, Walck, H, Washbrook, C, Weiser, Aj, Wetherell, C, Wicke, Am, Wickens, D, Wilkinson, J, Winter, G, Witek, M, Wlodek, M, Yi, T, Yushchenko, J, Zaitsev, O, Zalewska, A, Zalewski, A, Zavrtanik, P, Zevgolatakos, D, Zhuravlov, E, Zimin, V, Zintchenko, Ni, Zoller, A, Zucchelli, P, Zumerle, Gc, Zupan, G, Acciarri, M, Achard, M, Adriani, P, O, Aguilar, Benitez, Alcaraz, M, Alemanni, J, Allaby, G, Aloisio, J, Alviggi, A, Ambrosi, Mg, Anderhub, G, Andreev, H, Angelescu, Vp, Anselmo, T, Arefiev, F, Azemoon, A, Aziz, T, Bagnaia, T, Bajo, P, Baksay, A, Baksay, G, Balandras, L, Baldew, A, Ball, Sv, Banerjee, Rc, Barczyk, S, Barillere, A, Barone, R, Bartalini, L, Basile, P, Batalova, M, Battiston, N, Bay, R, Becattini, A, Behner, F, Bellucci, F, Berbeco, L, Berdugo, R, Berges, J, Bertucci, P, Betev, B, Bhattacharya, Bl, Biasini, S, Biglietti, M, Biland, M, Blaising, A, Blyth, Jj, Bobbink, Sc, Bohm, Bj, Boldizsar, A, Borgia, L, Bottai, B, Bourilkov, S, Bourquin, D, Braccini, M, Branson, S, Brigljevic, Jg, Brochu, V, Brock, F, Buffini, Ic, Buijs, A, Burger, A, Burger, Jd, Button, Wj, Cai, A, Campanelli, Xd, Capell, M, Romeo, M, Carlino, Gc, Cartacci, G, Casaus, A, Castellini, J, Cavallari, G, Cavallo, E, Cecchi, N, Cerrada, C, Cesaroni, M, Chamizo, F, Chang, M, Chaturvedi, Yh, Chemarin, Uk, Chen, M, Chen, A, Chen, G, Chen, Gm, Chen, Hf, Chiefari, Hs, Cifarelli, G, Cindolo, L, Civinini, F, Clare, C, Clare, I, Coignet, R, Colijn, G, Colino, Ap, Costantini, N, Cotorobai, S, Cozzoni, F, de la Cruz, Csilling, B, Cucciarelli, A, Dai, S, Van, Dalen, Dalessandro, Ja, Asmundis, De, Debreczeni, R, Deglon, J, Degre, P, Dehmelt, P, Deiters, K, Della, Volpe, Delmeire, D, Denes, E, Denotaristefani, P, F, Salvo, De, Diemoz, A, Dierckxsens, M, Van, Dierendonck, Lodovico, Di, Dionisi, F, Dittmar, C, Dominguez, M, Doria, A, Dova, A, Duchesneau, Mt, Dufournaud, D, Duda, D, Duinker, M, Duran, P, Dutta, I, Echenard, S, Eline, B, Hage, El, Mamouni, El, Engler, H, Eppling, A, Erne, Fj, Extermann, Fc, Fabre, P, Faccini, M, Falagan, R, Falciano, Ma, Favara, S, Fay, A, Fedin, J, Felcini, O, Ferguson, M, Ferroni, T, Fesefeldt, F, Fiandrini, H, Field, E, Filthaut, Jh, Fisher, F, Fisher, Ph, Fisk, W, Forconi, I, Fredj, G, Freudenreich, L, Furetta, K, Galaktionov, C, Ganguli, Y, Garcia, Abia, Gataullin, P, Gau, M, Gentile, Ss, Gheordanescu, S, Giagu, N, Gong, S, Grenier, Zf, Grimm, G, Gruenewald, O, Guida, Mw, Van, Gulik, Van, Gupta, Gurtu, Vk, Gutay, A, Haas, Lj, Hasan, D, Hatzifotiadou, A, Hebbeker, D, Herve, T, Hidas, A, Hirschfelder, P, Hofer, J, Hohlmann, H, Holzner, M, Hoorani, G, Hou, H, Lashvili, Sr, Innocente, I, Jin, V, Jindal, Bn, Jones, P, Dejong, Lw, Josa, Mutuberria, Khan, I, Kaur, Ra, Kienzle, Focacci, Kim, Mn, Kim, D, Kirkby, Jk, Kiss, J, Kittel, D, Klimentov, W, Konig, A, Koffeman, Ac, Kopal, E, Kopp, M, Koutsenko, A, Kraber, V, Kraemer, M, Krenz, Rw, Kruger, W, Kuijten, A, Kunin, H, Guevara, De, Laktineh, Pl, Landi, I, Lassila, Perini, Lebeau, K, Lebedev, M, Lebrun, A, Lecomte, P, Lecoq, P, Coultre, Le, Lee, P, Goff, Le, Leiste, Jm, Leonardi, R, Levtchenko, E, Levtchenko, M, Li, P, Likhoded, C, Lin, S, Lin, Ch, Linde, Wt, Lista, Fl, Liu, L, Lohmann, Za, Longo, W, Lu, E, Lu, Ys, Lubelsmeyer, W, Luci, K, Luckey, C, Luminari, D, Lugnier, L, Lustermann, L, Ma, W, Maity, Wg, Malgeri, M, Malinin, L, Mana, A, Mangeol, C, Mans, D, Marchesini, J, Marian, P, Martin, G, Marzano, Jp, Massaro, F, Ggg, Mazumdar, Mcneil, K, Mele, Rr, Merola, S, Merk, L, Meschini, M, Metzger, M, von der Mey, Mihul, M, Milcent, A, Mirabelli, H, Mnich, G, Mohanty, J, Molnar, Gb, Monteleoni, P, Moulik, B, Muanza, T, Muheim, Gs, Muijs, F, Ajm, Musicar, Musy, B, Nagy, M, Natale, S, Napolitano, S, Nessi, Tedaldi, Newman, F, Niessen, H, Nisati, T, Novak, A, Nowak, I, Ofierzynski, H, Organtini, R, Oulianov, G, Pal, A, Palomares, I, Pandoulas, C, Paoletti, D, Paoloni, S, Paolucci, A, Paramatti, P, Park, R, Park, Hk, Pascale, Ih, Passaleva, G, Patricelli, G, Paul, S, Pauluzzi, T, Paus, M, Pauss, C, Peach, F, Pedace, D, Pensotti, M, Perret, Gallix, Petersen, D, Piccolo, B, Pierella, D, Pieri, F, Pioppi, M, Piroue, M, Pistolesi, Pa, Plyaskin, E, Pohl, V, Pojidaev, M, Postema, V, Pothier, H, Produit, J, Prokofiev, N, Prokofiev, Do, Quartieri, D, Rahal, Callot, Rahaman, G, Raics, Ma, Raja, P, Ramelli, N, Rancoita, R, Ranieri, Pg, Raspereza, R, Razis, A, Ren, P, Rescigno, D, Reucroft, M, Van, Rhee, Riemann, T, Riles, S, Robohm, K, Rodin, A, Roe, J, Romero, Bp, Rosca, L, Rosemann, A, Rosenbleck, C, Rosier, Lees, Roth, S, Rubio, S, Ruggiero, Ja, Ruschmeier, G, Rykaczewski, D, Sakharov, H, Saremi, A, Sarkar, S, Salicio, S, Sanchez, J, Sanders, E, Sarakinos, Mp, Schafer, Me, Schegelsky, C, V, Schmidt, Kaerst, Schmitz, S, Schopper, D, Schotanus, H, Schwering, Dj, Sciacca, G, Sciarrino, C, Seganti, D, Servoli, A, Shevchenko, L, Shivarov, S, Shoutko, N, Shumilov, V, Shvorob, E, Siedenburg, A, Son, T, Smith, D, Souga, B, Spillantini, C, Steuer, P, Stickland, M, Stone, Dp, Stone, A, Stoyanov, H, Straessner, B, Sudhakar, A, Sultanov, K, Sun, G, Sushkov, Lz, Suter, S, Swain, H, Szillasi, Jd, Sztaricskai, Z, Tang, T, Tarjan, Xw, Tauscher, P, Taylor, L, Tellili, L, Teyssier, B, Timmermans, D, Ting, C, Scc, Ting, Tonwar, Sm, Toth, Sc, Tully, J, Tung, C, Uchida, Kl, Ulbricht, Y, Uwer, J, Valente, U, Van de Walle, Vasquez, Rt, Veszpremi, R, Vesztergombi, V, Vetlitsky, G, Vicinanza, I, Viertel, D, Villa, G, Vivargent, S, Vlachos, M, Vodopianov, S, Vogel, I, Vogt, H, Vorobiev, H, Vorobyov, I, Vorvolakos, Aa, Wadhwa, A, Wallraff, M, Wang, W, Wang, Xl, Weber, Zm, Weber, A, Wienemann, M, Wilkens, P, Wu, H, Wynhoff, Sx, Xia, S, Xu, L, Yamamoto, Zz, Yang, J, Yang, Bz, Yang, Cg, Yang, Hj, Ye, M, Yeh, Jb, You, Sc, Zalite, Jm, Zalite, A, Zhang, Y, Zhao, Zp, Zhu, J, Zhu, Gy, Zhuang, Ry, Zichichi, Hl, Zilizi, A, Zimmermann, G, Zoller, B, Abbiendi, M, Acton, G, Ainsley, Pd, Akesson, C, Alexander, Pf, Allison, G, Altekamp, J, Amaral, N, Ametewee, P, Anagnostou, K, Anderson, G, Anderson, Kj, Arcelli, S, Armitage, S, Asai, Jc, Ashby, S, Ashton, Sf, Astbury, P, Axen, A, Azuelos, D, Bahan, G, Bailey, Ga, Baines, I, Jtm, Ball, Banks, Ah, Barillari, J, Barker, T, Barlow, Gj, Barnett, Rj, Bartoldus, S, Batley, R, Beaudoin, Rj, Bechtle, G, Bechtluft, P, Beck, J, Beeston, J, Behnke, C, Bell, T, Bell, An, Bell, Kw, Bella, Pj, Bellerive, G, Benelli, A, Bentvelsen, G, Berlich, S, Bethke, P, Biebel, S, Binder, O, Blobel, U, Bloodworth, V, Bloomer, Ij, Bock, Je, Boden, P, Bohme, B, Boeriu, J, Bonacorsi, O, Bosch, D, Bougerolle, Hm, Bouterneur, S, Bouwens, M, Brabson, Bt, Braibant, Bb, Breuker, S, Brigliadori, H, Brown, L, Brun, Rm, Burgin, R, Buesser, R, Burckhart, K, Burgard, Hj, Cammin, C, Campana, J, Capiluppi, S, Carnegie, P, Caron, Rk, Carter, B, Carter, Aa, Chang, Jr, Charlesworth, Cy, Charlton, C, Chrin, Dg, Jtm, Chrisman, Chu, D, Ciocca, Sl, Clarke, C, Pel, Clay, Clayton, E, Cohen, Jc, Collins, I, Conboy, Wj, Cooke, Je, Cooper, Oc, Couch, M, Couchman, M, Coupland, J, Silva, M, Coxe, Ed, Cuffiani, Rl, Dado, M, Dallapiccola, S, Dallavalle, C, Dallison, Gm, Darling, S, Jong, De, Roeck, De, Wolf, De, Debu, Ea, Deng, P, Deninno, H, Dervan, Mm, Desch, P, Dieckmann, K, Dienes, A, Dixit, B, Donkers, Ms, Doucet, M, Dubbert, M, Duboscq, J, Duchovni, Je, Duckeck, E, Duerdoth, G, Dumas, Ip, Djp, Eckerlin, Edwards, G, Jeg, Elcombe, Estabrooks, Pa, Etzion, Pg, Evans, E, Evans, Hg, Fabbri, M, Fanti, F, Fath, M, Feld, P, Fiedler, L, Fierro, F, Fincke, Keeler, Fischer, M, Fleck, Hm, Folman, I, Fong, R, Ford, Dg, Foucher, M, Frey, M, Furtjes, A, Fukui, A, Fukunaga, H, Futyan, C, Gagnon, Di, Gaidot, P, Ganel, A, Gary, O, Gascon, Jw, Gascon, Shotkin, Gaycken, Sm, Geddes, G, Geich, Gimbel, Gensler, C, Gentit, Sw, Geralis, Fx, Giacomelli, T, Giacomelli, G, Giacomelli, P, Gibson, R, Gibson, V, Gillies, Wr, Gingrich, Jd, Giunta, Dm, Glenzinski, M, Goldberg, D, Goodrick, J, Gorn, Mj, Graham, W, Grandi, K, Grant, C, Gross, Fc, Grunhaus, E, Gruwe, J, Gunther, M, Gupta, Po, Hagemann, A, Hajdu, J, Hamann, C, Hanson, M, Hansroul, Gg, Hapke, M, Harder, M, Harel, K, Hargrovet, A, Harin, Dirac, Harrison, M, Hart, Pf, Hartmann, Pa, Hattersley, C, Hauschild, Pm, Hawkes, M, Hawkings, Cm, Heflin, R, Hemingway, E, Hensel, Rj, Herten, C, Heuer, G, Hildreth, Rd, Hill, Md, Hillier, Jc, Hilse, Sj, Hinshaw, T, Ho, Da, Hoare, C, Hobbs, J, Hobson, Jd, Hochman, Pr, Hocker, D, Hoffman, A, Holl, K, Homer, B, Honma, Rj, Horvath, Ak, Hossain, D, Howard, Kr, Howarth, R, Huntemeyer, Cp, Hughes, Jones, Humbert, Re, Igo, Kemenes, Ihssen, P, Imrie, H, Ingram, Dc, Ishii, M, Jacob, K, Janissen, Fr, Jawahery, Ac, Jeffreys, A, Jeremie, Pw, Jimack, H, Jobes, M, Joly, M, Jones, T, Jones, Cr, Jost, M, Jovanovic, U, Jui, P, Joly, C, Junk, A, Kanaya, Tr, Kanzaki, N, Karapetian, J, Karlen, G, Kartvelishvili, D, Kawagoe, V, Kawamoto, K, Keeler, T, Kellogg, Rk, Kennedy, Rg, Kim, Bw, King, Dh, Kirk, Bj, Klein, J, Kleinwort, K, Klem, C, Klier, De, Kluth, A, Kobayashi, S, Kobel, T, Kopke, M, Koetke, L, Kokott, Ds, Komamiya, Tp, Kormos, S, Kowalewski, L, Kramer, R, Kral, T, Kress, Jf, Kreutzmann, T, Krieger, H, Von, Krogh, Kroll, J, Krop, J, Kruger, D, Kuhl, K, Kupper, T, Kuwano, M, Kyberd, M, Lafferty, P, Lafoux, Gd, Lahmann, H, Lai, R, Lamarche, Wp, Landsman, F, Lanske, H, Larson, D, Lauber, Wj, Lautenschlager, J, Lawson, Sr, Layter, I, Lazic, Jg, Le, Du, Leblanc, P, Lefebvre, Am, Lehto, E, Leins, Mh, Lellouch, A, Lennert, D, Leroy, P, Lessard, C, Letts, L, Levegrun, J, Levinson, S, Lewis, L, Liebisch, C, Lillich, R, Littlewood, J, Lloyd, C, Lloyd, Aw, Loebinger, Sl, Long, Fk, Lorah, Gd, Lorazo, Jm, Losty, B, Lou, Mj, Lu, Xc, Ludwig, J, Ludwig, A, Luig, J, Macchiolo, A, Macpherson, A, Mader, A, Mattig, W, Malik, P, Mannelli, A, Marcellini, M, Marchant, S, Maringer, Te, Markus, G, Martin, C, Masetti, G, Mashimo, G, Matthews, T, Maur, W, Mcdonald, U, Mcgowan, Wj, Mckenna, Rf, Mckigney, J, Mcmahon, Ea, Mcnab, Tj, Mcnutt, Ai, Mcpherson, J, Mcpherson, Ac, Meijers, Ra, Mendez, Lorenzo, Menges, P, Menke, W, Menszner, S, Merritt, D, Mes, Fs, Meyer, H, Meyer, J, Michelini, N, Middleton, A, Mihara, Rp, Mikenberg, S, Mildenberger, G, Miller, J, Dj, Milstene, Mir, C, Moed, R, Mohr, S, Moisan, W, Montanari, C, Mori, A, Morii, T, Moss, M, Mouthuy, Mw, Muller, T, Murphy, U, Mutter, Pg, Nagai, A, Nakamura, K, Nanjo, I, Neal, H, Nellen, Ha, Nguyen, B, Nijjhar, Hh, Nisius, B, Nozaki, R, Oakham, M, Odorici, Fg, Ogg, F, Ogren, M, Oh, Ho, Oh, A, Okpara, H, Oldershaw, A, Omori, Nj, Oneale, T, Oneill, Sw, Oram, Bp, Oreglia, Cj, Orito, Mj, Pahl, S, Palinkas, C, Palmonari, J, Pansart, F, Panzer, Steindel, Paschievici, B, Pasztor, P, Pater, G, Patrick, Jr, Pawley, Gn, Paz, Jaoshvili, Pearce, N, Petzold, Mj, Pfeifenschneider, S, Pfister, P, Pilcher, P, Pinfold, Je, Pitman, J, Plane, D, Poffenberger, De, Poli, P, Polok, B, Pooth, J, Posthaus, O, Pouladdej, A, Del, Poz, Prebys, La, Pritchard, E, Przybycien, Tw, Przysiezniak, M, Quadt, H, Rabbertz, A, Raith, K, Redmond, B, Rees, Mw, Rembser, Dl, Renkel, C, Richards, P, Rick, Ge, Rigby, H, Robins, D, Robinson, Sa, Rodning, D, Rollnik, N, Roney, A, Rooke, Jm, Ros, A, Rosati, E, Roscoe, S, Rossberg, K, Rossi, S, Rosvick, Am, Routenburg, M, Rozen, P, Runge, Y, Runolfsson, K, Ruppel, O, Rust, U, Rylko, Dr, Sachs, R, Saeki, K, Sahr, T, Sanghera, O, Sarkisyan, S, Ekg, Sasaki, Sbarra, M, Schaile, C, Schaile, Ad, Schappert, O, Scharf, W, Scharff, Hansen, Schenk, P, Schieck, P, von der Schmitt, Schmitt, H, Schorner, Sadenius, Schreiber, T, Schroder, S, Schutz, M, Schultz, Coulon, Schulz, Hc, Schumacher, M, Schwarz, M, Schwick, J, Schwiening, C, Scott, J, Settles, Wg, Seuster, M, Shears, R, Shen, Tg, Shepherd, Themistocleous, Sherwood, Ch, Shypit, P, Simon, R, Singh, A, Siroli, P, Sittler, Gp, Skillman, A, Skuja, A, Smith, A, Smith, Am, Snow, Tj, Sobie, Ga, Soldner, Rembold, Spagnolo, S, Spano, S, Springer, F, Sproston, Rw, Stahl, M, Starks, A, Steiert, M, Stephens, M, Steuerer, K, Stier, J, Stockhausen, He, Stoll, B, Strohmer, K, Strom, R, Strumia, D, Stumpf, F, Surrow, L, Szymanski, B, Tafirout, P, Takeda, R, Takeshita, H, Talbot, T, Tanaka, Sd, Taras, S, Tarem, P, Tasevsky, S, Taylor, M, Tecchio, Rj, Tesch, M, Teuscher, N, Thackray, R, Thiergen, Nj, Thomson, M, Von, Torne, Torrence, E, Towers, E, Toya, S, Trocsanyi, D, Tran, Z, Trefzger, P, Tresilian, T, Trigger, Nj, Tscheulin, I, Tsukamoto, M, Tsur, T, Turcot, E, Tumer, Watson, Tysarczyk, Niemeyer, Ueda, G, Ujvari, I, Utzat, B, Vachon, P, Van den Plas, Van, Kooten, Vandalen, R, Vannerem, Gj, Vasseur, P, Vertesi, G, Verzocchi, R, Vikas, M, Vincter, P, Virtue, M, Vokurka, Cj, Vollmer, Eh, Voss, Cf, Vossebeld, H, Wackerle, J, Wagner, F, Wagner, A, Wahl, Dl, Walker, C, Waller, Jp, Ward, D, Ward, Cp, Watkins, Dr, Watson, Pm, Watson, At, Weber, Nk, Weisz, P, Wels, S, Wengler, Ps, Wermes, T, Wetterling, N, Weymann, D, Whalley, M, White, Ma, Wilkens, Js, Wilson, B, Wilson, Ja, Wingerter, Gw, Winterer, I, Wood, Vh, Wotton, Nc, Wyatt, S, Yaari, Tr, Yamashita, R, Yang, S, Yeaman, Y, Yekutieli, A, Yurko, G, Zacek, M, Zacharov, V, I, Zer, Zion, Zeuner, D, Zivkovic, W, Zorn, L, Abe, Gt, Abe, K, Abt, T, Adam, I, Agnew, I, Akagi, G, Akimoto, T, Allen, H, Ash, Nj, Aston, Ww, Bacchetta, D, Baird, N, Baltay, Kg, Band, C, Barakat, Hr, Baranko, Mb, Bardon, Gj, Barklow, O, Bashindzhagian, Tl, Bauer, Gl, Bazarko, Jm, Bean, Ao, Bellodi, A, Ben, David, Benvenuti, R, Berger, Ac, Bienz, R, Bilei, T, Bisello, Gm, Blaylock, D, Bogart, G, Bolen, J, Bolton, B, Bower, T, Brau, Gr, Breidenbach, Je, Bugg, M, Burke, Wm, Burnett, D, Burrows, Th, Busza, Pn, Calcaterra, W, Caldwell, A, Camanzi, Do, Carpinelli, B, Cassell, M, Castaldi, R, Castro, R, Cavalli, Sforza, Chadwick, M, Chou, Gb, Church, A, Claus, E, Cohn, R, Coller, Ho, Convery, Ja, Cook, Mr, Cotton, V, Cowan, R, Coyle, Rf, Coyne, Pa, Crawford, Dg, Doliveira, G, Damerell, A, Cjs, Daoudi, Dasu, M, Groot, De, Sangro, De, Simone, De, Dervan, S, Dima, Pj, Dong, M, Doser, Dn, Du, M, Pyc, Dubois, Eisenstein, R, Elia, Bi, Erdos, R, Erofeeva, E, Eschenburg, I, Fahey, V, Falciai, S, Fan, D, Fernandez, C, Fero, Jp, Flood, Mj, Frey, K, Friedman, R, Furuno, Ji, Garwin, K, Gillman, El, Gladding, T, Hallewell, G, Hart, Gd, Hasegawa, El, Hasuko, Y, Hedges, K, Hertzbach, S, Hitlin, Ss, Honma, Dg, Huber, A, Huffer, Js, Hughes, Me, Huynh, Ew, Hwang, X, Iwasaki, H, Iwasaki, M, Izen, Y, Jackson, Jm, Jacques, Dj, Jaros, P, Jiang, Ja, Johnson, Zy, Johnson, As, Johnson, Jr, Junk, Ra, Kajikawa, T, Kalelkar, R, Kamyshkov, M, Kang, Ya, Karliner, Hj, Kawahara, I, Kelsey, H, Kendall, Mh, Kim, Hw, King, Yd, King, M, Kofler, R, Krishna, R, Kwon, Nm, Labs, Y, Kroeger, Jf, Langston, Rs, Lath, M, Lauber, A, Leith, Ja, Dwg, Lia, Lin, V, Liu, C, Loreti, Mx, Lu, M, Lynch, A, Ma, Hl, Mancinelli, J, Manly, G, Mantovani, S, Markiewicz, G, Maruyama, Tw, Masuda, T, Mazzucato, H, Mcgowan, H, Mckemey, Jf, Meadows, Ak, Messner, Bt, Mockett, R, Moffeit, Pm, Moore, Kc, Mours, Tb, Muller, B, Mueller, D, Murzin, G, Nagamine, V, Narita, T, Nauenberg, S, Neal, U, Nesom, H, Nussbaum, G, Ohnishi, M, Oishi, Y, Onoprienko, N, Osborne, D, Panvini, Ls, Park, Rs, Park, Ch, Pavel, H, Peruzzi, Tj, Pescara, I, Piccolo, L, Piemontese, M, Pieroni, L, Pitts, E, Plano, Kt, Prepost, Rj, Prescott, R, Punkar, Cy, Quigley, G, Ratcliff, J, Reeves, Bn, Reeves, K, Reidy, Tw, Reinertsen, J, Rensing, Pl, Rochester, Pe, Rothberg, Ls, Rowson, Je, Russell, Pc, Saxton, Jj, Schalk, Oh, Schindler, T, Schneekloth, Rh, Schumm, U, Seiden, Ba, Sen, A, Serbo, S, Shaevitz, Vv, Shank, Mh, Shapiro, Jt, Sherden, G, Shmakov, Dj, Simopoulos, Kd, Sinev, C, Smith, Nb, Smy, Sr, Snyder, Mb, Sokoloff, Ja, Staengle, Md, Starner, H, Steiner, P, Steiner, H, Strauss, R, Su, Mg, Suekane, D, Sugiyama, F, Suzuki, A, Swartz, S, Szumilo, M, Takahashi, A, Taylor, T, Thaler, Fe, Thom, Jj, Trandafir, J, Turk, Ai, Usher, Jd, Vavra, T, Vella, J, Venuti, E, Verdier, Jp, Wagner, R, Waite, Sr, Walston, Ap, Wang, S, Watts, J, Weidemann, Sj, Weiss, Aw, Whitaker, Er, White, Js, Wickens, Sl, Williams, Fj, Williams, Da, Williams, Dc, Willocq, Sh, Wilson, S, Wisniewski, Rj, Wittlin, Wj, Woods, Jl, Word, M, Wright, Gb, Wyss, Tr, Yamamoto, J, Yang, Rk, Yashima, Xq, Yellin, J, Young, Sj, Yuta, Cc, Zapalac, H, Zdarko, G, Zeitlin, Rw, Zhou, C, Blondel, Alain, Schael, S, Barate, R, Bruneliere, R, Spagnolo, Stefania Antonia, S., Schael, Aloisio, Alberto, Alviggi, Mariagrazia, Canale, Vincenzo, Chiefari, Giovanni, DELLA VOLPE, Domenico, Merola, Leonardo, Napolitano, Marco, Patricelli, Sergio, Sciacca, Crisostomo, Lista, Luca, Laboratoire d'Annecy de Physique des Particules (LAPP), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Physique Corpusculaire - Clermont-Ferrand (LPC), Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Physique Théorique et Astroparticules (LPTA), Université Montpellier 2 - Sciences et Techniques (UM2)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Laboratoire Leprince-Ringuet (LLR), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-École polytechnique (X)-Centre National de la Recherche Scientifique (CNRS), Centre de Physique des Particules de Marseille (CPPM), Aix Marseille Université (AMU)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de l'Accélérateur Linéaire (LAL), Université Paris-Sud - Paris 11 (UP11)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Physique Nucléaire et de Hautes Énergies (LPNHE), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Physique Subatomique et de Cosmologie (LPSC), Université Joseph Fourier - Grenoble 1 (UJF)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Institut Polytechnique de Grenoble - Grenoble Institute of Technology-Centre National de la Recherche Scientifique (CNRS), Institut de Physique Nucléaire de Lyon (IPNL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Institut de Recherches Subatomiques (IReS), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Cancéropôle du Grand Est-Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS), Physique Corpusculaire et Cosmologie - Collège de France (PCC), Collège de France (CdF (institution))-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), ALEPH, DELPHI, L3, OPAL, SLD, BARBIELLINI AMIDEI, Guido, Bosisio, Luciano, DELLA RICCA, Giuseppe, Giannini, Gianrossano, Gregorio, Anna, Lanceri, Livio, Poropat, Paolo, Vitale, Lorenzo, Buskulic, D, De Bonis, I, Decamp, D, Ghez, P, Goy, C, Jezequel, S, Lees, J, Lucotte, A, Martin, F, Merle, E, Minard, M, Nief, J, Odier, P, Pietrzyk, B, Trocme, B, Bravo, S, Casado, M, Chmeissani, M, Comas, P, Crespo, J, Fernandez, E, Fernandez Bosman, M, Garrido, L, Grauges, E, Juste, A, Martinez, M, Merino, G, Miquel, R, Mir, L, Orteu, S, Pacheco, A, Park, I, Perlas, J, Riu, I, Ruiz, H, Sanchez, F, Colaleo, A, Creanza, D, De Filippis, N, De Palma, M, Iaselli, G, Maggi, G, Maggi, M, Nuzzo, S, Ranieri, A, Raso, G, Ruggieri, F, Selvaggi, G, Silvestris, L, Tempesta, P, Tricomi, A, Zito, G, Huang, X, Lin, J, Ouyang, Q, Wang, T, Xie, Y, Xu, R, Xue, S, Zhang, J, Zhang, L, Zhao, W, Abbaneo, D, Bazarko, A, Becker, U, Boix, G, Bird, F, Blucher, E, Bonvicini, B, Bright Thomas, P, Barklow, T, Buchmuller, O, Cattaneo, M, Cerutti, F, Ciulli, V, Clerbaux, B, Drevermann, H, Forty, R, Frank, M, Greening, T, Hagelberg, R, Halley, A, Gianotti, F, Girone, M, Hansen, J, Harvey, J, Jacobsen, R, Hutchcroft, D, Janot, R, Jost, B, Knobloch, J, Kado, M, Lehraus, I, Lazeyras, P, Maley, R, Mato, P, May, J, Moutussi, A, Pepe Altarelli, M, Ranjard, F, Rolandi, L, Schlatter, D, Schmitt, B, Schneider, O, Tejessy, W, Teubert, F, Tomalin, I, Tournefier, E, Veenhof, R, Valassi, A, Wiedenmann, W, Wright, A, Ajaltouni, Z, Badaud, F, Chazelle, G, Deschamps, O, Dessagne, S, Falvard, A, Ferdi, C, Fayolle, D, Gay, P, Guicheney, C, Henrard, P, Jousset, J, Michel, B, Monteil, S, Montret, J, Pallin, D, Pascolo, J, Perret, P, Podlyski, F, Bertelsen, H, Fernley, T, Hansen, P, Kraan, A, Lindahl, A, Mollerud, R, Nilsson, B, Rensch, B, Waananen, A, Daskalakis, G, Kyriakis, A, Markou, C, Simopoulou, E, Siotis, I, Vayaki, A, Zachariadou, K, Blondel, A, Bonneaud, G, Brient, J, Machefert, E, Rouge, A, Rumpf, M, Swynghedauw, M, Tanaka, R, Verderi, M, Videau, H, Focardi, E, Parrini, G, Corden, M, Georgiopoulos, C, Antonelli, A, Antonelli, M, Bencivenni, G, Bologna, G, Bossi, F, Campana, P, Capon, G, Chiarella, V, Felici, G, Laurelli, P, Mannocchi, G, Murtas, G, Passalacqua, L, Picchi, P, Colrain, P, Ten Have, I, Hughes, I, Kennedy, J, Knowles, I, Lynch, J, Morton, W, Negus, P, O'Shea, V, Raine, C, Reeves, P, Scarr, J, Smith, K, Thompson, A, Turnbull, R, Wasserbaech, S, Cavanaugh, R, Dhamotharan, S, Geweniger, C, Hanke, P, Hansper, G, Hepp, V, Kluge, E, Putzer, A, Sommer, J, Stenzel, H, Tittel, K, Werner, W, Wunsch, M, Beuselinck, R, Binnie, D, Cameron, W, Davies, G, Dornan, P, Goodsir, S, Marinelli, N, Martin, E, Nash, J, Nowell, J, Rutherford, S, Sedgbeer, J, Thompson, J, White, R, Williams, M, Ghete, V, Girtler, P, Kneringer, E, Kuhn, D, Rudolph, G, Bouhova Thacker, E, Bowdery, C, Buck, P, Clarke, D, Ellis, G, Finch, A, Foster, F, Hughes, G, Jones, R, Keemer, N, Pearson, M, Robertson, N, Sloan, T, Smizanska, M, Snow, S, Van Der Aa, O, Delaere, C, Leibenguth, G, Lemaitre, V, Bauerdick, L, Blumenschein, U, Van Gemmeren, P, Giehl, I, Holldorfer, F, Jakobs, K, Kasemann, M, Kayser, F, Kleinknecht, K, Muller, A, Quast, G, Renk, B, Rohne, E, Sander, H, Schmeling, S, Wachsmuth, H, Wanke, R, Zeitnitz, C, Ziegler, T, Aubert, J, Benchouk, C, Bonissent, A, Carr, J, Coyle, P, Curtil, C, Ealet, A, Etienne, F, Fouchez, D, Motsch, F, Payre, P, Rousseau, D, Tilquin, A, Talby, M, Thulasides, M, Aleppo, M, Ragusa, F, Buscher, V, David, A, Dietl, H, Ganis, G, Huttmann, K, Lutjens, G, Mannert, C, Manner, W, Moser, H, Settles, R, Seywerd, H, Villegas, M, Wolf, G, Azzurri, P, Boucrot, J, Callot, O, Chen, S, Cordier, A, Davier, M, Duflot, L, Grivaz, J, Heusse, P, Jacholkowska, A, Le Diberder, F, Lefrancois, J, Mutz, A, Schune, M, Serin, L, Veillet, J, Videau, I, Zerwas, D, Bagliesi, G, Bettarini, S, Boccali, T, Bozzi, C, Calderini, G, Dell'Orso, R, Fantechi, R, Ferrante, I, Fidecaro, F, Foa, L, Giammanco, A, Giassi, A, Gregorio, A, Ligabue, F, Lusiani, A, Marrocchesi, P, Messineo, A, Palla, F, Rizzo, G, Sanguinetti, G, Sciaba, A, Sguazzoni, G, Spagnolo, P, Steinberger, J, Tenchini, R, Venturi, A, Vannini, C, Verdini, P, Awunor, O, Blair, G, Cowan, G, Garcia Bellido, A, Green, M, Medcalf, T, Misiejuk, A, Strong, J, Teixeira Dias, P, Botterill, D, Clifft, R, Edgecock, T, Edwards, M, Haywood, S, Norton, P, Ward, J, Bloch Devaux, B, Boumediene, D, Colas, P, Emery, S, Fabbro, B, Kozanecki, W, Lancon, E, Lemaire, M, Locci, E, Perez, P, Rander, J, Renardy, J, Roussarie, A, Schuller, J, Schwindling, J, Tuchming, B, Vallage, B, Black, S, Dann, J, Kim, H, Konstantinidis, N, Litke, A, Mcneil, M, Taylor, G, Booth, C, Cartwright, S, Combley, F, Hodgson, P, Lehto, M, Thompson, L, Affholderbach, K, Barberio, E, Bohrer, A, Brandt, S, Burkhardt, H, Feigl, E, Grupen, C, Hess, J, Lutters, G, Meinhard, H, Minguet Rodriguez, J, Mirabito, L, Neugebauer, E, Ngac, A, Prange, G, Rivera, F, Saraiva, P, Schafer, U, Sieler, U, Smolik, L, Stephan, F, Trier, H, Apollonio, M, Borean, C, Bosisio, L, Della Marina, R, Giannini, G, Gobbo, B, Musolino, G, Pitis, L, He, H, Putz, J, Rothberg, J, Armstrong, S, Bellantoni, L, Berkelman, K, Cinabro, D, Conway, J, Cranmer, K, Elmer, P, Feng, Z, Ferguson, D, Gao, Y, Gonzalez, S, Grahl, J, Harton, J, Hayes, O, Hu, H, Jin, S, Johnson, R, Kile, J, Mcnamara, P, Nielsen, J, Orejudos, W, Pan, Y, Saadi, Y, Scott, I, Sharma, V, Walsh, A, Walsh, J, Wear, J, Von Wimmersperg Toeller, J, Wu, J, Wu, S, Wu, X, Yamartino, J, Zobernig, G, Dissertori, G, Abdallah, J, Abreu, P, Adam, W, Adye, T, Adzic, P, Ajinenko, I, Albrecht, T, Alderweireld, T, Alekseev, G, Alemany Fernandez, R, Allmendinger, T, Allport, P, Almehed, S, Amaldi, U, Amapane, N, Amato, S, Anashkin, E, Anassontzis, E, Andersson, P, Andreazza, A, Andringa, S, Anjos, N, Antilous, P, Apel, W, Arnoud, Y, Ask, S, Asman, B, Augustin, J, Augustinus, A, Baillon, P, Ballestrero, A, Bambade, P, Barao, F, Barbiellini, G, Barbier, R, Bardin, D, Barker, G, Baroncelli, A, Battaglia, M, Baubillier, M, Becks, K, Begalli, M, Behrmann, A, Beilliere, P, Belokopytov, Y, Belous, K, Ben Haim, E, Benekos, N, Benvenuti, A, Berat, C, Berggren, M, Berntzon, L, Bertini, D, Bertrand, D, Besancon, M, Besson, N, Bianchi, F, Bigi, M, Bilenky, M, Bizouard, M, Bloch, D, Blom, M, Bluj, M, Bonesini, M, Bonivento, W, Boonekamp, M, Booth, P, Borgland, A, Borisov, G, Bosio, C, Botner, O, Boudinov, E, Bouquet, B, Bourdarios, C, Bowcock, T, Boyko, I, Bozovic, I, Bozzo, M, Bracko, M, Branchini, P, Brenke, T, Brenner, R, Brodet, E, Bruckman, P, Brunet, J, Bugge, L, Buran, T, Burgsmueller, T, Buschbeck, B, Buschmann, P, Cabrera, S, Caccia, M, Calvi, M, Rozas, A, Camporesi, T, Canale, V, Canepa, M, Carena, F, Carroll, L, Caso, C, Gimenez, M, Castro, N, Cattai, A, Cavallo, F, Cerruti, C, Chabaud, V, Chapkin, M, Charpentier, P, Chaussard, L, Checchia, P, Chelkov, G, Chen, M, Chierici, R, Chliapnikov, R, Chochula, P, Chorowicz, V, Chudoba, J, Chung, S, Cieslik, K, Collins, P, Colomer, M, Contri, R, Cortina, E, Cosme, G, Cossuti, F, Costa, M, Cowell, J, Crawley, H, Crennell, D, Crepe, S, Crosetti, G, Cuevas, J, Czellar, S, D'Hondt, J, Dalmagne, B, Dalmau, J, Damgaard, G, Davenport, M, Da Silva, T, Da Silva, W, Deghorain, A, Della Ricca, G, Delpierre, P, Demaria, N, De Angelis, A, De Boer, W, De Brabandere, S, De Clercq, C, De Lotto, B, De Maria, N, De Min, A, De Paula, L, Dijkstra, H, Di Ciaccio, L, Di Diodato, A, Di Simone, A, Djannati, A, Dolbeau, J, Doroba, K, Dracos, M, Drees, J, Drees, K, Dris, M, Duperrin, A, Durand, J, Ehret, R, Eigen, G, Ekelof, T, Ekspong, G, Ellert, M, Elsing, M, Engel, J, Erzen, B, Santo, M, Falk, E, Fanourakis, G, Fassouliotis, D, Fayot, J, Feindt, M, Fenyuk, A, Fernandez, J, Ferrari, P, Ferrer, A, Ferrer Ribas, E, Ferro, F, Fichet, S, Firestone, A, Fischer, P, Flagmeyer, U, Foeth, H, Fokitis, E, Fontanelli, F, Franek, B, Frodesen, A, Fruhwirth, R, Fulda Quenzer, F, Fuster, J, Galloni, A, Gamba, D, Gamblin, S, Gandelman, M, Garcia, C, Garcia, J, Gaspar, C, Gaspar, M, Gasparini, U, Gavillet, P, Gazis, E, Gele, D, Gerber, J, Gerdyukov, L, Ghodbane, N, Gil, I, Glege, F, Gokieli, R, Golob, B, Gomez Ceballos, G, Goncalves, P, Caballero, I, Gopal, G, Gorn, L, Gorski, M, Gouz, Y, Gracco, V, Graziani, E, Green, C, Grefrath, A, Grimm, H, Gris, P, Grosdidier, G, Grzelak, K, Gunther, M, Guy, J, Haag, C, Hahn, F, Hahn, S, Hallgren, A, Hamacher, K, Hamilton, K, Harris, F, Haug, S, Hauler, F, Hedberg, V, Heising, S, Hennecke, M, Henriques, R, Hernandez, J, Herquet, P, Herr, H, Hessing, T, Heuser, J, Higon, E, Hoffman, J, Holmgren, S, Holt, P, Holthuizen, D, Hoorelbeke, S, Houlden, M, Hrubec, J, Huber, M, Huet, K, Hultqvist, K, Jackson, J, Jacobsson, R, Jalocha, P, Janik, R, Jarlskog, C, Jarlskog, G, Jarry, P, Jean Marie, B, Jeans, D, Johansson, E, Johansson, P, Jonsson, P, Joram, C, Juillot, P, Jungermann, L, Kapusta, F, Karafasoulis, K, Katsanevas, S, Katsoufis, E, Keranen, R, Kernel, G, Kersevan, B, Kerzel, U, Khomenko, B, Khovanski, N, Kiiskinen, A, King, B, Kinvig, A, Kjaer, N, Klapp, O, Klein, H, Kluit, P, Knoblauch, D, Kokkinias, P, Konopliannikov, A, Koratzinos, M, Kostioukhine, V, Kourkoumelis, C, Kouznetsov, O, Krammer, M, Kreuter, C, Kriznic, E, Krstic, J, Krumstein, Z, Kubinec, P, Kucewicz, W, Kucharczyk, M, Kurowska, J, Kurvinen, K, Lamsa, J, Lanceri, L, Lane, D, Langefeld, P, Lapin, V, Laugier, J, Lauhakangas, R, Leder, G, Ledroit, F, Lefebure, V, Leinonen, L, Leisos, A, Leitner, R, Lemonne, J, Lenzen, G, Lepeltier, V, Lesiak, T, Lethuillier, M, Libby, J, Liebig, W, Liko, D, Lipniacka, A, Lippi, I, Loerstad, B, Lokajicek, M, Loken, J, Lopes, J, Lopez, J, Lopez Femandez, R, Loukas, D, Lutz, P, Lyons, L, Macnaughton, J, Mahon, J, Maio, A, Malek, A, Malmgren, T, Maltezos, S, Malychev, V, Mandl, F, Marco, J, Marco, R, Marechal, B, Margoni, M, Marin, J, Mariotti, C, Markou, A, Martinez Rivero, C, Martinez Vidal, F, Garcia, S, Masik, J, Mastroyiannopoulos, N, Matorras, F, Matteuzzi, C, Matthiae, G, Mazik, J, Mazzucato, F, Mazzucato, M, Mccubbin, M, Mckay, R, Mcnulty, R, Meroni, C, Meyer, W, Miagkov, A, Migliore, E, Mitaroff, W, Mjoernmark, U, Moa, T, Moch, M, Moeller, R, Moenig, K, Monge, R, Montenegro, J, Moraes, D, Moreau, X, Moreno, S, Morettini, P, Morton, G, Mueller, U, Muenich, K, Mulders, M, Mulet Marquis, C, Mundim, L, Muresan, R, Murray, W, Muryn, B, Myatt, G, Myklebust, T, Naraghi, F, Nassiakou, M, Navarria, F, Navas, S, Nawrocki, K, Negri, P, Neufeld, N, Neumann, W, Neumeister, N, Nicolaidou, R, Nielsen, B, Nieuwenhuizen, M, Niezurawski, P, Nikolaenko, V, Nikolenko, M, Nomokonov, V, Normand, A, Nygren, A, Oblakowska Mucha, A, Obraztsov, V, Olshevski, A, Onofre, A, Orava, R, Orazi, G, Osterberg, K, Ouraou, A, Oyanguren, A, Paganini, P, Paganoni, M, Paiano, S, Pain, R, Paiva, R, Palacios, J, Palka, H, Papadopoulou, T, Papageorgiou, K, Pape, L, Parkes, C, Parodi, F, Parzefall, U, Passeri, A, Passon, O, Pavel, T, Pegoraro, M, Peralta, L, Perepelitsa, V, Pernicka, M, Perrotta, A, Petridou, C, Petrolini, A, Philips, H, Piana, G, Piedra, J, Pieri, L, Pierre, F, Pimenta, M, Piotto, E, Podobnik, T, Poireau, V, Pol, M, Polok, G, Polycarpo, E, Poropat, P, Pozdniakov, V, Privitera, R, Pukhaeva, N, Pullia, A, Radojicic, D, Ragazzi, S, Rahmani, H, Rakoczy, D, Rames, J, Ramler, L, Ratoff, P, Read, A, Rebecchi, P, Redaelli, N, Regler, M, Rehn, J, Reid, D, Reinhardt, R, Renton, P, Resvanis, L, Richard, F, Ridky, J, Rinaudo, G, Ripp Baudot, I, Rivero, M, Rodriguez, D, Rohne, O, Romero, A, Ronchese, P, Rosenberg, E, Rosinsky, P, Roudeau, R, Rovelli, T, Royon, C, Ruhlmann Kleider, V, Ruiz, A, Ryabtchikov, D, Saarikko, H, Sacquin, Y, Sadovsky, A, Sajot, G, Salmi, L, Salt, J, Sampsonidis, D, Sannino, M, Savoy Navarro, A, Scheidle, T, Schneider, H, Schwemling, P, Schwering, B, Schwickerath, U, Schyns, M, Scuri, F, Seager, P, Sedykh, Y, Segar, A, Seibert, N, Sekulin, R, Shellard, R, Sheridan, A, Siebel, M, Silvestre, R, Simard, L, Simonetto, F, Sisakian, A, Skaali, T, Smadja, G, Smirnov, N, Smirnova, O, Smith, G, Sokolov, A, Sopczak, A, Sosnowski, R, Spassov, T, Spiriti, E, Sponholz, P, Squarcia, S, Stampfer, D, Stanescu, C, Stanic, S, Stanitzki, M, Stapnes, S, Stevenson, K, Stocchi, A, Strauss, J, Strub, R, Stugu, B, Szczekowski, M, Szeptycka, M, Szumlak, T, TABARELLI DE FATIS, T, Taffard, A, Tegenfeldt, F, Terranova, F, Thomas, J, Timmermans, J, Tinti, N, Tkatchev, L, Tobin, M, Todorov, T, Todorovova, S, Toet, D, Tomaradze, A, Tome, B, Tonazzo, A, Tortora, L, Tortosa, P, Transtromer, G, Travnicek, P, Treille, D, Tristram, G, Trochimczuk, M, Trombini, A, Troncon, C, Tsirou, A, Turluer, M, Tyapkin, I, Tyapkin, P, Tzamarias, S, Ullaland, O, Uvarov, V, Valenti, G, Vallazza, E, Vander Velde, C, Van Apeldoorn, G, Van Dam, P, Van Den Boeck, W, Van Doninck, W, Van Eldik, J, Van Lysebetten, A, Van Remortel, N, Van Vulpen, I, Vassilopoulos, N, Vegni, G, Velos, F, Ventura, L, Venus, W, Verbeure, F, Verdier, P, Verlato, M, Vertogradov, L, Verzi, V, Vilanova, D, Vitale, L, Vlasov, E, Vodopyanov, A, Vollmer, C, Voulgaris, G, Vrba, V, Wahlen, H, Walck, C, Washbrook, A, Weiser, C, Wetherell, A, Wicke, D, Wickens, J, Wilkinson, G, Winter, M, Witek, M, Wlodek, T, Yi, J, Yushchenko, O, Zaitsev, A, Zalewska, A, Zalewski, P, Zavrtanik, D, Zevgolatakos, E, Zhuravlov, V, Zimin, N, Zintchenko, A, Zoller, P, Zucchelli, G, Zumerle, G, Zupan, M, Acciarri, M, Achard, P, Adriani, O, Aguilar Benitez, M, Alcaraz, J, Alemanni, G, Allaby, J, Aloisio, A, Alviggi, M, Ambrosi, G, Anderhub, H, Andreev, V, Angelescu, T, Anselmo, F, Arefiev, A, Azemoon, T, Aziz, T, Bagnaia, P, Bajo, A, Baksay, G, Baksay, L, Balandras, A, Baldew, S, Ball, R, Banerjee, S, Barczyk, A, Barillere, R, Barone, L, Bartalini, P, Basile, M, Batalova, N, Battiston, R, Bay, A, Becattini, F, Behner, F, Bellucci, L, Berbeco, R, Berdugo, J, Berges, P, Bertucci, B, Betev, B, Bhattacharya, S, Biasini, M, Biglietti, M, Biland, A, Blaising, J, Blyth, S, Bobbink, B, Bohm, A, Boldizsar, L, Borgia, B, Bottai, S, Bourilkov, D, Bourquin, M, Braccini, S, Branson, J, Brigljevic, V, Brochu, F, Brock, I, Buffini, A, Buijs, A, Burger, J, Burger, W, Button, A, Cai, X, Campanelli, M, Capell, M, Romeo, G, Carlino, G, Cartacci, A, Casaus, J, Castellini, G, Cavallari, E, Cavallo, N, Cecchi, C, Cerrada, M, Cesaroni, F, Chamizo, M, Chang, Y, Chaturvedi, U, Chemarin, M, Chen, A, Chen, G, Chen, H, Chiefari, G, Cifarelli, L, Cindolo, F, Civinini, C, Clare, I, Clare, R, Coignet, G, Colijn, A, Colino, N, Costantini, S, Cotorobai, F, Cozzoni, B, De La Cruz, B, Csilling, A, Cucciarelli, S, Dai, T, Van Dalen, J, D'Alessandro, R, De Asmundis, R, Debreczeni, J, Deglon, P, Degre, P, Dehmelt, K, Deiters, K, Della Volpe, D, Delmeire, E, Denes, P, Denotaristefani, F, De Salvo, A, Diemoz, M, Dierckxsens, M, Van Dierendonck, D, Di Lodovico, F, Dionisi, C, Dittmar, M, Dominguez, A, Doria, A, Dova, M, Duchesneau, D, Dufournaud, D, Duda, M, Duinker, P, Duran, I, Dutta, S, Echenard, B, Eline, A, El Hage, A, El Mamouni, H, Engler, A, Eppling, F, Erne, F, Extermann, P, Fabre, M, Faccini, R, Falagan, M, Falciano, S, Favara, A, Fay, J, Fedin, O, Felcini, M, Ferguson, T, Ferroni, F, Fesefeldt, H, Fiandrini, E, Field, J, Filthaut, F, Fisher, P, Fisher, W, Fisk, I, Forconi, G, Fredj, L, Freudenreich, K, Furetta, C, Galaktionov, Y, Ganguli, S, Garcia Abia, P, Gataullin, M, Gau, S, Gentile, S, Gheordanescu, N, Giagu, S, Gong, Z, Grenier, G, Grimm, O, Gruenewald, M, Guida, M, Van Gulik, R, Van Gupta, V, Gurtu, A, Gutay, L, Haas, D, Hasan, A, Hatzifotiadou, D, Hebbeker, T, Herve, A, Hidas, P, Hirschfelder, J, Hofer, H, Hohlmann, M, Holzner, G, Hoorani, H, Hou, S, Lashvili, I, Innocente, V, Jin, B, Jindal, P, Jones, L, Dejong, P, Josa Mutuberria, I, Khan, R, Kaur, M, Kienzle Focacci, M, Kim, D, Kim, J, Kirkby, J, Kiss, D, Kittel, W, Klimentov, A, Konig, A, Koffeman, E, Kopal, M, Kopp, A, Koutsenko, V, Kraber, M, Kraemer, R, Krenz, W, Kruger, A, Kuijten, H, Kunin, A, De Guevara, P, Laktineh, I, Landi, G, Lassila Perini, K, Lebeau, M, Lebedev, A, Lebrun, P, Lecomte, P, Lecoq, P, Le Coultre, P, Lee, H, Le Goff, J, Leiste, R, Leonardi, E, Levtchenko, M, Levtchenko, P, Li, C, Likhoded, S, Lin, C, Lin, W, Linde, F, Lista, L, Liu, Z, Lohmann, W, Longo, E, Lu, Y, Lu, W, Lubelsmeyer, K, Luci, C, Luckey, D, Luminari, L, Lugnier, L, Lustermann, W, Ma, W, Maity, M, Malgeri, L, Malinin, A, Mana, C, Mangeol, D, Mans, J, Marchesini, P, Marian, G, Martin, J, Marzano, F, Massaro, G, Mazumdar, K, Mcneil, R, Mele, S, Merola, L, Merk, M, Meschini, M, Metzger, W, Von Der Mey, M, Mihul, A, Milcent, H, Mirabelli, G, Mnich, J, Mohanty, G, Molnar, P, Monteleoni, B, Moulik, T, Muanza, G, Muheim, F, Muijs, A, Musicar, B, Musy, M, Nagy, S, Natale, S, Napolitano, M, Nessi Tedaldi, F, Newman, H, Niessen, T, Nisati, A, Novak, I, Nowak, H, Ofierzynski, R, Organtini, G, Oulianov, A, Pal, I, Palomares, C, Pandoulas, D, Paoletti, S, Paoloni, A, Paolucci, P, Paramatti, R, Park, H, Pascale, G, Passaleva, G, Patricelli, S, Paul, T, Pauluzzi, M, Paus, C, Pauss, F, Peach, D, Pedace, M, Pensotti, S, Perret Gallix, D, Petersen, B, Piccolo, D, Pierella, F, Pieri, M, Pioppi, M, Piroue, P, Pistolesi, E, Plyaskin, V, Pohl, M, Pojidaev, V, Postema, H, Pothier, J, Produit, N, Prokofiev, D, Quartieri, J, Rahal Callot, G, Rahaman, M, Raics, P, Raja, N, Ramelli, R, Rancoita, P, Ranieri, R, Raspereza, A, Razis, P, Ren, D, Rescigno, M, Reucroft, S, Van Rhee, T, Riemann, S, Riles, K, Robohm, A, Rodin, J, Roe, B, Romero, L, Rosca, A, Rosemann, C, Rosenbleck, C, Rosier Lees, S, Roth, S, Rubio, J, Ruggiero, G, Ruschmeier, D, Rykaczewski, H, Sakharov, A, Saremi, S, Sarkar, S, Salicio, J, Sanchez, E, Sanders, M, Sarakinos, M, Schafer, C, Schegelsky, V, Schmidt Kaerst, S, Schmitz, D, Schopper, H, Schotanus, D, Schwering, G, Sciacca, C, Sciarrino, D, Seganti, A, Servoli, L, Shevchenko, S, Shivarov, N, Shoutko, V, Shumilov, E, Shvorob, A, Siedenburg, T, Son, D, Smith, B, Souga, C, Spillantini, P, Steuer, M, Stickland, D, Stone, A, Stone, H, Stoyanov, B, Straessner, A, Sudhakar, K, Sultanov, G, Sun, L, Sushkov, S, Suter, H, Swain, J, Szillasi, Z, Sztaricskai, T, Tang, X, Tarjan, P, Tauscher, L, Taylor, L, Tellili, B, Teyssier, D, Timmermans, C, Ting, S, Tonwar, S, Toth, J, Tully, C, Tung, K, Uchida, Y, Ulbricht, J, Uwer, U, Valente, E, Van De Walle, R, Vasquez, R, Veszpremi, V, Vesztergombi, G, Vetlitsky, I, Vicinanza, D, Viertel, G, Villa, S, Vivargent, M, Vlachos, S, Vodopianov, I, Vogel, H, Vogt, H, Vorobiev, I, Vorobyov, A, Vorvolakos, A, Wadhwa, M, Wallraff, W, Wang, Q, Wang, X, Wang, Z, Weber, A, Weber, M, Wienemann, P, Wilkens, H, Wynhoff, S, Xia, L, Xu, Z, Yamamoto, J, Yang, B, Yang, C, Yang, H, Yang, M, Ye, J, Yeh, S, You, J, Zalite, A, Zalite, Y, Zhang, Z, Zhao, J, Zhu, G, Zhu, R, Zhuang, H, Zichichi, A, Zilizi, G, Zimmermann, B, Zoller, M, Abbiendi, G, Acton, P, Ainsley, C, Akesson, P, Alexander, G, Allison, J, Altekamp, N, Amaral, P, Ametewee, K, Anagnostou, G, Anderson, K, Anderson, S, Arcelli, S, Armitage, J, Asai, S, Ashby, S, Ashton, P, Astbury, A, Axen, D, Azuelos, G, Bahan, G, Bailey, I, Baines, J, Ball, A, Banks, J, Barillari, T, Barlow, R, Barnett, S, Bartoldus, R, Batley, R, Beaudoin, G, Bechtle, P, Bechtluft, J, Beck, A, Becker, J, Beeston, C, Behnke, T, Bell, A, Bell, K, Bell, P, Bella, G, Bellerive, A, Benelli, G, Bentvelsen, S, Berlich, P, Bethke, S, Biebel, O, Binder, U, Blobel, V, Bloodworth, I, Bloomer, J, Bock, P, Boden, B, Bohme, J, Boeriu, O, Bonacorsi, D, Bosch, H, Bougerolle, S, Bouterneur, M, Bouwens, B, Brabson, B, Braibant, S, Breuker, H, Brigliadori, L, Brown, R, Brun, R, Burgin, R, Buesser, K, Burckhart, H, Burgard, C, Cammin, J, Campana, S, Capiluppi, P, Carnegie, R, Caron, B, Carter, A, Carter, J, Chang, C, Charlesworth, C, Charlton, D, Chrin, J, Chrisman, D, Chu, S, Ciocca, C, Clarke, P, Clay, E, Clayton, J, Cohen, I, Collins, W, Conboy, J, Cooke, O, Cooper, M, Couch, M, Couchman, J, Coupland, M, Silva, E, Coxe, R, Cuffiani, M, Dado, S, Dallapiccola, C, Dallavalle, G, Dallison, S, Darling, C, De Jong, S, De Roeck, A, De Wolf, E, Debu, P, Deng, H, Deninno, M, Dervan, P, Desch, K, Dieckmann, A, Dienes, B, Dixit, M, Donkers, M, Doucet, M, Dubbert, J, Duboscq, J, Duchovni, E, Duckeck, G, Duerdoth, I, Dumas, D, Eckerlin, G, Edwards, J, Elcombe, P, Estabrooks, P, Etzion, E, Evans, H, Evans, M, Fabbri, F, Fanti, M, Fath, P, Feld, L, Fiedler, F, Fierro, M, Fincke Keeler, M, Fischer, H, Fleck, I, Folman, R, Fong, D, Ford, M, Foucher, M, Frey, A, Furtjes, A, Fukui, H, Fukunaga, C, Futyan, D, Gagnon, P, Gaidot, A, Ganel, O, Gary, J, Gascon, J, Gascon Shotkin, S, Gaycken, G, Geddes, N, Geich Gimbel, C, Gensler, S, Gentit, F, Geralis, T, Giacomelli, G, Giacomelli, P, Giacomelli, R, Gibson, V, Gibson, W, Gillies, J, Gingrich, D, Giunta, M, Glenzinski, D, Goldberg, J, Goodrick, M, Gorn, W, Graham, K, Grandi, C, Grant, F, Gross, E, Grunhaus, J, Gruwe, M, Gunther, P, Gupta, A, Hagemann, J, Hajdu, C, Hamann, M, Hanson, G, Hansroul, M, Hapke, M, Harder, K, Harel, A, Hargrovet, C, Harin Dirac, M, Harrison, P, Hart, P, Hartmann, C, Hattersley, P, Hauschild, M, Hawkes, C, Hawkings, R, Heflin, E, Hemingway, R, Hensel, C, Herten, G, Heuer, R, Hildreth, M, Hill, J, Hillier, S, Hilse, T, Hinshaw, D, Ho, C, Hoare, J, Hobbs, J, Hobson, P, Hochman, D, Hocker, A, Hoffman, K, Holl, B, Homer, R, Honma, A, Horvath, D, Hossain, K, Howard, R, Howarth, C, Huntemeyer, P, Hughes Jones, R, Humbert, R, Igo Kemenes, P, Ihssen, H, Imrie, D, Ingram, M, Ishii, K, Jacob, F, Janissen, A, Jawahery, A, Jeffreys, P, Jeremie, H, Jimack, M, Jobes, M, Joly, T, Jones, C, Jones, G, Jones, M, Jost, U, Jovanovic, P, Jui, C, Joly, A, Junk, T, Kanaya, N, Kanzaki, J, Karapetian, G, Karlen, D, Kartvelishvili, V, Kawagoe, K, Kawamoto, T, Keeler, R, Kellogg, R, Kennedy, B, Kirk, J, Klein, K, Kleinwort, C, Klem, D, Klier, A, Kluth, S, Kobayashi, T, Kobel, M, Kopke, L, Koetke, D, Kokott, T, Komamiya, S, Kormos, L, Kowalewski, R, Kramer, T, Kral, J, Kress, T, Kreutzmann, H, Krieger, P, Von Krogh, J, Kroll, J, Krop, D, Kruger, K, Kuhl, T, Kupper, M, Kuwano, M, Kyberd, P, Lafferty, G, Lafoux, H, Lahmann, R, Lai, W, Lamarche, F, Landsman, H, Lanske, D, Larson, W, Lauber, J, Lautenschlager, S, Lawson, I, Layter, J, Lazic, D, Le Du, P, Leblanc, P, Lee, A, Lefebvre, E, Leins, A, Lellouch, D, Lennert, P, Leroy, C, Lessard, L, Letts, J, Levegrun, S, Levinson, L, Lewis, C, Liebisch, R, Lillich, J, Littlewood, C, Lloyd, A, Lloyd, S, Loebinger, F, Long, G, Lorah, J, Lorazo, B, Losty, M, Lou, X, Lu, J, Ludwig, A, Ludwig, J, Luig, A, Macchiolo, A, Macpherson, A, Mader, W, Mattig, P, Malik, A, Mannelli, M, Marcellini, S, Marchant, T, Maringer, G, Markus, C, Martin, A, Martinez, G, Masetti, G, Mashimo, T, Matthews, W, Maur, U, Mcdonald, W, Mcgowan, R, Mckenna, J, Mckigney, E, Mcmahon, T, Mcnab, A, Mcnutt, J, Mcpherson, A, Mcpherson, R, Meijers, F, Mendez Lorenzo, P, Menges, W, Menke, S, Menszner, D, Merritt, F, Mes, H, Meyer, J, Meyer, N, Michelini, A, Middleton, R, Mihara, S, Mikenberg, G, Mildenberger, J, Miller, D, Milstene, C, Mir, R, Moed, S, Mohr, W, Moisan, C, Montanari, A, Mori, T, Morii, M, Moss, M, Mouthuy, T, Muller, U, Murphy, P, Mutter, A, Nagai, K, Nakamura, I, Nanjo, H, Neal, H, Nellen, B, Nguyen, H, Nijjhar, B, Nisius, R, Nozaki, M, Oakham, F, Odorici, F, Ogg, M, Ogren, H, Oh, A, Oh, H, Okpara, A, Oldershaw, N, Omori, T, O'Neale, S, O'Neill, B, Oram, C, Oreglia, M, Orito, S, Pahl, C, Palinkas, J, Palmonari, F, Pansart, J, Panzer Steindel, B, Paschievici, P, Pasztor, G, Pater, J, Patrick, G, Pawley, S, Paz Jaoshvili, N, Pearce, M, Petzold, S, Pfeifenschneider, P, Pfister, P, Pilcher, J, Pinfold, J, Pitman, D, Plane, D, Poffenberger, P, Poli, B, Polok, J, Pooth, O, Posthaus, A, Pouladdej, A, Del Poz, L, Prebys, E, Pritchard, T, Przybycien, M, Przysiezniak, H, Quadt, A, Rabbertz, K, Raith, B, Redmond, M, Rees, D, Rembser, C, Renkel, P, Richards, G, Rick, H, Rigby, D, Robins, S, Robinson, D, Rodning, N, Rollnik, A, Roney, J, Rooke, A, Ros, E, Rosati, S, Roscoe, K, Rossberg, S, Rossi, A, Rosvick, M, Routenburg, P, Rozen, Y, Runge, K, Runolfsson, O, Ruppel, U, Rust, D, Rylko, R, Sachs, K, Saeki, T, Sahr, O, Sanghera, S, Sarkisyan, E, Sasaki, M, Sbarra, C, Schaile, A, Schaile, O, Schappert, W, Scharf, F, Scharff Hansen, P, Schenk, P, Schieck, J, Von Der Schmitt, H, Schmitt, S, Schorner Sadenius, T, Schreiber, S, Schroder, M, Schutz, P, Schultz Coulon, H, Schulz, M, Schumacher, M, Schwarz, J, Schwick, C, Schwiening, J, Scott, W, Settles, M, Seuster, R, Shears, T, Shen, B, Shepherd Themistocleous, C, Sherwood, P, Shypit, R, Simon, A, Singh, P, Siroli, G, Sittler, A, Skillman, A, Skuja, A, Smith, A, Smith, T, Snow, G, Sobie, R, Soldner Rembold, S, Spagnolo, S, Spano, F, Springer, R, Sproston, M, Stahl, A, Starks, M, Steiert, M, Stephens, K, Steuerer, J, Stier, H, Stockhausen, B, Stoll, K, Strohmer, R, Strom, D, Strumia, F, Stumpf, L, Surrow, B, Szymanski, P, Tafirout, R, Takeda, H, Takeshita, T, Talbot, S, Tanaka, S, Taras, P, Tarem, S, Tasevsky, M, Taylor, R, Tecchio, M, Tesch, N, Teuscher, R, Thackray, N, Thiergen, M, Thomson, M, Von Torne, E, Torrence, E, Towers, S, Toya, D, Trocsanyi, Z, Tran, P, Trefzger, T, Tresilian, N, Trigger, I, Tscheulin, M, Tsukamoto, T, Tsur, E, Turcot, A, Tumer Watson, M, Tysarczyk Niemeyer, G, Ueda, I, Ujvari, B, Utzat, P, Vachon, B, Van Den Plas, D, Van Kooten, R, Vandalen, G, Vannerem, P, Vasseur, G, Vertesi, R, Verzocchi, M, Vikas, P, Vincter, M, Virtue, C, Vokurka, E, Voss, H, Vossebeld, J, Wackerle, F, Wagner, A, Wagner, D, Wahl, C, Walker, J, Waller, D, Ward, C, Ward, D, Watkins, P, Watson, A, Watson, N, Weber, P, Weisz, S, Wels, P, Wengler, T, Wermes, N, Wetterling, D, Weymann, M, Whalley, M, White, J, Wilkens, B, Wilson, J, Wilson, G, Wingerter, I, Winterer, V, Wood, N, Wotton, S, Wyatt, T, Yaari, R, Yamashita, S, Yang, Y, Yeaman, A, Yekutieli, G, Yurko, M, Zacek, V, Zacharov, I, Zer Zion, D, Zeuner, W, Zivkovic, L, Zorn, G, Abe, K, Abe, T, Abt, I, Adam, I, Agnew, G, Akagi, T, Akimoto, H, Allen, N, Ash, W, Aston, D, Bacchetta, N, Baird, K, Baltay, C, Band, H, Barakat, M, Baranko, G, Bardon, O, Bashindzhagian, G, Bauer, J, Bean, A, Bellodi, G, Ben David, R, Berger, R, Bienz, T, Bilei, G, Bisello, D, Blaylock, G, Bogart, J, Bolen, B, Bolton, T, Bower, G, Brau, J, Breidenbach, M, Bugg, W, Burke, D, Burnett, T, Burrows, P, Busza, W, Calcaterra, A, Caldwell, D, Camanzi, B, Carpinelli, M, Cassell, R, Castaldi, R, Castro, A, Cavalli Sforza, M, Chadwick, G, Chou, A, Church, E, Claus, R, Cohn, H, Coller, J, Convery, M, Cook, V, Cotton, R, Cowan, R, Coyne, D, Crawford, G, D'Oliveira, A, Damerell, C, Daoudi, M, Dasu, S, De Groot, N, De Sangro, R, De Simone, P, De Simone, S, Dima, M, Dong, D, Doser, M, Du, P, Dubois, R, Eisenstein, B, Elia, R, Erdos, E, Erofeeva, I, Eschenburg, V, Fahey, S, Falciai, D, Fan, C, Fero, M, Flood, K, Frey, R, Friedman, J, Furuno, K, Garwin, E, Gillman, T, Gladding, G, Hallewell, G, Hart, E, Hasegawa, Y, Hasuko, K, Hedges, S, Hertzbach, S, Hitlin, D, Huber, J, Huffer, M, Hughes, E, Huynh, X, Hwang, H, Iwasaki, M, Iwasaki, Y, Izen, J, Jackson, D, Jacques, P, Jaros, J, Jiang, Z, Johnson, A, Johnson, J, Kajikawa, R, Kalelkar, M, Kamyshkov, Y, Kang, H, Karliner, I, Kawahara, H, Kelsey, M, Kendall, H, Kim, Y, King, M, King, R, Kofler, R, Krishna, N, Kwon, Y, Labs, J, Kroeger, R, Langston, M, Lath, A, Leith, D, Lia, V, Liu, M, Loreti, M, Lu, A, Lynch, H, Ma, J, Mancinelli, G, Manly, S, Mantovani, G, Markiewicz, T, Maruyama, T, Masuda, H, Mazzucato, H, Mcgowan, J, Mckemey, A, Meadows, B, Messner, R, Mockett, P, Moffeit, K, Moore, T, Mours, B, Muller, D, Mueller, G, Murzin, V, Nagamine, T, Narita, S, Nauenberg, U, Nesom, G, Nussbaum, M, Ohnishi, Y, Oishi, N, Onoprienko, D, Osborne, L, Panvini, R, Park, C, Peruzzi, I, Pescara, L, Piccolo, M, Piemontese, L, Pieroni, E, Pitts, K, Plano, R, Prepost, R, Prescott, C, Punkar, G, Quigley, J, Ratcliff, B, Reeves, K, Reeves, T, Reidy, J, Reinertsen, P, Rensing, P, Rochester, L, Rowson, P, Russell, J, Saxton, O, Schalk, T, Schindler, R, Schneekloth, U, Schumm, B, Seiden, A, Sen, S, Serbo, V, Shaevitz, M, Shank, J, Shapiro, G, Sherden, D, Shmakov, K, Simopoulos, C, Sinev, N, Smith, S, Smy, M, Snyder, J, Sokoloff, M, Staengle, H, Starner, P, Steiner, H, Steiner, R, Strauss, M, Su, D, Suekane, F, Sugiyama, A, Suzuki, A, Suzuki, S, Swartz, M, Szumilo, A, Takahashi, T, Taylor, F, Thaler, J, Thom, J, Trandafir, A, Turk, J, Usher, T, Va'Vra, J, Vella, E, Venuti, J, Verdier, R, Wagner, S, Waite, A, Walston, S, Wang, J, Watts, S, Weidemann, A, Weiss, E, Whitaker, J, White, S, Wickens, F, Williams, D, Williams, S, Willocq, S, Wilson, R, Wisniewski, W, Wittlin, J, Woods, M, Word, G, Wright, T, Wyss, J, Yamamoto, R, Yang, X, Yashima, J, Yellin, S, Young, C, Yuta, H, Zapalac, G, Zdarko, R, Zeitlin, C, Zhou, J, Lees, Jp, Minard, Mn, Nief, Jy, Casado, Mp, Crespo, Jm, Mir, Lm, Park, Ic, de Palma, M, Forty, Rw, Greening, Tc, Halley, Aw, Hansen, Jb, Hutchcroft, De, Rolandi, Luigi, Tomalin, Ir, Wright, Ae, Montret, Jc, Pascolo, Jm, Hansen, Jd, Hansen, Jr, Hansen, Ph, Kraan, Ac, Brient, Jc, Murtas, Gp, Knowles, Ig, Lynch, Jg, Morton, Wt, Scarr, Jm, Turnbull, Rm, Kluge, Ee, Binnie, Dm, Dornan, Pj, Martin, Eb, Rutherford, Sa, Sedgbeer, Jk, Thompson, Jc, Williams, Md, Ghete, Vm, Bowdery, Ck, Buck, Pg, Clarke, Dp, Finch, Aj, Jones, Rwl, Keemer, Nr, Pearson, Mr, Robertson, Na, Snow, Sw, Williams, Mi, van der Aa, O, Bauerdick, Lat, van Gemmeren, P, Sander, Hg, Aubert, Jj, Moser, Hg, Grivaz, Jf, Mutz, Am, Schune, Mh, Veillet, Jj, Ligabue, Franco, Lusiani, Alberto, Verdini, Pg, Blair, Ga, Green, Mg, Strong, Ja, Botterill, Dr, Clifft, Rw, Edgecock, Tr, Haywood, Sj, Norton, Pr, Ward, Jj, Lemaire, Mc, Renardy, Jf, Schuller, Jp, Black, Sn, Dann, Jh, Kim, Hy, Litke, Am, Mcneil, Ma, Booth, Cn, Hodgson, Pn, Thompson, Lf, Armstrong, Sr, Ferguson, Dp, Harton, Jl, Hayes, Oj, Johnson, Rp, Mcnamara, Pa, Scott, Ij, Walsh, Am, von Wimmersperg Toeller, Jh, Wu, Sl, Yamartino, Jm, Alekseev, Gd, Allport, Pp, Anassontzis, Eg, Apel, Wd, Augustin, Je, Becks, Kh, Bizouard, Ma, Booth, Psl, Borgland, Aw, Bowcock, Tjv, Brunet, Jm, Rozas, Ajc, Gimenez, Mvc, Chelkov, Ga, Chung, Su, Costa, Mj, Cowell, Jh, Crawley, Hb, da Silva, T, de Brabandere, S, de Paula, L, Drees, Ka, Durand, Jd, Engel, Jp, Santo, Mce, Fischer, Pa, Frodesen, Ag, Gerber, Jp, Caballero, Ig, Grimm, Hj, Harris, Fj, Hernandez, Jj, Hessing, Tl, Heuser, Jm, Holmgren, So, Holt, Pj, Houlden, Ma, Hughes, Gj, Jackson, Jn, Johansson, Ek, Johansson, Pd, Kersevan, Bp, Khomenko, Ba, Khovanski, Nn, King, Bt, Kjaer, Nj, Lane, Dw, Laugier, Jp, Loken, Jg, Lopes, Jh, Lopez, Jm, Mahon, Jr, Malmgren, Tgm, Marin, Jc, Garcia, Smi, Meyer, Wt, Palacios, Jp, Papadopoulou, Td, Philips, Ht, Pol, Me, Ratoff, Pn, Redaelli, Ng, Resvanis, Lk, Rosenberg, Ei, Schyns, Mae, Shellard, Rc, Skaali, Tb, Smith, Gr, Tabarelli, T, Taffard, Ac, Toet, Dz, Turluer, Ml, Tyapkin, Ia, Van Apeldoorn, Gw, Van den Boeck, W, Van Doninck, Wk, van Remortel, N, Washbrook, Aj, Wetherell, Am, Zimin, Ni, Zucchelli, Gc, Alviggi, Mg, Andreev, Vp, Baldew, Sv, Ball, Rc, Betev, Bl, Blaising, Jj, Blyth, Sc, Bobbink, Bj, Branson, Jg, Brock, Ic, Burger, Jd, Burger, Wj, Cai, Xd, Romeo, Gc, Chang, Yh, Chaturvedi, Uk, Chen, Gm, Chen, Hf, Colijn, Ap, de la Cruz, B, van Dalen, Ja, de Asmundis, R, della Volpe, D, van Dierendonck, D, Dova, Mt, Eppling, Fj, Erne, Fc, Falagan, Ma, Field, Jh, Fisher, Ph, Ganguli, Sn, Gong, Zf, Gruenewald, Mw, van Gulik, R, van Gupta, Vk, Gutay, Lj, Hou, Sr, Jin, Bn, Jones, Lw, Khan, Ra, Kienzle Focacci, Mn, Kim, Jk, Konig, Ac, Kraemer, Rw, de Guevara, Pl, Lee, Hj, Le Goff, Jm, Lin, Ch, Lin, Wt, Linde, Fl, Liu, Za, Ma, Wg, Martin, Jp, Massaro, Ggg, Mcneil, Rr, Metzger, Wj, von der Mey, M, Mohanty, Gb, Muijs, Ajm, Park, Hk, Park, Ih, Piroue, Pa, Prokofiev, Do, Rahaman, Ma, Rancoita, Pg, van Rhee, T, Roe, Bp, Rubio, Ja, Sanders, Mp, Sarakinos, Me, Schotanus, Dj, Stickland, Dp, Sun, Lz, Swain, Jd, Tang, Xw, Ting, Scc, Ting, Sm, Tonwar, Sc, Tung, Kl, Van de Walle, Rt, Vorobyov, Aa, Wang, Xl, Wang, Zm, Wu, Sx, Xu, Zz, Yang, Bz, Yang, Cg, Yang, Hj, Ye, Jb, Yeh, Sc, You, Jm, Zhang, Zp, Zhu, Gy, Zhu, Ry, Zhuang, Hl, Acton, Pd, Akesson, Pf, Anderson, Kj, Armitage, Jc, Ashby, Sf, Bahan, Ga, Baines, Jtm, Ball, Ah, Barker, Gj, Barlow, Rj, Batley, Rj, Bell, An, Bell, Kw, Bell, Pj, Bloodworth, Ij, Bloomer, Je, Bosch, Hm, Bouwens, Bt, Brabson, Bb, Brown, Rm, Burckhart, Hj, Carnegie, Rk, Carter, Aa, Carter, Jr, Chang, Cy, Charlton, Dg, Chrin, Jtm, Chu, Sl, Clarke, Pel, Clayton, Jc, Collins, Wj, Conboy, Je, Cooke, Oc, Silva, Ed, Coxe, Rl, Dallavalle, Gm, De Wolf, Ea, Deninno, Mm, Duboscq, Je, Duerdoth, Ip, Dumas, Djp, Edwards, Jeg, Elcombe, Pa, Estabrooks, Pg, Evans, Hg, Fischer, Hm, Fong, Dg, Futyan, Di, Gary, Jw, Gascon Shotkin, Sm, Geddes, Ni, Gensler, Sw, Gentit, Fx, Gibson, Wr, Gillies, Jd, Gingrich, Dm, Goodrick, Mj, Grant, Fc, Gunther, Po, Hanson, Gg, Hargrovet, Ck, Harrison, Pf, Hart, Pa, Hattersley, Pm, Hawkes, Cm, Hemingway, Rj, Heuer, Rd, Hildreth, Md, Hill, Jc, Hillier, Sj, Hinshaw, Da, Hobbs, Jd, Hobson, Pr, Homer, Rj, Honma, Ak, Hossain, Kr, Howarth, Cp, Hughes Jones, Re, Imrie, Dc, Jacob, Fr, Janissen, Ac, Jeffreys, Pw, Jones, Cr, Junk, Tr, Keeler, Rk, Kellogg, Rg, Kennedy, Bw, Kim, Dh, King, Bj, Klem, De, Kokott, Tp, Kral, Jf, von Krogh, J, Lafferty, Gd, Lai, Wp, Larson, Wj, Lautenschlager, Sr, Layter, Jg, Lee, Am, Lehto, Mh, Lloyd, Aw, Lloyd, Sl, Loebinger, Fk, Long, Gd, Lorah, Jm, Losty, Mj, Lou, Xc, Marchant, Te, Mcdonald, Wj, Mcgowan, Rf, Mckigney, Ea, Mcmahon, Tj, Mcnab, Ai, Mcpherson, Ac, Mcpherson, Ra, Middleton, Rp, Miller, Dj, Moss, Mw, Murphy, Pg, Neal, Ha, Nguyen, Hh, Oakham, Fg, Ogren, Ho, Oldershaw, Nj, O'Neale, Sw, O'Neill, Bp, Oram, Cj, Oreglia, Mj, Pansart, Jp, Pater, Jr, Patrick, Gn, Pawley, Sj, Pearce, Mj, Pilcher, Je, Plane, De, del Poz, La, Pritchard, Tw, Redmond, Mw, Rees, Dl, Richards, Ge, Robins, Sa, Roney, Jm, Rossi, Am, Rust, Dr, Sarkisyan, Ekg, Schaile, Ad, von der Schmitt, H, Schultz Coulon, Hc, Scott, Wg, Shears, Tg, Shen, Bc, Shepherd Themistocleous, Ch, Siroli, Gp, Smith, Am, Smith, Tj, Snow, Ga, Springer, Rw, Stier, He, Talbot, Sd, Taylor, Rj, Thackray, Nj, Thomson, Ma, von Torne, E, Tresilian, Nj, Tumer Watson, Mf, Van den Plas, D, Vandalen, Gj, Virtue, Cj, Vokurka, Eh, Vollmer, Cf, Wagner, Dl, Walker, Jp, Ward, Cp, Ward, Dr, Watkins, Pm, Watson, At, Watson, Nk, Whalley, Ma, Wilson, Ja, Wilson, Gw, Winterer, Vh, Wood, Nc, Wyatt, Tr, Zorn, Gt, Allen, Nj, Ash, Ww, Baird, Kg, Band, Hr, Barakat, Mb, Baranko, Gj, Barklow, Tl, Bashindzhagian, Gl, Bauer, Jm, Bazarko, Ao, Benvenuti, Ac, Bilei, Gm, Bower, Gr, Brau, Je, Bugg, Wm, Burnett, Th, Burrows, Pn, Caldwell, Do, Chadwick, Gb, Cohn, Ho, Coller, Ja, Convery, Mr, Cowan, Rf, Coyle, Pa, Coyne, Dg, Damerell, Cj, de Groot, N, de Sangro, R, Dervan, Pj, Dong, Dn, Du, Pyc, Eisenstein, Bi, Fernandez, Jp, Fero, Mj, Friedman, Ji, Garwin, El, Hallewell, Gd, Hart, El, Hitlin, Dg, Huffer, Me, Hughes, Ew, Izen, Jm, Jackson, Dj, Jaros, Ja, Jiang, Zy, Johnson, Jr, Johnson, Ra, Kamyshkov, Ya, Kang, Hj, Kelsey, Mh, Kendall, Hw, Kim, Yd, Krishna, Nm, Labs, Jf, Lauber, Ja, Leith, Dwg, Liu, Mx, Lynch, Hl, Markiewicz, Tw, Mcgowan, Jf, Mckemey, Ak, Meadows, Bt, Mockett, Pm, Moffeit, Kc, Moore, Tb, Park, Ch, Pavel, Tj, Pitts, Kt, Plano, Rj, Prescott, Cy, Ratcliff, Bn, Reeves, Tw, Reinertsen, Pl, Rensing, Pe, Rothberg, Je, Rowson, Pc, Russell, Jj, Saxton, Oh, Schindler, Rh, Schumm, Ba, Serbo, Vv, Shaevitz, Mh, Shank, Jt, Sherden, Dj, Shmakov, Kd, Sinev, Nb, Smith, Sr, Smy, Mb, Snyder, Ja, Sokoloff, Md, Strauss, Mg, Taylor, Fe, Thaler, Jj, Trandafir, Ai, Turk, Jd, Venuti, Jp, Wagner, Sr, Waite, Ap, Watts, Sj, Weidemann, Aw, Weiss, Er, White, Sl, Wickens, Fj, Williams, Da, Williams, Dc, Williams, Sh, Wilson, Rj, Wisniewski, Wj, Wittlin, Jl, Word, Gb, Wright, Tr, Yamamoto, Rk, Yang, Xq, Yellin, Sj, Young, Cc, Zdarko, Rw, Zhou, J., UCL, S. SCHAEL, R. BARATE, R. BRUNELIERE, D. BUSKULIC, I. DE BONIS, D. DECAMP, P. GHEZ, C. GOY, S. JEZEQUEL, J.-P. LEES, A. LUCOTTE, F. MARTIN, E. MERLE, M.-N. MINARD, J.-Y. NIEF, P. ODIER, B. PIETRZYK, B. TROCME, S. BRAVO, M.P. CASADO, M. CHMEISSANI, P. COMAS, J.M. CRESPO, E. FERNANDEZ, M. FERNANDEZ-BOSMAN, LL. GARRIDO, E. GRAUGES, A. JUSTE, M. MARTINEZ, G. MERINO, R. MIQUEL, LL.M. MIR, S. ORTEU, A. PACHECO, I.C. PARK, J. PERLAS, I. RIU, H. RUIZ, F. SANCHEZ, A. COLALEO, D. CREANZA, N. DE FILIPPIS, M. DE PALMA, G. IASELLI, G. MAGGI, M. MAGGI, S. NUZZO, A. RANIERI, G. RASO, F. RUGGIERI, G. SELVAGGI, L. SILVESTRIS, P. TEMPESTA, A. TRICOMI, G. ZITO, X. HUANG, J. LIN, Q. OUYANG, T. WANG, Y. XIE, R. XU, S. XUE, J. ZHANG, L. ZHANG, W. ZHAO, D. ABBANEO, A. BAZARKO, G. BOIX, F. BIRD, E. BLUCHER, B. BONVICINI, T. BARKLOW, M. CATTANEO, B. CLERBAUX, H. DREVERMANN, R.W. FORTY, M. FRANK, T.C. GREENING, R. HAGELBERG, A.W. HALLEY, F. GIANOTTI, M. GIRONE, J.B. HANSEN, J. HARVEY, R. JACOBSEN, P. JANOT, B. JOST, J. KNOBLOCH, M. KADO, I. LEHRAUS, P. LAZEYRAS, P. MALEY, P. MATO, J. MAY, A. MOUTOUSSI, M. PEPE-ALTARELLI, F. RANJARD, L. ROLANDI, D. SCHLATTER, O. SCHNEIDER, W. TEJESSY, F. TEUBERT, E. TOURNEFIER, R. VEENHOF, A. VALASSI, A.E. WRIGHT, Z. AJALTOUNI, F. BADAUD, G. CHAZELLE, O. DESCHAMPS, S. DESSAGNE, A. FALVARD, C. FERDI, D. FAYOLLE, P. GAY, C. GUICHENEY, P. HENRARD, J. JOUSSET, B. MICHEL, S. MONTEIL, J.C. MONTRET, D. PALLIN, J.M. PASCOLO, P. PERRET, F. PODLYSKI, H. BERTELSEN, T. FERNLEY, J.D. HANSEN, J.R. HANSEN, P.H. HANSEN, A.C. KRAAN, A. LINDAHL, R. MOLLERUD, B.S. NILSSON, B. RENSCH, A. WAANANEN, G. DASKALAKIS, A. KYRIAKIS, C. MARKOU, E. SIMOPOULOU, I. SIOTIS, A. VAYAKI, A. BLONDEL, G. BONNEAUD, J.-C. BRIENT, F. MACHEFERT, A. ROUGE, M. RUMPF, M. SWYNGHEDAUW, R. TANAKA, M. VERDERI, H. VIDEAU, V. CIULLI, E. FOCARDI, G. PARRINI, K. ZACHARIADOU, M. CORDEN, C. GEORGIOPOULOS, A. ANTONELLI, G. BENCIVENNI, G. BOLOGNA, F. BOSSI, P. CAMPANA, G. CAPON, F. CERUTTI, V. CHIARELLA, G. FELICI, P. LAURELLI, G. MANNOCCHI, G.P. MURTAS, L. PASSALACQUA, P. PICCHI, P. COLRAIN, I. TEN HAVE, I.S. HUGHES, J. KENNEDY, I.G. KNOWLES, J.G. LYNCH, W.T. MORTON, P. NEGUS, V. O’SHEA, C. RAINE, P. REEVES, J.M. SCARR, K. SMITH, A.S. THOMPSON, R.M. TURNBULL, S. WASSERBAECH, O. BUCHMULLER, R. CAVANAUGH, S. DHAMOTHARAN, C. GEWENIGER, P. HANKE, G. HANSPER, V. HEPP, E.E. KLUGE, A. PUTZER, J. SOMMER, K. TITTEL, W. WERNER, M. WUNSCH, R. BEUSELINCK, D.M. BINNIE, W. CAMERON, G. DAVIES, P.J. DORNAN, S. GOODSIR, N. MARINELLI, E.B MARTIN, J. NASH, J. NOWELL, S.A. RUTHERFORD, J.K. SEDGBEER, J.C. THOMPSON, R. WHITE, M.D. WILLIAMS, V.M. GHETE, P. GIRTLER, E. KNERINGER, D. KUHN, G. RUDOLPH, E. BOUHOVA- THACKER, C.K. BOWDERY, P.G. BUCK, D.P. CLARKE, G. ELLIS, A.J. FINCH, F. FOSTER, G. HUGHES, N.R. KEEMER, M.R. PEARSON, N.A. ROBERTSON, T. SLOAN, M. SMIZANSKA, S.W. SNOW, M.I.WILLIAMS, O. VAN DER AA, C. DELAERE, G. LEIBENGUTH, V. LEMAITRE, L.A.T. BAUERDICK, U. BLUMENSCHEIN, P. VAN GEMMEREN, I. GIEHL, F. HOLLDORFER, K. JAKOBS, M. KASEMANN, F. KAYSER, K. KLEINKNECHT, A.-S. MULLER, B. RENK, E. ROHNE, H.-G. SANDER, S. SCHMELING, H. WACHSMUTH, R. WANKE, C. ZEITNITZ, T. ZIEGLER, J.J. AUBERT, C. BENCHOUK, A. BONISSENT, P. COYLE, C. CURTIL, A. EALET, F. ETIENNE, D. FOUCHEZ, F. MOTSCH, P. PAYRE, D. ROUSSEAU, M. TALBY, M. THULASIDAS, M. ALEPPO, M. ANTONELLI, F. RAGUSA, V. BUSCHER, A. DAVID, H. DIETL, G. GANIS, K. HUTTMANN, G. LUTJENS, C. MANNERT, W. MANNER, H.-G. MOSER, R. SETTLES, H. SEYWERD, H. STENZEL, M. VILLEGAS, J. BOUCROT, O. CALLOT, S. CHEN, A. CORDIER, M. DAVIER, L. DUFLOT, J.-F. GRIVAZ, PH. HEUSSE, A. JACHOLKOWSKA, F. LE DIBERDER, J. LEFRANCOIS, A.M. MUTZ, M.H. SCHUNE, L. SERIN, J.-J. VEILLET, I. VIDEAU, D. ZERWAS, P. AZZURRI, G. BAGLIESI, S. BETTARINI, T. BOCCALI, C. BOZZI, G. CALDERINI, R. FANTECHI, I. FERRANTE, F. FIDECARO, L. FOA, A. GIAMMANCO, A. GIASSI, A. GREGORIO, F. LIGABUE, A. LUSIANI, P.S. MARROCCHESI, A. MESSINEO, F. PALLA, G. RIZZO, G. SANGUINETTI, A. SCIABA, G. SGUAZZONI, P. SPAGNOLO, J. STEINBERGER, R. TENCHINI, A. VENTURI, O. AWUNOR, G.A. BLAIR, G. COWAN, A. GARCIA-BELLIDO, M.G. GREEN, T. MEDCALF, J.A. STRONG, D.R. BOTTERILL, R.W. CLIFFT, T.R. EDGECOCK, M. EDWARDS, S.J. HAYWOOD, P.R. NORTON, I.R. TOMALIN, B. BLOCH-DEVAUX, D. BOUMEDIENE, P. COLAS, S. EMERY, B. FABBRO, W. KOZANECKI, E. LANCON, M.-C. LEMAIRE, E. LOCCI, P. PEREZ, J. RANDER, J.F. RENARDY, A. ROUSSARIE, J.P. SCHULLER, J. SCHWINDLING, B. TUCHMING, B. VALLAGE, S.N. BLACK, J.H. DANN, H.Y. KIM, N. KONSTANTINIDIS, A.M. LITKE, M.A. MCNEIL, G. TAYLOR, C.N. BOOTH, S. CARTWRIGHT, F. COMBLEY, P.N. HODGSON, M. LEHTO, L.F. THOMPSON, K. AFFHOLDERBACH, A. BOHRER, S. BRANDT, H. BURKHARDT, E. FEIGL, C. GRUPEN, J. HESS, G. LUTTERS, H. MEINHARD, J. MINGUET-RODRIGUEZ, A. MISIEJUK, E. NEUGEBAUER, A. NGAC, G. PRANGE, F. RIVERA, P. SARAIVA, U. SCHAFER, U. SIELER, L. SMOLIK, F. STEPHAN, H. TRIER, M. APOLLONIO, C. BOREAN, L. BOSISIO, R. DELLA MARINA, G. GIANNINI, B. GOBBO, G. MUSOLINO, L. PITIS, H. HE, H. KIM, J. PUTZ, J. ROTHBERG, S.R. ARMSTRONG, L. BELLANTONI, K. BERKELMAN, D. CINABRO, J.S. CONWAY, K. CRANMER, P. ELMER, Z. FENG, D.P.S. FERGUSON, Y. GAO, O.J. HAYES, H. HU, S. JIN, R.P. JOHNSON, J. KILE, P.A. MCNAMARA III, J. NIELSEN, W. OREJUDOS, Y.B. PAN, Y. SAADI, I.J. SCOTT, V. SHARMA, A. M. WALSH, J. WALSH, J. WEAR, J.H. VON WIMMERSPERG-TOELLER, W. WIEDENMANN, J. WU, S. L. WU, X. WU, J. M. YAMARTINO, G. ZOBERNIG, G. DISSERTORI, J. ABDALLAH, P. ABREU, W. ADAM, T. ADYE, P. ADZIC, I. AJINENKO, T. ALBRECHT, T. ALDERWEIRELD, G.D. ALEKSEEV, R. ALEMANY-FERNANDEZ, T. ALLMENDINGER, S. ALMEHED, U. AMALDI, N. AMAPANE, S. AMATO, E. ANASHKIN, E.G. ANASSONTZIS, P. ANDERSSON, A. ANDREAZZA, S. ANDRINGA, N. ANJOS, P. ANTILOGUS, W.-D. APEL, Y. ARNOUD, S. ASK, B. ASMAN, J.E. AUGUSTIN, A. AUGUSTINUS, P. BAILLON, A. BALLESTRERO, P. BAMBADE, F. BARAO, G. BARBIELLINI, R. BARBIER, D. BARDIN, G. BARKER, A. BARONCELLI, M. BATTAGLIA, M. BAUBILLIER, K.-H. BECKS, M. BEGALLI, A. BEHRMANN, P. BEILLIERE, YU. BELOKOPYTOV, K. BELOUS, E. BEN-HAIM, N. BENEKOS, A. BENVENUTI, C. BERAT, M. BERGGREN, L. BERNTZON, D. BERTINI, D. BERTRAND, M. BESANCON, N. BESSON, F. BIANCHI, M. BIGI, M.S. BILENKY, M.-A. BIZOUARD, D. BLOCH, M. BLOM, M. BLUJ, M. BONESINI, W. BONIVENTO, M. BOONEKAMP, P.S.L. BOOTH, A.W. BORGLAND, G. BORISOV, C. BOSIO, O. BOTNER, E. BOUDINOV, B. BOUQUET, C. BOURDARIOS, T.J.V. BOWCOCK, I. BOYKO, I. BOZOVIC, M. BOZZO, M. BRACKO, P. BRANCHINI, T. BRENKE, R. BRENNER, E. BRODET, P. BRUCKMAN, J.M. BRUNET, L. BUGGE, T. BURAN, T. BURGSMUELLER, B. BUSCHBECK, P. BUSCHMANN, S. CABRERA, M. CACCIA, M. CALVI, A.J. CAMACHO ROZAS, T. CAMPORESI, V. CANALE, M. CANEPA, F. CARENA, L. CARROLL, C. CASO, M.V. CASTILLO GIMENEZ, N. CASTRO, A. CATTAI, F. CAVALLO, CH. CERRUTI, V. CHABAUD, M. CHAPKIN, PH. CHARPENTIER, L. CHAUSSARD, P. CHECCHIA, G.A. CHELKOV, M. CHEN, R. CHIERICI, P. CHLIAPNIKOV, P. CHOCHULA, V. CHOROWICZ, J. CHUDOBA, S.U. CHUNG, K. CIESLIK, P. COLLINS, M. COLOMER, R. CONTRI, E. CORTINA, G. COSME, F. COSSUTTI, M.J. COSTA, J.-H. COWELL, H.B. CRAWLEY, D. CRENNELL, S. CREPE, G. CROSETTI, J. CUEVAS, S. CZELLAR, J. D’HONDT, B. DALMAGNE, J. DALMAU, G. DAMGAARD, M. DAVENPORT, T. DA SILVA, W. DA SILVA, A. DEGHORAIN, G. DELLA RICCA, P. DELPIERRE, N. DEMARIA, A. DE ANGELIS, W. DE BOER, S. DE BRABANDERE, C. DE CLERCQ, B. DE LOTTO, N. DE MARIA, A. DE MIN, L. DE PAULA, H. DIJKSTRA, L. DI CIACCIO, A. DI DIODATO, A. DI SIMONE, A. DJANNATI, J. DOLBEAU, K. DOROBA, M. DRACOS, J. DREES, K.-A. DREES, M. DRIS, A. DUPERRIN, J.-D. DURAND, R. EHRET, T. EKELOF, G. EKSPONG, M. ELLERT, M. ELSING, J.-P. ENGEL, B. ERZEN, M.C. ESPIRITO SANTO, E. FALK, G. FANOURAKIS, D. FASSOULIOTIS, J. FAYOT, M. FEINDT, A. FENYUK, J. FERNANDEZ, A. FERRER, E. FERRER-RIBAS, F. FERRO, S. FICHET, A. FIRESTONE, P.-A. FISCHER, U. FLAGMEYER, H. FOETH, E. FOKITIS, F. FONTANELLI, B. FRANEK, A.G. FRODESEN, R. FRUHWIRTH, F. FULDA-QUENZER, J. FUSTER, A. GALLONI, D. GAMBA, S. GAMBLIN, M. GANDELMAN, C. GARCIA, J. GARCIA, C. GASPAR, M. GASPAR, U. GASPARINI, PH. GAVILLET, E. GAZIS, D. GELE, J.-P. GERBER, L. GERDYUKOV, N. GHODBANE, I. GIL, F. GLEGE, R. GOKIELI, B. GOLOB, G. GOMEZ-CEBALLOS, P. GONCALVES, I. GONZALEZ CABALLERO, G. GOPAL, L. GORN, M. GORSKI, YU. GOUZ, V. GRACCO, J. GRAHL, E. GRAZIANI, C. GREEN, A. GREFRATH, H.-J. GRIMM, P. GRIS, G. GROSDIDIER, K. GRZELAK, M. GUNTHER, J. GUY, C. HAAG, F. HAHN, S. HAHN, S. HAIDER, A. HALLGREN, K. HAMACHER, K. HAMILTON, J. HANSEN, F.J. HARRIS, S. HAUG, F. HAULER, V. HEDBERG, S. HEISING, M. HENNECKE, R. HENRIQUES, J.J. HERNANDEZ, P. HERQUET, H. HERR, T.L. HESSING, J.-M. HEUSER, E. HIGON, J. HOFFMAN, S.-O. HOLMGREN, P.J. HOLT, D. HOLTHUIZEN, S. HOORELBEKE, M.A. HOULDEN, J. HRUBEC, M. HUBER, K. HUET, G.J. HUGHES, K. HULTQVIST, J.N. JACKSON, R. JACOBSSON, P. JALOCHA, R. JANIK, CH. JARLSKOG, G. JARLSKOG, P. JARRY, B. JEAN-MARIE, D. JEANS, E.K. JOHANSSON, P.D. JOHANSSON, P. JONSSON, C. JORAM, P. JUILLOT, L. JUNGERMANN, F. KAPUSTA, K. KARAFASOULIS, S. KATSANEVAS, E. KATSOUFIS, R. KERANEN, G. KERNEL, B.P. KERSEVAN, U. KERZEL, B.A. KHOMENKO, N.N. KHOVANSKI, A. KIISKINEN, B.T. KING, A. KINVIG, N.J. KJAER, O. KLAPP, H. KLEIN, P. KLUIT, D. KNOBLAUCH, P. KOKKINIAS, A. KONOPLIANNIKOV, M. KORATZINOS, V. KOSTIOUKHINE, C. KOURKOUMELIS, O. KOUZNETSOV, M. KRAMMER, C. KREUTER, E. KRIZNIC, J. KRSTIC, Z. KRUMSTEIN, P. KUBINEC, W. KUCEWICZ, M. KUCHARCZYK, J. KUROWSKA, K. KURVINEN, J. LAMSA, L. LANCERI, D.W. LANE, P. LANGEFELD, V. LAPIN, J.-P. LAUGIER, R. LAUHAKANGAS, G. LEDER, F. LEDROIT, V. LEFEBURE, L. LEINONEN, A. LEISOS, R. LEITNER, J. LEMONNE, G. LENZEN, V. LEPELTIER, T. LESIAK, M. LETHUILLIER, J. LIBBY, W. LIEBIG, D. LIKO, A. LIPNIACKA, I. LIPPI, B. LOERSTAD, M. LOKAJICEK, J.G. LOKEN, J.H. LOPES, J.M. LOPEZ, R. LOPEZ-FERNANDEZ, D. LOUKAS, P. LUTZ, L. LYONS, J. MACNAUGHTON, J.R. MAHON, A. MAIO, A. MALEK, T.G.M. MALMGREN, S. MALTEZOS, V. MALYCHEV, F. MANDL, J. MARCO, R. MARCO, B. MARECHAL, M. MARGONI, J.-C. MARIN, C. MARIOTTI, A. MARKOU, C. MARTINEZ-RIVERO, F. MARTINEZ-VIDAL, S. MARTI I GARCIA, J. MASIK, N. MASTROYIANNOPOULOS, F. MATORRAS, C. MATTEUZZI, G. MATTHIAE, J. MAZIK, F. MAZZUCATO, M. MAZZUCATO, M. MC CUBBIN, R. MC KAY, R. MC NULTY, G. MC PHERSON, C. MERONI, W.T. MEYER, A. MIAGKOV, E. MIGLIORE, L. MIRABITO, W. MITAROFF, U. MJOERNMARK, T. MOA, M. MOCH, R. MOELLER, K. MOENIG, R. MONGE, J. MONTENEGRO, D. MORAES, X. MOREAU, S. MORENO, P. MORETTINI, G. MORTON, U. MUELLER, K. MUENICH, M. MULDERS, C. MULET-MARQUIS, L. MUNDIM, R. MURESAN, W. MURRAY, B. MURYN, G. MYATT, T. MYKLEBUST, F. NARAGHI, M. NASSIAKOU, F. NAVARRIA, S. NAVAS, K. NAWROCKI, P. NEGRI, N. NEUFELD, W. NEUMANN, N. NEUMEISTER, R. NICOLAIDOU, B.S. NIELSEN, M. NIEUWENHUIZEN, P. NIEZURAWSKI, V. NIKOLAENKO, M. NIKOLENKO, V. NOMOKONOV, A. NORMAND, A. NYGREN, A. OBLAKOWSKA-MUCHA, V. OBRAZTSOV, A. OLSHEVSKI, A. ONOFRE, R. ORAVA, G. ORAZI, K. OSTERBERG, A. OURAOU, A. OYANGUREN, P. PAGANINI, M. PAGANONI, S. PAIANO, R. PAIN, R. PAIVA, J.P. PALACIOS, H. PALKA, TH.D. PAPADOPOULOU, K. PAPAGEORGIOU, L. PAPE, C. PARKES, F. PARODI, U. PARZEFALL, A. PASSERI, O. PASSON, T. PAVEL, M. PEGORARO, L. PERALTA, V. PEREPELITSA, M. PERNICKA, A. PERROTTA, C. PETRIDOU, A. PETROLINI, H.T. PHILLIPS, G. PIANA, J. PIEDRA, L. PIERI, F. PIERRE, M.PIMENTA, E. PIOTTO, T. PODOBNIK, V. POIREAU, M.E. POL, G. POLOK, E. POLYCARPO, P. POROPAT, V. POZDNIAKOV, P. PRIVITERA, N. PUKHAEVA, A. PULLIA, D. RADOJICIC, S. RAGAZZI, H. RAHMANI, D. RAKOCZY, J. RAMES, L. RAMLER, P.N. RATOFF, A. READ, P. REBECCHI, N.G. REDAELLI, M. REGLER, J. REHN, D. REID, R. REINHARDT, P. RENTON, L.K. RESVANIS, F. RICHARD, J. RIDKY, G. RINAUDO, I. RIPP-BAUDOT, M. RIVERO, D. RODRIGUEZ, O. ROHNE, A. ROMERO, P. RONCHESE, E.I. ROSENBERG, P. ROSINSKY, P. ROUDEAU, T. ROVELLI, CH. ROYON, V. RUHLMANN-KLEIDER, A. RUIZ, D. RYABTCHIKOV, H. SAARIKKO, Y. SACQUIN, A. SADOVSKY, G. SAJOT, L. SALMI, J. SALT, D. SAMPSONIDIS, M. SANNINO, A. SAVOY-NAVARRO, T. SCHEIDLE, H. SCHNEIDER, PH. SCHWEMLING, B. SCHWERING, U. SCHWICKERATH, M.A.E. SCHYNS, F. SCURI, P. SEAGER, Y. SEDYKH, A. SEGAR, N. SEIBERT, R. SEKULIN, R.C. SHELLARD, A. SHERIDAN, M. SIEBEL, R. SILVESTRE, L. SIMARD, F. SIMONETTO, A. SISAKIAN, T.B. SKAALI, G. SMADJA, N. SMIRNOV, O. SMIRNOVA, G.R. SMITH, A. SOKOLOV, A. SOPCZAK, R. SOSNOWSKI, T. SPASSOV, E. SPIRITI, P. SPONHOLZ, S. SQUARCIA, D. STAMPFER, C. STANESCU, S. STANIC, M. STANITZKI, S. STAPNES, K. STEVENSON, A. STOCCHI, J. STRAUSS, R. STRUB, B. STUGU, M. SZCZEKOWSKI, M. SZEPTYCKA, T. SZUMLAK, T. TABARELLI, A.C. TAFFARD, F. TEGENFELDT, F. TERRANOVA, A. TILQUIN, J. TIMMERMANS, N. TINTI, L. TKATCHEV, M. TOBIN, T. TODOROV, S. TODOROVOVA, D.Z. TOET, A. TOMARADZE, B. TOME, A. TONAZZO, L. TORTORA, P. TORTOSA, P. TRAVNICEK, D. TREILLE, G. TRISTRAM, M. TROCHIMCZUK, A. TROMBINI, C. TRONCON, A. TSIROU, M.-L. TURLUER, I.A. TYAPKIN, P. TYAPKIN, S. TZAMARIAS, O. ULLALAND, V. UVAROV, G. VALENTI, E. VALLAZZA, C. VANDER VELDE, G.W. VAN APELDOORN, P. VAN DAM, W. VAN DEN BOECK, W.K. VAN DONINCK, J. VAN ELDIK, A. VAN LYSEBETTEN, N. VAN REMORTEL, I. VAN VULPEN, N. VASSILOPOULOS, G. VEGNI, F. VELOSO, L. VENTURA, W. VENUS, F. VERBEURE, P. VERDIER, M. VERLATO, L.S. VERTOGRADOV, V. VERZI, D. VILANOVA, L. VITALE, E. VLASOV, A.S. VODOPYANOV, C. VOLLMER, G. VOULGARIS, V. VRBA, H. WAHLEN, C. WALCK, A.J. WASHBROOK, C.WEISER, A.M. WETHERELL, D. WICKE, J. WICKENS, G. WILKINSON, M. WINTER, M. WITEK, J. YI, O. YUSHCHENKO, A. ZAITSEV, A. ZALEWSKA, P. ZALEWSKI, D. ZAVRTANIK, E. ZEVGOLATAKOS, V. ZHURAVLOV, N.I. ZIMIN, A. ZINTCHENKO, PH. ZOLLER, G.C. ZUCCHELLI, G. ZUMERLE, M. ZUPAN, M. ACCIARRI, P. ACHARD, O. ADRIANI, M. AGUILAR-BENITEZ, J. ALCARAZ, G. ALEMANNI, J. ALLABY, A. ALOISIO, M.G. ALVIGGI, G. AMBROSI, H. ANDERHUB, V.P. ANDREEV, T. ANGELESCU, F. ANSELMO, A. AREFIEV, T. AZEMOON, T. AZIZ, P. BAGNAIA, A. BAJO, G. BAKSAY, L. BAKSAY, A. BALANDRAS, S.V. BALDEW, R.C. BALL, S. BANERJEE, SW. BANERJEE, A. BARCZYK, R. BARILLERE, L. BARONE, P. BARTALINI, M. BASILE, N. BATALOVA, A. BAY, F. BECATTINI, U. BECKER, F. BEHNER, L. BELLUCCI, R. BERBECO, J. BERDUGO, P. BERGES, B. BERTUCCI, B.L. BETEV, S. BHATTACHARYA, M. BIGLIETTI, A. BILAND, J.J. BLAISING, S.C. BLYTH, G.J. BOBBINK, A. BOHM, L. BOLDIZSAR, B. BORGIA, S. BOTTAI, D. BOURILKOV, M. BOURQUIN, S. BRACCINI, J.G. BRANSON, V. BRIGLJEVIC, F. BROCHU, I.C. BROCK, A. BUFFINI, J.D. BURGER, W.J. BURGER, A. BUTTON, X.D. CAI, M. CAMPANELLI, M. CAPELL, G. CARA ROMEO, G. CARLINO, A. CARTACCI, J. CASAUS, G. CASTELLINI, F. CAVALLARI, N. CAVALLO, C. CECCHI, M. CERRADA, F. CESARONI, M. CHAMIZO, Y.H. CHANG, U.K. CHATURVEDI, M. CHEMARIN, A. CHEN, G. CHEN, G.M. CHEN, H.F. CHEN, H.S. CHEN, G. CHIEFARI, L. CIFARELLI, F. CINDOLO, C. CIVININI, I. CLARE, R. CLARE, G. COIGNET, A.P. COLIJN, N. COLINO, S. COSTANTINI, F. COTOROBAI, B. COZZONI, B. DE LA CRUZ, S. CUCCIARELLI, T.S. DAI, J.A. VAN DALEN, R. D’ALESSANDRO, R. DE ASMUNDIS, J. DEBRECZENI, P. DEGLON, A. DEGRE, K. DEHMELT, K. DEITERS, D. DELLA VOLPE, E. DELMEIRE, P. DENES, F. DE NOTARISTEFANI, A. DE SALVO, M. DIEMOZ, M. DIERCKXSENS, D. VAN DIERENDONCK, F. DI LODOVICO, C. DIONISI, A. DOMINGUEZ, A. DORIA, M.T. DOVA, D. DUCHESNEAU, D. DUFOURNAUD, M. DUDA, P. DUINKER, I. DURAN, S. DUTTA, B. ECHENARD, A. ELINE, A. EL HAGE, H. EL MAMOUNI, A. ENGLER, F.J. EPPLING, F.C. ERNE, P. EXTERMANN, M. FABRE, R. FACCINI, M.A. FALAGAN, S. FALCIANO, A. FAVARA, J. FAY, O. FEDIN, M. FELCINI, T. FERGUSON, F. FERRONI, H. FESEFELDT, E. FIANDRINI, J.H. FIELD, F. FILTHAUT, P.H. FISHER, W. FISHER, I. FISK, G. FORCONI, L. FREDJ, K. FREUDENREICH, C. FURETTA, YU. GALAKTIONOV, S.N. GANGULI, P. GARCIA-ABIA, M. GATAULLIN, S.S. GAU, S. GENTILE, N. GHEORDANESCU, S. GIAGU, Z.F. GONG, G. GRENIER, O. GRIMM, M.W. GRUENEWALD, M. GUIDA, R. VAN GULIK, V.K. GUPTA, A. GURTU, L.J. GUTAY, D. HAAS, D. HATZIFOTIADOU, T. HEBBEKER, A. HERVE, P. HIDAS, J. HIRSCHFELDER, H. HOFER, M. HOHLMANN, G. HOLZNER, H. HOORANI, I. IASHVILI, V. INNOCENTE, B.N. JIN, P. JINDAL, L.W. JONES, P. DEJONG, I. JOSA-MUTUBERRIA, R.A. KHAN, M. KAUR, M.N. KIENZLE-FOCACCI, D. KIM, J.K. KIM, J. KIRKBY, D. KISS, W. KITTEL, A. KLIMENTOV, A.C. KONIG, E. KOFFEMAN, M. KOPAL, A. KOPP, V. KOUTSENKO, M. KRABER, R.W. KRAEMER, W. KRENZ, A. KRUGER, H. KUIJTEN, A. KUNIN, P. LADRON DE GUEVARA, I. LAKTINEH, G. LANDI, K. LASSILA-PERINI, M. LEBEAU, A. LEBEDEV, P. LEBRUN, P. LECOMTE, P. LECOQ, P. LE COULTRE, H.J. LEE, J.M. LE GOFF, R. LEISTE, E. LEONARDI, M. LEVTCHENKO, P. LEVTCHENKO, C. LI, S. LIKHODED, C.H. LIN, W.T. LIN, F.L. LINDE, L. LISTA, Z.A. LIU, W. LOHMANN, E. LONGO, Y.S. LU, W. LU, K.LUBELSMEYER, C. LUCI, D. LUCKEY, L. LUMINARI, L. LUGNIER, W. LUSTERMANN, W.G. MA, M. MAITY, L. MALGERI, A. MALININ, C. MANA, D. MANGEOL, J. MANS, P. MARCHESINI, G. MARIAN, F. MARZANO, G.G.G. MASSARO, K. MAZUMDAR, R.R. MCNEIL, S. MELE, L. MEROLA, M. MERK, M. MESCHINI, W.J. METZGER, M. VON DER MEY, A. MIHUL, H. MILCENT, G. MIRABELLI, J. MNICH, G.B. MOHANTY, P. MOLNAR, B. MONTELEONI, T. MOULIK, G.S. MUANZA, F. MUHEIM, A.J.M. MUIJS, B. MUSICAR, M. MUSY, S. NAGY, S. NATALE, M. NAPOLITANO, F. NESSI-TEDALDI, H. NEWMAN, T. NIESSEN, A. NISATI, T. NOVAK, H. NOWAK, R. OFIERZYNSKI, G. ORGANTINI, A. OULIANOV, I. PAL, C. PALOMARES, D. PANDOULAS, S. PAOLETTI, A. PAOLONI, P. PAOLUCCI, R. PARAMATTI, H.K. PARK, I.H. PARK, G. PASCALE, G. PASSALEVA, S. PATRICELLI, T. PAUL, M. PAULUZZI, C. PAUS, F. PAUSS, D. PEACH, M. PEDACE, S. PENSOTTI, D. PERRET-GALLIX, B. PETERSEN, D. PICCOLO, F. PIERELLA, M. PIERI, M. PIOPPI, P.A. PIROUE, E. PISTOLESI, V. PLYASKIN, M. POHL, V. POJIDAEV, H. POSTEMA, J. POTHIER, N. PRODUIT, D.O. PROKOFIEV, D. PROKOFIEV, J. QUARTIERI, G. RAHAL-CALLOT, M.A. RAHAMAN, P. RAICS, N. RAJA, R. RAMELLI, P.G. RANCOITA, R. RANIERI, A. RASPEREZA, P. RAZIS, D. REN, M. RESCIGNO, S. REUCROFT, T. VAN RHEE, S. RIEMANN, A. ROBOHM, J. RODIN, B.P. ROE, L. ROMERO, A. ROSCA, C. ROSEMANN, C. ROSENBLECK, S. ROSIER-LEES, S. ROTH, J.A. RUBIO, G. RUGGIERO, D. RUSCHMEIER, H. RYKACZEWSKI, A. SAKHAROV, S. SAREMI, S. SARKAR, J. SALICIO, E. SANCHEZ, M.P. SANDERS, M.E. SARAKINOS, C. SCHAFER, V. SCHEGELSKY, S. SCHMIDT-KAERST, D. SCHMITZ, H. SCHOPPER, D.J. SCHOTANUS, G. SCHWERING, C. SCIACCA, D. SCIARRINO, A. SEGANTI, S. SHEVCHENKO, N. SHIVAROV, V. SHOUTKO, E. SHUMILOV, A. SHVOROB, T. SIEDENBURG, D. SON, B. SMITH, C. SOUGA, P. SPILLANTINI, M. STEUER, D.P. STICKLAND, A. STONE, H. STONE, B.STOYANOV, A. STRAESSNER, K. SUDHAKAR, G. SULTANOV, L.Z. SUN, S. SUSHKOV, H. SUTER, J.D. SWAIN, Z. SZILLASI, T. SZTARICSKAI, X.W. TANG, P. TARJAN, L. TAUSCHER, L. TAYLOR, B. TELLILI, D. TEYSSIER, C. TIMMERMANS, S.C.C. TING, S.M. TING, S.C. TONWAR, J. TOTH, C. TULLY, K.L. TUNG, Y. UCHIDA, J. ULBRICHT, U. UWER, E.VALENTE, R.T.VAN DEWALLE, R.VASQUEZ, V.VESZPREMI, G.VESZTERGOMBI, I.VETLITSKY, D. VICINANZA, G. VIERTEL, S. VILLA, M. VIVARGENT, S. VLACHOS, I. VODOPIANOV, H. VOGEL, H. VOGT, I. VOROBIEV, A.A. VOROBYOV, A. VORVOLAKOS, M. WADHWA, W. WALLRAFF, Q. WANG, X.L. WANG, Z.M. WANG, A. WEBER, P. WIENEMANN, H. WILKENS, S.X. WU, S. WYNHOFF, L. XIA, Z.Z. XU, J. YAMAMOTO, B.Z. YANG, C.G. YANG, H.J. YANG, M. YANG, J.B. YE, S.C. YEH, J.M. YOU, AN. ZALITE, YU. ZALITE, Z.P. ZHANG, J.ZHAO, G.Y. ZHU, R.Y. ZHU, H.L. ZHUANG, A. ZICHICHI, G. ZILIZI, B. ZIMMERMANN, M. ZOLLER, G. ABBIENDI, C. AINSLEY, P.F. AKESSON, G. ALEXANDER, J. ALLISON, P.P. ALLPORT, N. ALTEKAMP, P. AMARAL, K. AMETEWEE, G. ANAGNOSTOU, K.J. ANDERSON, S. ANDERSON, S. ARCELLI, J.C. ARMITAGE, S. ASAI, S.F. ASHBY, P. ASHTON, A. ASTBURY, D. AXEN, G. AZUELOS, G.A. BAHAN, I. BAILEY, J.T.M. BAINES, A.H. BALL, J. BANKS, E. BARBERIO, T. BARILLARI, G.J. BARKER, R.J. BARLOW, S. BARNETT, R. BARTOLDUS, R.J. BATLEY, G. BEAUDOIN, P. BECHTLE, J. BECHTLUFT, A. BECK, J. BECKER, C. BEESTON, T. BEHNKE, A.N. BELL, K.W. BELL, P.J. BELL, G. BELLA, A. BELLERIVE, G. BENELLI, S. BENTVELSEN, P. BERLICH, S. BETHKE, O.BIEBEL, U. BINDER, V. BLOBEL, I.J. BLOODWORTH, J.E. BLOOMER, P. BOCK, B. BODEN, J. BOHME, O. BOERIU, D. BONACORSI, H.M. BOSCH, S. BOUGEROLLE, M. BOUTEMEUR, B.T. BOUWENS, B.B. BRABSON, S. BRAIBANT, H. BREUKER, P. BRIGHT-THOMAS, L. BRIGLIADORI, R.M. BROWN, R. BRUN, R. BURGIN, K. BUESSER, A. BUIJS, H.J. BURCKHART, C. BURGARD, J. CAMMIN, S. CAMPANA, P. CAPILUPPI, R.K. CARNEGIE, B. CARON, A.A. CARTER, J.R. CARTER, C.Y. CHANG, C. CHARLESWORTH, D.G. CHARLTON, J.T.M. CHRIN, D. CHRISMAN, S.L. CHU, C. CIOCCA, P.E.L. CLARKE, E. CLAY, J.C. CLAYTON, I. COHEN, W.J. COLLINS, J.E. CONBOY, O.C. COOKE, M. COOPER, M. COUCH, J.COUCHMAN, M. COUPLAND, E. DO COUTO E SILVA, R.L. COXE, A. CSILLING, M. CUFFIANI, S. DADO, C. DALLAPICCOLA, G.M. DALLAVALLE, S. DALLISON, C. DARLING, S. DE JONG, A. DE ROECK, E.A. DE WOLF, P. DEBU, H. DENG, M.M. DENINNO, P. DERVAN, K. DESCH, A. DIECKMANN, B. DIENES, M. DITTMAR, M.S. DIXIT, M. DONKERS, M. DOUCET, J. DUBBERT, E. DUCHOVNI, G. DUCKECK, I.P. DUERDOTH, D.J.P. DUMAS, G. ECKERLIN, J.E.G. EDWARDS, P.A. ELCOMBE, P.G. ESTABROOKS, H.G. EVANS, M. EVANS, F. FABBRI, M. FANTI, P. FATH, L. FELD, P. FERRARI, F. FIEDLER, M. FIERRO, M. FINCKE- KEELER, H.M. FISCHER, I. FLECK, R. FOLMAN, D.G.FONG, M. FORD, M. FOUCHER, A. FREY, A. FURTJES, H. FUKUI, C. FUKUNAGA, D.I. FUTYAN, P. GAGNON, A. GAIDOT, O. GANEL, J.W. GARY, J. GASCON, S.M. GASCON-SHOTKIN, G. GAYCKEN, N.I. GEDDES, C. GEICH-GIMBEL, S.W. GENSLER, F.X. GENTIT, T. GERALIS, G. GIACOMELLI, P. GIACOMELLI, R. GIACOMELLI, V. GIBSON, W.R. GIBSON, J.D. GILLIES, D.M. GINGRICH, M. GIUNTA, D. GLENZINSKI, J. GOLDBERG, M.J. GOODRICK, W. GORN, K. GRAHAM, C. GRANDI, F.C. GRANT, E. GROSS, J. GRUNHAUS, M. GRUWE, P.O. GUNTHER, A. GUPTA, J. HAGEMANN, C. HAJDU, M. HAMANN, G.G. HANSON, M. HANSROUL, M. HAPKE, K. HARDER, A. HAREL, C.K. HARGROVE, M. HARIN-DIRAC, P.F. HARRISON, P.A. HART, C. HARTMANN, P.M. HATTERSLEY, M. HAUSCHILD, C.M. HAWKES, R. HAWKINGS, E. HEFLIN, R.J. HEMINGWAY, C. HENSEL, G. HERTEN, R.D. HEUER, J.C. HILL, S.J. HILLIER, T. HILSE, D.A. HINSHAW, C. HO, J. HOARE, J.D. HOBBS, P.R. HOBSON, D. HOCHMAN, A. HOCKER, K. HOFFMAN, B. HOLL, R.J. HOMER, A.K. HONMA, D. HORVATH, K.R. HOSSAIN, S.R. HOU, R. HOWARD, C.P. HOWARTH, P. HUNTEMEYER, R.E. HUGHES-JONES, R. HUMBERT, D.E. HUTCHCROFT, P. IGO-KEMENES, H. IHSSEN, D.C. IMRIE, M.R. INGRAM, K. ISHII, F.R. JACOB, A.C. JANISSEN, A. JAWAHERY, P.W. JEFFREYS, H. JEREMIE, M. JIMACK, M. JOBES, A. JOLY, C.R. JONES, G. JONES, M. JONES, R.W.L. JONES, U. JOST, P. JOVANOVIC, C. JUI, T.R. JUNK, N. KANAYA, J. KANZAKI, G. KARAPETIAN, D. KARLEN, V. KARTVELISHVILI, K. KAWAGOE, T. KAWAMOTO, R.K. KEELER, R.G. KELLOGG, B.W. KENNEDY, D.H. KIM, B.J. KING, J. KIRK, K. KLEIN, C. KLEINWORT, D.E. KLEM, A. KLIER, S. KLUTH, T. KOBAYASHI, M. KOBEL, L. KOPKE, D.S. KOETKE, T.P. KOKOTT, S. KOMAMIYA, L. KORMOS, R.V. KOWALEWSKI, T. KRAMER, J.F. KRAL, T. KRESS, H. KREUTZMANN, P. KRIEGER, J. VON KROGH, J. KROLL, D. KROP, K. KRUGER, T. KUHL, M. KUPPER, M. KUWANO, P. KYBERD, G.D. LAFFERTY, H. LAFOUX, R. LAHMANN, W.P. LAI, F. LAMARCHE, H. LANDSMAN, D. LANSKE, W.J. LARSON, J. LAUBER, S.R. LAUTENSCHLAGER, I. LAWSON, J.G. LAYTER, D. LAZIC, P. LE DU, P. LEBLANC, A.M. LEE, E. LEFEBVRE, M.H. LEHTO, A. LEINS, D. LELLOUCH, P. LENNERT, C. LEROY, L. LESSARD, J. LETTS, S. LEVEGRUN, L. LEVINSON, C. LEWIS, R. LIEBISCH, J. LILLICH, C. LITTLEWOOD, A.W. LLOYD, S.L. LLOYD, F.K. LOEBINGER, G.D. LONG, J.M. LORAH, B. LORAZO, M.J. LOSTY, X.C. LOU, J. LU, A. LUDWIG, J. LUDWIG, A. LUIG, A. MACCHIOLO, A. MACPHERSON, W. MADER, P. MATTIG, A. MALIK, M. MANNELLI, S. MARCELLINI, T.E. MARCHANT, G.MARINGER, C. MARKUS, A.J. MARTIN, J.P. MARTIN, G. MARTINEZ, G. MASETTI, T. MASHIMO, W. MATTHEWS, U. MAUR, W.J. MCDONALD, R.F. MCGOWAN, J. MCKENNA, E.A. MCKIGNEY, T.J. MCMAHON, A.I. MCNAB, J.R. MCNUTT, A.C. MCPHERSON, R.A. MCPHERSON, F. MEIJERS, P. MENDEZ-LORENZO, W. MENGES, S. MENKE, D. MENSZNER, F.S. MERRITT, H. MES, J. MEYER, N. MEYER, A. MICHELINI, R.P. MIDDLETON, S. MIHARA, G. MIKENBERG, J. MILDENBERGER, D.J. MILLER, C. MILSTENE, R. MIR, S. MOED, W. MOHR, C. MOISAN, A. MONTANARI, T. MORI, M.W. MOSS, T. MOUTHUY, U. MULLER, P.G. MURPHY, A. MUTTER, K. NAGAI, I. NAKAMURA, H. NANJO, H.A. NEAL, B. NELLEN, H.H. NGUYEN, B. NIJJHAR, R. NISIUS, M. NOZAKI, F.G. OAKHAM, F. ODORICI, M. OGG, H.O. OGREN, A. OH, H. OH, A. OKPARA, N.J. OLDERSHAW, T. OMORI, S.W. O’NEALE, B.P. O’NEILL, C.J. ORAM, M.J. OREGLIA, S. ORITO, C. PAHL, J. PALINKAS, F. PALMONARI, J.P. PANSART, B. PANZER-STEINDEL, P. PASCHIEVICI, G. PASZTOR, J.R. PATER, G.N. PATRICK, S.J. PAWLEY, N. PAZ-JAOSHVILI, M.J. PEARCE, S. PETZOLD, P. PFEIFENSCHNEIDER, P. PFISTER, J.E. PILCHER, J. PINFOLD, D. PITMAN, D.E. PLANE, P. POFFENBERGER, B. POLI, J. POLOK, O. POOTH, A. POSTHAUS, A. POULADDEJ, L.A. DEL POZO, E. PREBYS, T.W. PRITCHARD, M.PRZYBYCIE´N, H. PRZYSIEZNIAK, A. QUADT, G. QUAST, K. RABBERTZ, B. RAITH, M.W. REDMOND, D.L. REES, C. REMBSER, P. RENKEL, G.E. RICHARDS, H. RICK, D. RIGBY, K. RILES, S.A. ROBINS, D. ROBINSON, N. RODNING, A. ROLLNIK, J.M. RONEY, A. ROOKE, E. ROS, S. ROSATI, K. ROSCOE, S. ROSSBERG, A.M. ROSSI, M. ROSVICK, P. ROUTENBURG, Y. ROZEN, K. RUNGE, O. RUNOLFSSON, U. RUPPEL, D.R. RUST, R. RYLKO, K. SACHS, T. SAEKI, O. SAHR, S. SANGHERA, E.K.G. SARKISYAN, M. SASAKI, C. SBARRA, A.D. SCHAILE, O. SCHAILE, W. SCHAPPERT, F. SCHARF, P. SCHARFF-HANSEN, P. SCHENK, J. SCHIECK, B. SCHMITT, H. VON DER SCHMITT, S.SCHMITT, T. SCHORNER-SADENIUS, S. SCHREIBER, M. SCHRODER, P. SCHUTZ, H.C. SCHULTZ-COULON, M. SCHULZ, M. SCHUMACHER, J. SCHWARZ, C. SCHWICK, W.G. SCOTT, M. SETTLES, R. SEUSTER, T.G. SHEARS, B.C. SHEN, C.H. SHEPHERD-THEMISTOCLEOUS, P. SHERWOOD, R. SHYPIT, A. SIMON, P. SINGH, G.P. SIROLI, A. SITTLER, A. SKILLMAN, A. SKUJA, A.M. SMITH, T.J. SMITH, G.A. SNOW, R. SOBIE, S. SOLDNER-REMBOLD, S. SPAGNOLO, F. SPANO, R.W. SPRINGER, M. SPROSTON, M. STARKS, M. STEIERT, K. STEPHENS, J. STEUERER, H.E. STIER, B. STOCKHAUSEN, K. STOLL, R. STROHMER, D. STROM, F. STRUMIA, L. STUMPF, B. SURROW, P. SZYMANSKI, R. TAFIROUT, H. TAKEDA, T. TAKESHITA, S.D. TALBOT, S. TANAKA, P. TARAS, S. TAREM, M. TASEVSKY, R.J. TAYLOR, M. TECCHIO, P. TEIXEIRA-DIAS, N. TESCH, R. TEUSCHER, N.J. THACKRAY, M. THIERGEN, J. THOMAS, M.A. THOMSON, E. VON TORNE, S. TOWERS, D. TOYA, Z. TROCSANYI, P. TRAN, G. TRANSTROMER, T. TREFZGER, N.J. TRESILIAN, I. TRIGGER, M. TSCHEULIN, T. TSUKAMOTO, E. TSUR, A.S. TURCOT, M.F. TURNER-WATSON, G. TYSARCZYK-NIEMEYER, I. UEDA, B. UJVARI, P. UTZAT, B. VACHON, D. VAN DEN PLAS, R. VAN KOOTEN, G.J. VAN DALEN, P. VANNEREM, G. VASSEUR, R. VERTESI, M. VERZOCCHI, P. VIKAS, M. VINCTER, C.J. VIRTUE, E.H. VOKURKA, C.F. VOLLMER, H. VOSS, J. VOSSEBELD, F. WACKERLE, A. WAGNER, C. WAHL, J.P. WALKER, D. WALLER, C.P. WARD, D.R. WARD, J.J. WARD, P.M. WATKINS, A.T. WATSON, N.K. WATSON, M. WEBER, P. WEBER, S. WEISZ, P.S. WELLS, T. WENGLER, N. WERMES, D. WETTERLING, M. WEYMANN, M.A. WHALLEY, J.S. WHITE, B. WILKENS, J.A. WILSON, G.W. WILSON, I. WINGERTER, V.-H. WINTERER, T. WLODEK, G. WOLF, N.C. WOOD, S. WOTTON, T.R. WYATT, R. YAARI, S. YAMASHITA, Y. YANG, A. YEAMAN, G. YEKUTIELI, M. YURKO, V. ZACEK, I. ZACHAROV, D. ZER-ZION, W. ZEUNER, L. ZIVKOVIC, G.T. ZORN, KENJI ABE, KOYA ABE, T. ABE, I. ABT, P.D. ACTON, I. ADAM, G. AGNEW, T. AKAGI, H. AKIMOTO, N.J. ALLEN, W.W. ASH, D. ASTON, N. BACCHETTA, K.G. BAIRD, C. BALTAY, H.R. BAND, M.B. BARAKAT, G.J. BARANKO, O. BARDON, T.L. BARKLOW, G.L. BASHINDZHAGIAN, R. BATTISTON, J.M. BAUER, A.O. BAZARKO, A. BEAN, G. BELLODI, R. BEN-DAVID, A.C. BENVENUTI, R. BERGER, M. BIASINI, T. BIENZ, G.M. BILEI, D. BISELLO, G. BLAYLOCK, J.R. BOGART, B. BOLEN, T. BOLTON, G.R. BOWER, J.E. BRAU, M. BREIDENBACH, W.M. BUGG, D. BURKE, T.H. BURNETT, P.N. BURROWS, W. BUSZA, A. CALCATERRA, D.O. CALDWELL, B. CAMANZI, M. CARPINELLI, J. CARR, R. CASSELL, R. CASTALDI, A. CASTRO, M. CAVALLI-SFORZA, G.B. CHADWICK, A. CHOU, E. CHURCH, R. CLAUS, H.O. COHN, J.A. COLLER, M.R. CONVERY, V. COOK, R. COTTON, R.F. COWAN, P.A. COYLE, D.G. COYNE, G. CRAWFORD, A. D’OLIVEIRA, C.J.S. DAMERELL, M. DAOUDI, S. DASU, N. DE GROOT, R. DE SANGRO, P. DE SIMONE, S. DE SIMONE, R. DELL’ORSO, P.J. DERVAN, M. DIMA, D.N. DONG, M. DOSER, P.Y.C. DU, R. DUBOIS, J.E. DUBOSCQ, G. EIGEN, B.I. EISENSTEIN, R. ELIA, E. ERDOS, I. EROFEEVA, V. ESCHENBURG, E. ETZION, S. FAHEY, D. FALCIAI, C. FAN, J.P. FERNANDEZ, M.J. FERO, K. FLOOD, R. FREY, J.I. FRIEDMAN, K. FURUNO, E.L. GARWIN, T. GILLMAN, G. GLADDING, S. GONZALEZ, G.D. HALLEWELL, E.L. HART, J.L. HARTON, A. HASAN, Y. HASEGAWA, K. HASUKO, S. HEDGES, S.S. HERTZBACH, M.D. HILDRETH, D.G. HITLIN, A.HONMA, J. S. HUBER, M.E. HUFFER, E.W. HUGHES, X. HUYNH, H.HWANG, M. IWASAKI, Y. IWASAKI, J.M. IZEN, D.J. JACKSON, P. JACQUES, J.A. JAROS, Z.Y. JIANG, A.S. JOHNSON, J.R. JOHNSON, R.A. JOHNSON, T. JUNK, R. KAJIKAWA, M. KALELKAR, Y.A. KAMYSHKOV, H.J. KANG, I. KARLINER, H. KAWAHARA, M.H. KELSEY, H.W. KENDALL, Y.D. KIM, M. KING, R. KING, R. KOFLER, N.M. KRISHNA, Y. KWON, J.F. LABS, R.S. KROEGER, M. LANGSTON, A. LATH, J.A. LAUBER, D.W.G. LEITH, V.LIA, C. LIN, M.X. LIU, M. LORETI, A. LU, H.L. LYNCH, J. MA, G. MANCINELLI, S. MANLY, G. MANTOVANI, T.W. MARKIEWICZ, T. MARUYAMA, H. MASUDA, E. MAZZUCATO, J.F. MCGOWAN, A.K. MCKEMEY, B.T. MEADOWS, R. MESSNER, P.M. MOCKETT, K.C. MOFFEIT, T.B. MOORE, M. MORII, B. MOURS, D. MULLER, G. MUELLER, V. MURZIN, T. NAGAMINE, S. NARITA, U. NAUENBERG, H. NEAL, G. NESOM, M. NUSSBAUM, Y. OHNISHI, N. OISHI, D. ONOPRIENKO, L.S. OSBORNE, R.S. PANVINI, C.H.PARK, H. PARK, T.J. PAVEL, I. PERUZZI, L. PESCARA, M. PICCOLO, L. PIEMONTESE, E. PIERONI, K.T. PITTS, R.J. PLANO, R. PREPOST, C.Y. PRESCOTT, G. PUNKAR, J. QUIGLEY, B.N. RATCLIFF, K. REEVES, T.W. REEVES, J. REIDY, P.L. REINERTSEN, P.E. RENSING, L.S. ROCHESTER, J.E. ROTHBERG, P.C. ROWSON, J.J. RUSSELL, O.H. SAXTON, T. SCHALK, R.H. SCHINDLER, U. SCHNEEKLOTH, B.A. SCHUMM, J. SCHWIENING, A. SEIDEN, S. SEN, V.V. SERBO, L. SERVOLI, M.H. SHAEVITZ, J.T. SHANK, G. SHAPIRO, D.J. SHERDEN, K.D. SHMAKOV, C. SIMOPOULOS, N.B. SINEV, S.R. SMITH, M.B. SMY, J.A. SNYDER, M.D. SOKOLOFF, H. STAENGLE, A. STAHL, P. STAMER, H. STEINER, R. STEINER, M.G. STRAUSS, D. SU, F. SUEKANE, A. SUGIYAMA, A. SUZUKI, S. SUZUKI, M. SWARTZ, A. SZUMILO, T. TAKAHASHI, F.E. TAYLOR, J.J. THALER, J. THOM, E. TORRENCE, A.I. TRANDAFIR, J.D. TURK, T. USHER, J. VA VRA, C. VANNINI, E. VELLA, J.P. VENUTI, R. VERDIER, P.G. VERDINI, D.L. WAGNER, S.R. WAGNER, A.P. WAITE, S. WALSTON, J. WANG, S.J. WATTS, A.W. WEIDEMANN, E.R. WEISS, J.S. WHITAKER, S.L. WHITE, F.J. WICKENS, D.A. WILLIAMS, D.C. WILLIAMS, S.H. WILLIAMS, S. WILLOCQ, R.J. WILSON, W.J. WISNIEWSKI, J.L. WITTLIN, M. WOODS, G.B. WORD, T.R. WRIGHT, J. WYSS, R.K. YAMAMOTO, J.M. YAMARTINO, X.Q. YANG, J. YASHIMA, S.J. YELLIN, C.C.YOUNG, H.YUTA, G. ZAPALAC, R.W. ZDARKO, C. ZEITLIN, J. ZHOU, Centre National de la Recherche Scientifique (CNRS)-École polytechnique (X)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3), Centre National de la Recherche Scientifique (CNRS)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Paris-Sud - Paris 11 (UP11), Centre National de la Recherche Scientifique (CNRS)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Pierre et Marie Curie - Paris 6 (UPMC), Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Institut Polytechnique de Grenoble - Grenoble Institute of Technology-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Joseph Fourier - Grenoble 1 (UJF)-Centre National de la Recherche Scientifique (CNRS), Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3), Laboratoire d'Annecy de Physique des Particules (LAPP/Laboratoire d'Annecy-le-Vieux de Physique des Particules), Centre National de la Recherche Scientifique (CNRS)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3), Centre National de la Recherche Scientifique (CNRS)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Aix Marseille Université (AMU), Université Joseph Fourier - Grenoble 1 (UJF)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Institut Polytechnique de Grenoble - Grenoble Institute of Technology-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA), Collège de France (CdF)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), GRUNEVALD M, NEWALD M, SCHAEL S, BARATE R, BRUNELIE, RE R, BUSKULIC D, DE BONIS I, DECAMP D, GHEZ P, GOY C, JE, ZE, QUEL S, LEES J, LUCOTTE A, MARTIN M, MERLE E, MINARD M, NIEF J, ODIER P, PIETRZYK B, TROCME, BRAVO S, CASADO MP, CHMEISSANI M, COMAS P, CRESPO JM, FERNANDEZ E, FERNANDEZ-BOSMAN M, GARRIDO L, GRAUGES E, JUSTE A, MARTINEZ M, MERINO G, MIQUEL R, MIR LM, ORTEU S, PACHECO A, PARK IC, PERLAS J, RIU I, RUIZ H, SANCHEZ F, COLALEO A, CREANZA D, DE FILIPPIS N, DE PALMA M, IASELLI G, MAGGI G, MAGGI M, NUZZO S, RANIERI, A, RASO, G, RUGGIERI F, SELVAGGI, G, SILVESTRIS L, TEMPESTA P, TRICOMI A, ZITO G, HUANG X, LIN J, OUYANG Q, WANG T, XIE Y, XU R, XUE S, ZHANG J, ZHANG L, ZHAO W, ABBANEO D, BAZARKO A, BECKER U, BOIX G, BIRD F, BLUCHER E, BONVICINI B, BRIGHT-THOMAS P, BARKLOW T, BUCHMU, LLER O, CATTANEO M, CERUTTI F, CIULLI V, CLERBAUX B, DREVERMANN H, FORTY RW, FRANK M, GREENING TC, HAGELBERG R, HALLEY AW, GIANOTTI F, GIRONE M, HANSEN JB, HARVEY J, JACOBSEN J, HUTCHCROFT DE, JANOT P, JOST B, KNOBLOCH J, KADO M, LEHRAUS I, LAZEYRAS P, and MALEY P
- Subjects
Top quark ,FORWARD-BACKWARD ASYMMETRY ,PARTICLE PHYSICS ,LARGE ELECTRON POSITRON COLLIDER ,ALEPH ,DELPHI ,L3 ,OPAL ,General Physics and Astronomy ,01 natural sciences ,7. Clean energy ,High Energy Physics - Experiment ,Settore FIS/04 - Fisica Nucleare e Subnucleare ,High Energy Physics - Experiment (hep-ex) ,High Energy Physics - Phenomenology (hep-ph) ,electron-positron physics ,[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex] ,Electroweak interaction ,Physics ,Quantum chromodynamics ,Electron–positron physics ,Electroweak interactions ,Decays of heavy intermediate gauge bosons ,Fermion–antifermion production ,Precision measurements at the Z resonance ,Tests of the Standard Model ,Radiative corrections ,Effective coupling constants ,Neutral weak current ,Z boson ,W boson ,Higgs boson ,Particle physics - Experiment ,Settore FIS/01 - Fisica Sperimentale ,FERMION-PAIR PRODUCTION ,HADRONIC-Z-DECAYS ,TOP-QUARK MASS ,ANGLE BHABHA SCATTERING ,W-BOSON MASS ,CROSS-SECTION ASYMMETRY ,Z-LINE-SHAPE ,SEMILEPTONIC BRANCHING RATIOS ,CARLO EVENT GENERATOR ,decays of heavy intermediate gauge bosons ,effective coupling constants ,electroweak interactions ,fermion-antifermion production ,higgs boson ,neutral weak current ,precision measurements at the z resonance ,radiative corrections ,tests of the standard model ,top quark ,w boson ,z boson ,Radiative correction ,High Energy Physics - Phenomenology ,FIS/01 - FISICA SPERIMENTALE ,Física nuclear ,Neutrino ,Particle physics ,FOS: Physical sciences ,ddc:500.2 ,Elementary particle physics ,LEP ,electroweak ,Decays of heavy intermediate gauge boson ,Effective coupling constant ,Partícules (Física nuclear) ,Standard Model ,electroweak theory, Z boson, DELPHI, ALEPH, OPAL, L3 ,0103 physical sciences ,010306 general physics ,Coupling constant ,010308 nuclear & particles physics ,High Energy Physics::Phenomenology ,Fermion ,FORWARD-BACKWARD ASYMMETRY, FERMION-PAIR PRODUCTION, HADRONIC-Z-DECAYS, TOP-QUARK MASS, ANGLE BHABHA SCATTERING, W-BOSON MASS, CROSS-SECTION ASYMMETRY, Z-LINE-SHAPE, SEMILEPTONIC BRANCHING RATIOS, CARLO EVENT GENERATOR ,[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph] ,Experimental High Energy Physics ,Electron–positron physic ,High Energy Physics::Experiment ,FIS/04 - FISICA NUCLEARE E SUBNUCLEARE - Abstract
We report on the final electroweak measurements performed with data taken at the Z resonance by the experiments operating at the electron-positron colliders SLC and LEP. The data consist of 17 million Z decays accumulated by the ALEPH, DELPHI, L3 and OPAL experiments at LEP, and 600 thousand Z decays by the SLD experiment using a polarised beam at SLC. The measurements include cross-sections, forward-backward asymmetries and polarised asymmetries. The mass and width of the Z boson, $\MZ$ and $\GZ$, and its couplings to fermions, for example the $\rho$ parameter and the effective electroweak mixing angle, are precisely measured. The number of light neutrino species is determined to be 2.9840+/-0.0082. The results are compared to the predictions of the Standard Model. Electroweak radiative corrections beyond the running of the QED and QCD coupling constants are observed with a significance of five standard deviations, and in agreement with the Standard Model. Of the many Z-pole measurements, the forward-backward asymmetry in b-quark production shows the largest difference with respect to its Standard Model expectation, at the level of 2.8 standard deviations. Through radiative corrections evaluated in the framework of the Standard Model, the masses of the top quark and the W Boson are predicted. These indirect constraints are compared to the direct measurements, providing a stringent test of the Standard Model. Using in addition the direct measurements of $\Mt$ and $\MW$, the mass of the as yet unobserved Standard Model Higgs boson is predicted., Comment: 302 pages, v2: minor corrections and updates of references. Accepted for publication by Physics Reports, v3: further small corrections and journal version
- Published
- 2006
- Full Text
- View/download PDF
8. Progression pattern and adverse events with bevacizumab in glioblastoma.
- Author
-
Mamo, A., Baig, A., Azam, M., Rho, Y. S., Sahebjam, S., Muanza, T., Owen, S., Petrecca, K., Guiot, M. C., Al-Shami, J., Sharma, R., and Kavan, P.
- Subjects
BEVACIZUMAB ,GLIOBLASTOMA multiforme ,DISEASE progression ,LEUCOPENIA ,NEUTROPENIA ,DRUG side effects - Abstract
Background The use of bevacizumab in the management of glioblastoma multiforme (GBM) remains controversial. In Canada, bevacizumab is approved for the treatment of recurrent GBM. We describe a pattern of progression across treatment lines in GBM. Methods During 2008-2014, 64 patients diagnosed with GBM were treated with bevacizumab at McGill University hospitals. Of those patients, 30 (46.9%) received bevacizumab in the first line (B1L), and 34 (53.1%) received it in the second line and beyond (B2L+). The average length of treatment with bevacizumab was 24.4 weeks (range: 0-232.7 weeks). The patterns of progression were categorized as local, distant, diffuse, multifocal, or multi-pattern. Results Local progression was seen in 46.7% of B1L patients and 26.5% of B2L+ patients, distant in 3.3% and 2.9%, diffuse in 20% and 47%, multifocal in 10% and 8.8%, and multi-pattern in 3.3% and 11.8%. No differences between the groups were observed for the distant (p = 0.3) or diffuse (p = 0.4) patterns. Grades 3 and 4 adverse events in the B1L and B2L+ groups were fatigue (33.3% vs. 17.6% respectively), hypertension (26.7% vs. 5.9%), thrombocytopenia (26.7% vs. 11.8%), neutropenia (26.7% vs. 11.8%), anemia (23.3% vs. 11.8%), leucopenia (20% vs. 8.8%), deep vein thrombosis (23.3% vs. 5.9%), seizure (16.7% vs. 8.8%), brain hemorrhage (6.7% vs. <1%), and delayed wound healing (6.7% vs. 2.9%). More total grades 3 and 4 adverse events occurred in the B1L group (p = 0.000519). Conclusions In our cohort, patterns of progression were not different in B1L and B2L+ patients. Moreover, both groups experienced similar adverse events, although more grades 3 and 4 events occurred in the B1L group, implying that severe adverse events in B1L patients could negatively affect survival outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
9. Synchronous metastatic skull base chordoma to the breast: case report and literature review.
- Author
-
Shakir, S. I., Pelmus, M., Florea, A., Boileau, J. F., Guiot, M. C., Di Maio, S., and Muanza, T. M.
- Subjects
SKULL base ,BREAST cancer ,BREAST cancer treatment ,CHORDOMA ,BRAIN imaging ,DISEASES ,BREAST metastasis - Abstract
Clinical Scenario During routine staging work-up for a left breast mass, a 68-year-old woman complained of dysphagia and dysphonia. During further investigations, a left-sided lesion at the foramen magnum was observed on brain imaging. Both lesions were biopsied and showed a classical chordoma. Management The skull-base lesion and the breast lesion were surgically resected, and adjuvant radiotherapy was given. Summary Chordoma is a rare primary central nervous system tumour that seldom metastasizes. The lung is the most common site of metastasis. Synchronous breast metastasis from a skull-base chordoma is very rare, and a safe management option includes a maximum resection followed by adjuvant radiotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
10. 432P - Patterns and Efficacy of Bevacizumab Use Across Treatment Lines in Glioblastoma
- Author
-
Azam, M.B., Rho, Y.S., Mamo, A., Sahebjam, S., Muanza, T., Guiot, M., Al-Shami, J., Sharma, R., and Kavan, P.
- Published
- 2014
- Full Text
- View/download PDF
11. Effects of DNA-dependent protein kinase inhibition by NU7026 on DNA repair and cell survival in irradiated gastric cancer cell line N87.
- Author
-
Niazi, M. T., Mok, G., Heravi, M., Lee, L., Vuong, T., Aloyz, R., Panasci, L., and Muanza, T.
- Subjects
DNA repair ,PROTEIN kinase inhibitors ,CANCER cells ,CELL lines ,PROTEIN kinase structure ,CELL cycle regulation ,APOPTOSIS ,CELL-mediated cytotoxicity - Abstract
Repair of radiation-induced DNA double-strand breaks is a key mechanism in cancer cell radio-resistance. The synthesized compound NU7026 specifically inhibits DNA-dependent protein kinase (DNA-PK) within the non-homologous end-joining repair mechanism. Earlier studies demonstrated increased radiosensitivity in DNA-PK deficient cells compared with wild-type cells. In chronic leukemia cells, NU7026 appears to enhance the cytotoxic effect of chlorambucil. The radio-modifying effects of NU7026 on cell survival, cell cycle, apoptosis, and dna double-strand break repair have yet to be studied in gastric cancer cells. Methods The gastric cancer cell line N87 was treated with 0 Gy or 4 Gy in the presence of NU7026 at a dose range of 0-20 μmol/L. Clonogenic assays were used to assess cell survival after treatment. Cell-cycle distribution was analyzed using propidium iodide with fluorescence-activated cell sorting. Apoptosis was detected using annexin-V and propidium iodide with fluorescence-activated cell sorting. The γH2AX assay was used to measure dna double-strand breaks. Results Statistically significant increases in G2/M arrest were observed inTM87 cells treated with radiation and NU7026 compared with those treated with radiation alone (p = 0.0004). Combined treatment also led to an increase in apoptosis (p = 0.01). At 24 hours, the γH2AX analysis revealed more dna double-strand breaks in N87 cells treated with radiation and NU7026 than in those treated with radiation alone (p = 0.04). Clonogenic assays demonstrated declining cell survival as both the radiation and the NU7026 dose increased. The dose enhancement factor at 0.1 survival fraction was 1.28 when N87 cells were treated with 4 Gy radiation and 5 μmol/L NU7026. Conclusions In gastric cancer cells, NU7026 appears to enhance the cytotoxic effect of irradiation as assessed by clonogenic assays. This increased cytotoxicity might be the result of an increase in dna double-strand breaks resulting in G2/M cell arrest and possibly higher levels of apoptosis. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
12. Effect of exercise in reducing breast and chest-wall pain in patients with breast cancer: a pilot study.
- Author
-
Wong, P., Muanza, T., Hijal, T., Masse, L., Pillay, S., Chasen, M., Lowensteyn, I., Gold, M., and Grover, S.
- Subjects
- *
EXERCISE therapy , *CHEST pain , *BREAST cancer patients , *QUALITY of life , *PHYSICAL training & conditioning , *RANDOMIZED controlled trials - Abstract
Background Breast or chest-wall pain (BCP) is prevalent in 20%-50% of breast cancer survivors, and it affects quality of life (QOL). To determine the feasibility and potential efficacy of an exercise program to improve patient qol and bcp, such a program was offered to breast cancer patients suffering from bcp. Methods The study enrolled 10 breast cancer patients with moderate-to-severe bcp at 3-6 months after completion of all adjuvant treatments. These patients participated in a 12-week comprehensive health improvement program (CHIP). Intensity was adjusted to reach 65%-85% of the patient's maximal heart rate. Before the chip and at 1 and 6 months after completion of the chip, qol and pain were measured using questionnaires [European Organisation for Research and Treatment of Cancer Quality of Life core and breast cancer modules (QLQ-C30, -BR23) and the McGill Pain Questionnaire short form] completed by the patients. Results were compared with those from case-matched control subjects from another study at McGill University. Results After the chip, patients reported significant and clinically important improvements in QOL and symptoms. At 1 and 6 months post-chip, patients in the study felt, on average, better in overall QOL than did historical control subjects. Conclusions Our study suggests that patients who experience chronic bcp may benefit from an exercise program. A randomized controlled trial is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
13. Characteristics and outcomes of medulloblastoma in adults.
- Author
-
Ang C, Hauerstock D, Guiot M, Kasymjanova G, Roberge D, Kavan P, and Muanza T
- Published
- 2008
14. 740 poster ADJUVANT INTERSTITIAL HIGH DOSE RATE BRACHYTHERAPY AS RE-IRRADIATION FOR RECURRENT BREAST CANCER-SAFETY AND EFFICACY
- Author
-
Bahoric, B., Stroian, G., Devic, S., DeBlois, F., Muanza, T., Tamim, N., sultanem, K., and Vuong, T.
- Published
- 2011
- Full Text
- View/download PDF
15. 61 THE EFFECT OF DNA-PK INHIBITION ON RADIOMODULATION AND CELL CYCLE DISTRIBUTION ON GASTRIC CANCER: PRELIMINARY RESULTS
- Author
-
Mok, G., Niazi, T., Heravi, M., Vuong, T., Sultanem, K., Bahoric, B., Aloyz, R., Panasci, L., and Muanza, T.
- Published
- 2009
- Full Text
- View/download PDF
16. 2522 POSTER Adult medulloblastoma: McGill experience
- Author
-
Ang, C., Hauerstock, D., Guiot, M.C., Kavan, P., Muanza, T., and Roberge, D.
- Published
- 2007
- Full Text
- View/download PDF
17. 1125 POSTER Chemotherapy has no impact on acute and late skin toxicity when combined with a hypofractionated regimen of breast irradiation
- Author
-
Al Hamad, A.N., Hijal, T., Sultanem, K., Faria, S., and Muanza, T.
- Published
- 2007
- Full Text
- View/download PDF
18. 110 A retrospective analysis of clinical and molecular characteristics of Her2/neu breast cancer patients with brain metastases
- Author
-
Hijal, T., Dawood, J., and Muanza, T.
- Published
- 2006
- Full Text
- View/download PDF
19. 77 Erythropoietin receptor expression in human squamous cell carcinoma of the tongue: Molecular considerations for radiation oncologists
- Author
-
Huang, F., Chauvin, P., Mehio, A., Muanza, T., and Shenouda, G.
- Published
- 2006
- Full Text
- View/download PDF
20. 42 A novel approach using accelerated hypo-fractionation-IMRT (AH-IMRT) and temozolomide (TMZ) in patients with glioblastoma multiforme (GBM)
- Author
-
Shenouda, G., Roberge, D., Kavan, P., Muanza, T., Lambert, C., Leblanc, R., Del Maestro, R., Guiot, M-C., and Souhami, L.
- Published
- 2006
- Full Text
- View/download PDF
21. 63 Evaluation of radiation-induced oral mucositis by optical coherence tomography
- Author
-
Muanza, T., Cotrim, A., Baumt, B., McAuliffe, M., Feldchtein, F., Amazeen, P., Coleman, N., Sowers, A., Cook, J., and Mitchell, J.
- Published
- 2005
- Full Text
- View/download PDF
22. Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
- Author
-
Marco Sergio, Thuraisingam Thusanth, Heravi Mitra, Xu Yong, Muanza Thierry, and Radzioch Danuta
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Secreted protein, acidic and rich in cysteine (SPARC) is a matricellular protein that mediates cell-matrix interactions. It has been shown, depending on the type of cancer, to possess either pro- or anti-tumorigenic properties. The transcriptional regulation of the SPARC gene expression has not been fully elucidated and the effects of anti-cancer drugs on this process have not been explored. Results In the present study, we demonstrated that chromatin remodeling factor Brg-1 is recruited to the proximal SPARC promoter region (-130/-56) through an interaction with transcription factor Sp1. We identified Brg-1 as a critical regulator for the constitutive expression levels of SPARC mRNA and protein in mammary carcinoma cell lines and for SPARC secretion into culture media. Furthermore, we found that Brg-1 cooperates with Sp1 to enhance SPARC promoter activity. Interestingly, fenretinide [N-4(hydroxyphenyl) retinamide, 4-HPR], a synthetic retinoid with anti-cancer properties, was found to up-regulate the transcription, expression and secretion of SPARC via induction of the Brg-1 in a dose-dependent manner. Finally, our results demonstrated that fenretinide-induced expression of SPARC contributes significantly to a decreased invasion of mammary carcinoma cells. Conclusions Overall, our results reveal a novel cooperative role of Brg-1 and Sp1 in mediating the constitutive and fenretinide-induced expression of SPARC, and provide new insights for the understanding of the anti-cancer effects of fenretinide.
- Published
- 2010
- Full Text
- View/download PDF
23. EGFR/DNA Targeting Molecule Potentiates Radiation Response in a Murine Breast Cancer Model.
- Author
-
Heravi, M., Muanza, T., Kumala, S., Rachid, Z., Jean-Claude, B., and Radzioch, D.
- Subjects
- *
BREAST cancer treatment , *EPIDERMAL growth factor receptors , *DNA , *RADIATION doses , *LABORATORY mice - Published
- 2013
- Full Text
- View/download PDF
24. Combination of Ionizing Radiation and DNA/EGFR Binary Targeting Molecule Delays DNA Double-Strands Repair
- Author
-
Heravi, M., Muanza, T., Rachid, Z., Jean-Claude, B., and Radzioch, D.
- Published
- 2012
- Full Text
- View/download PDF
25. Combination of Sorafenib with Ionizing Radiation Induces G2/M Cell Cycle Arrest in Breast Cancer Cells
- Author
-
Heravi, M., Muanza, T., Maeda, A., Lee, F., Tomic, N., Devic, S., Deblois, F., Liang, L., Vuong, T., and Radzioch, D.
- Published
- 2010
- Full Text
- View/download PDF
26. Use of 3D-ultrasound in the Detection of Breast Tumor Bed Displacement during Radiotherapy
- Author
-
Wong, P., Muanza, T., Reynard, E., Barker, J., Robert, K., and Sultanem, K.
- Published
- 2009
- Full Text
- View/download PDF
27. A Comparison of Helical Tomotherapy (HT), Fixed-field Intensity-modulated Radiotherapy (IMRT) and 3D Conformal Radiotherapy (3DCRT) Plans in Stereotactic Radiation Therapy of Skull Base Meningioma
- Author
-
Elhateer, H.S., Ruo, R., Muanza, T., Roberge, D., Lambert, C., Souhami, L., and Shenouda, G.
- Published
- 2008
- Full Text
- View/download PDF
28. What is the Actual Rate of Acute Skin Toxicity in Women Undergoing Adjuvant Radiation Therapy for Early Breast Cancer? Final Results of a Single Institution Phase II Study
- Author
-
Niazi, T., Azoulay, M., Sultanem, K., Muanza, T., Bahoric, B., Faria, S., and Vuong, T.
- Published
- 2011
- Full Text
- View/download PDF
29. DNA-PK inhibition of DNA Repair in Irradiated Gastric Cancer Cell Lines
- Author
-
Mok, G., Niazi, T., Heravi, M., Vuong, T., Aloyz, R., Panasci, L., and Muanza, T.
- Published
- 2010
- Full Text
- View/download PDF
30. In Vitro Radiomodulation of Gastric Cancer via DNA-PK Inhibition: Preliminary Results
- Author
-
Mok, G., Niazi, T., Heravi, M., Aloyz, R., Panasci, L., and Muanza, T.
- Published
- 2009
- Full Text
- View/download PDF
31. Chemotherapy has no Impact on Quality of Life when Combined with a Hypofractionated Regimen of Breast Irradiation
- Author
-
Hijal, T., Al Hamad, A., Khalaf, N., Sultanem, K., Faria, S., and Muanza, T.
- Published
- 2008
- Full Text
- View/download PDF
32. Long-term Analysis of Pure Low Grade Oligodendroglioma
- Author
-
Souhami, L., Elhateer, H.S., Roberge, D., Guiot, M.C., Del Maestro, R.F., Eldebawy, E., Muanza, T., Kavan, P., and Leblanc, R.
- Published
- 2008
- Full Text
- View/download PDF
33. A Multi-institutional Comparison Study Evaluating the use of 3D-ultrasound for Defining the Breast Tumor Bed for IGRT in Chemotherapy versus Non-chemotherapy Patients
- Author
-
Wong, P., Heimann, R., Hard, D., Archambault, J., Muanza, T., and Sultanem, K.
- Published
- 2008
- Full Text
- View/download PDF
34. Accelerated Hypofractionated Intensity Modulated Radiotherapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma Multiforme: A Safety and Efficacy Analysis
- Author
-
Panet-Raymond, V., Roberge, D., Souhami, L., Shakibnia, L., Kavan, P., Muanza, T., Lambert, C., Guiot, M.C., and Shenouda, G.
- Published
- 2007
- Full Text
- View/download PDF
35. Estrogen Receptor Status Is a Significant Predictor of Overall and Brain Metastasis-Free Survival in Patients With Breast Cancer and Brain Metastases Treated With Trastuzumab
- Author
-
Hijal, T., Rajakesari, S., Patel, S., and Muanza, T.
- Published
- 2007
- Full Text
- View/download PDF
36. Models and Biomarkers for Local Response Prediction in Early-Stage and Oligometastatic Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy Using Machine Learning.
- Author
-
Ramasamy G, Muanza T, Kasymjanova G, and Agulnik J
- Abstract
Background A minority of patients receiving stereotactic body radiation therapy (SBRT) for non-small cell lung cancer (NSCLC) are not good responders. Radiomic features can be used to generate predictive algorithms and biomarkers that can determine treatment outcomes and stratify patients to their therapeutic options. This study investigated and attempted to validate the radiomic and clinical features obtained from early-stage and oligometastatic NSCLC patients who underwent SBRT, to predict local response. Methodology A single-institution, Institutional Review Board (IRB)-approved retrospective review was conducted on adult patients with early-stage and oligometastatic SBRT-treated NSCLC at the Jewish General Hospital. The study included 98 patients (82 with early-stage NSCLC and 16 with oligometastatic disease), with a median age of 76 years and a male-to-female ratio of 46:52. A total of 116 lesions were treated with SBRT between 2009 and 2022. Radiomics features ( n = 107) were extracted from CT planning scans using PyRadiomics, and clinical data were collected for all 98 patients. Local response was assessed according to Response Evaluation Criteria In Solid Tumors (RECIST 1.1) criteria. Classification models, including support vector machines, random forests, adaptive boosting, and multi-layer perceptrons (MLPs), were used. Models were trained using a fivefold cross-validation scheme. Their performances were measured with receiver operating characteristic plots on the validation folds. Using the importance of the permutation feature, predictive biomarkers were identified. Results The most predictive model, incorporating all patients and using an MLP classifier with Adaptive Synthetic (ADASYN) sampling, a combined-input approach, and a radiomic filter, achieved an area under the curve (AUC) of 0.94 ± 0.05. When oligometastatic patients were omitted, the best model (AUC 0.95 ± 0.06) was also predictive, using a support vector classification (SVC) radial basis function (RBF) classifier, ADASYN sampling, and a clinical-based input. Treatment site and performance status, along with radiomic features such as first-order root-mean-squared-intensity, first-order skewness, and gray-level nonuniformity, were found to be predictive biomarkers. Conclusions The predictive models generated and the biomarkers identified could be used in clinical decision support systems for SBRT-treated NSCLC patients. Additionally, treatment site, performance status, and radiomic features were the most predictive variables., Competing Interests: Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. The Research Ethics Board of CIUSSS West-Central Montreal issued approval 2019-1488. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: This work was supported by Medteq Innovation [10-30 AI Multicentrique]. The funding source had no involvement in: the study design; the collection, analysis and interpretation of data; the writing of the report; and the decision to submit the article for publication. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Ramasamy et al.)
- Published
- 2024
- Full Text
- View/download PDF
37. Radiomics As Biomarkers for the Treatment of Non-small Cell Lung Cancer With Stereotactic Body Radiation Therapy: A Review of Concepts.
- Author
-
Ramasamy G and Muanza T
- Abstract
Stereotactic body radiation therapy (SBRT) is currently the alternative for inoperable early-stage and oligometastatic non-small cell lung cancer (NSCLC) patients. While most patients are good responders among this specific group, some patients do not experience the benefits of this treatment. Even though physicians use clinical variables and semantic radiological features to make treatment decisions, medical images contain a wealth of personalized pathophysiological information that can be extracted and used for clinical decision support systems. In the form of radiomics features, details unique to each patient's medical scans can be utilized to create predictive models and to identify biomarking signatures. Then, these tools and indices can predict treatment outcomes and categorize patients to the most optimal treatment regimen. A conceptual review of relevant topics centered around the identification and development of radiomic-based biomarkers for SBRT-treated NSCLC was conducted. To begin with, an overview of the nature and management of non-small cell lung cancer was provided. To continue, biomarkers were defined in the context of cancer care. Then, the uses of stereotactic body radiation therapy in the treatment of NSCLC were further explained. Finally, the study of radiomics was discussed, and the uses and limitations of radiomic features and ML for SBRT-treated NSCLC were expanded upon. Radiomics-based biomarkers and predictive algorithmic models can potentially improve the SBRT treatment of early-stage and oligometastatic NSCLC by providing personalized support systems to healthcare professionals. While many institutions are attempting to optimize their biomarkers and AI-based tools for clinical use, additional prospective studies are needed to properly ensure their efficacy. As such, the improvements made in the field of personalized medicine are promising., Competing Interests: Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: This work was supported by Medteq Innovation [10-30 AI Multicentrique]. The funding source had no involvement in the study design, the writing of the manuscript, and the decision to submit the article for publication. . Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Ramasamy et al.)
- Published
- 2024
- Full Text
- View/download PDF
38. Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.
- Author
-
Tonneau M, Phan K, Manem VSK, Low-Kam C, Dutil F, Kazandjian S, Vanderweyen D, Panasci J, Malo J, Coulombe F, Gagné A, Elkrief A, Belkaïd W, Di Jorio L, Orain M, Bouchard N, Muanza T, Rybicki FJ, Kafi K, Huntsman D, Joubert P, Chandelier F, and Routy B
- Abstract
Background: Recent developments in artificial intelligence suggest that radiomics may represent a promising non-invasive biomarker to predict response to immune checkpoint inhibitors (ICIs). Nevertheless, validation of radiomics algorithms in independent cohorts remains a challenge due to variations in image acquisition and reconstruction. Using radiomics, we investigated the importance of scan normalization as part of a broader machine learning framework to enable model external generalizability to predict ICI response in non-small cell lung cancer (NSCLC) patients across different centers., Methods: Radiomics features were extracted and compared from 642 advanced NSCLC patients on pre-ICI scans using established open-source PyRadiomics and a proprietary DeepRadiomics deep learning technology. The population was separated into two groups: a discovery cohort of 512 NSCLC patients from three academic centers and a validation cohort that included 130 NSCLC patients from a fourth center. We harmonized images to account for variations in reconstruction kernel, slice thicknesses, and device manufacturers. Multivariable models, evaluated using cross-validation, were used to estimate the predictive value of clinical variables, PD-L1 expression, and PyRadiomics or DeepRadiomics for progression-free survival at 6 months (PFS-6)., Results: The best prognostic factor for PFS-6, excluding radiomics features, was obtained with the combination of Clinical + PD-L1 expression (AUC = 0.66 in the discovery and 0.62 in the validation cohort). Without image harmonization, combining Clinical + PyRadiomics or DeepRadiomics delivered an AUC = 0.69 and 0.69, respectively, in the discovery cohort, but dropped to 0.57 and 0.52, in the validation cohort. This lack of generalizability was consistent with observations in principal component analysis clustered by CT scan parameters. Subsequently, image harmonization eliminated these clusters. The combination of Clinical + DeepRadiomics reached an AUC = 0.67 and 0.63 in the discovery and validation cohort, respectively. Conversely, the combination of Clinical + PyRadiomics failed generalizability validations, with AUC = 0.66 and 0.59., Conclusion: We demonstrated that a risk prediction model combining Clinical + DeepRadiomics was generalizable following CT scan harmonization and machine learning generalization methods. These results had similar performances to routine oncology practice using Clinical + PD-L1. This study supports the strong potential of radiomics as a future non-invasive strategy to predict ICI response in advanced NSCLC., Competing Interests: Author BR reports research funding with the company Imagia. Authors KP, CL-K, FD, LJ, FR, KK, DH, and FIC were Imagia employees at the time of the study. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Tonneau, Phan, Manem, Low-Kam, Dutil, Kazandjian, Vanderweyen, Panasci, Malo, Coulombe, Gagné, Elkrief, Belkaïd, Di Jorio, Orain, Bouchard, Muanza, Rybicki, Kafi, Huntsman, Joubert, Chandelier and Routy.)
- Published
- 2023
- Full Text
- View/download PDF
39. Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.
- Author
-
Auclin E, Benitez-Montanez J, Tagliamento M, Parisi F, Gorria T, Garcia-Campelo R, Dempsey N, Pinato DJ, Reyes R, Albarrán-Artahona V, Dall'Olio F, Soldato D, Hendriks L, Nana FA, Tonneau M, Lopez-Castro R, Nadal E, Kazandjian S, Muanza T, Blanc-Durand F, Fabre E, Castro N, Arasanz H, Rochand A, Besse B, Routy B, and Mezquita L
- Subjects
- Humans, Female, Middle Aged, Male, Retrospective Studies, Immunotherapy, Progression-Free Survival, Taxoids therapeutic use, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carcinoma, Non-Small-Cell Lung drug therapy, Lung Neoplasms pathology
- Abstract
Introduction: Chemotherapy plus immunotherapy is the standard of care for patients with metastatic NSCLC. No study has evaluated the outcomes of second-line chemotherapy treatments after progression following first-line chemo-immunotherapy., Method: This multicenter retrospective study evaluated the efficacy of second line (2L) chemotherapies after progression under first-line (1L) chemo-immunotherapy, measured by overall survival (2L-OS) and progression free survival (2L-PFS)., Results: A total of 124 patients were included. The mean age was 63.1 years, 30.6 % of the patients were female, 72.6 % had an adenocarcinoma and 43.5 % had a poor ECOG-performance status prior to 2L initiation. Sixty-four (52.0 %) patients were considered resistant to first line chemo-immunotherapy. (1L-PFS < 6 months). In 2L treatments, 57 (46.0 %) patients received taxane monotherapy, 25 (20.1 %) taxane plus anti-angiogenic, 12 (9.7 %) platinum-based chemotherapy and 30 (24.2 %) other chemotherapy. At a median follow-up of 8.3 months (95 %CI: 7.2-10.2), post initiation of 2L treatment, the median 2L-OS was 8.1 months (95 % CI: 6.4-12.7) and the median 2L-PFS was 2.9 months (95 %CI: 2.4-3.3). Overall, the 2L-objective response and 2L-disease control rates were 16.0 %, and 42.5 %, respectively. Taxane plus anti-angiogenic and platinum rechallenge achieved longest median 2L-OS: not reached (95 %CI: 5.8-NR) and 17.6 months (95 %CI 11.6-NR), respectively (p = 0.05). Patients resistant to the 1L treatment had inferior outcomes (2L-OS 5.1 months, 2L-PFS 2.3 months) compared with 1L responders (2L-OS 12.7 months, 2L-PFS 3.2 months)., Conclusion: In this real-life cohort, 2L chemotherapy achieved modest activity following progression under chemo-immunotherapy. 1L-resistant patients remained a refractory population, highlighting a need for new 2L strategies., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2023
- Full Text
- View/download PDF
40. Neuronal GPR81 regulates developmental brain angiogenesis and promotes brain recovery after a hypoxic ischemic insult.
- Author
-
Chaudhari P, Madaan A, Rivera JC, Charfi I, Habelrih T, Hou X, Nezhady M, Lodygensky G, Pineyro G, Muanza T, and Chemtob S
- Subjects
- Animals, Animals, Newborn, Brain metabolism, Female, Infarction, Ischemia metabolism, Lactic Acid metabolism, Mice, Mice, Knockout, Neurons metabolism, Pregnancy, Thrombospondin 1 metabolism, Brain Injuries metabolism, Hypoxia-Ischemia, Brain metabolism, Neovascularization, Physiologic, Receptors, G-Protein-Coupled genetics
- Abstract
Perinatal hypoxic/ischemic (HI) brain injury is a major clinical problem with devastating neurodevelopmental outcomes in neonates. During HI brain injury, dysregulated factor production contributes to microvascular impairment. Glycolysis-derived lactate accumulated during ischemia has been proposed to protect against ischemic injury, but its mechanism of action is poorly understood. Herein, we hypothesize that lactate via its G-protein coupled receptor (GPR81) controls postnatal brain angiogenesis and plays a protective role after HI injury. We show that GPR81 is predominantly expressed in neurons of the cerebral cortex and hippocampus. GPR81-null mice displayed a delay in cerebral microvascular development linked to reduced levels of various major angiogenic factors and augmented expression of anti-angiogenic Thrombospondin-1 (TSP-1) in comparison to their WT littermates. Coherently, lactate stimulation induced an increase in growth factors (VEGF, Ang1 and 2, PDGF) and reduced TSP-1 expression in neurons, which contributed to accelerating angiogenesis. HI injury in GPR81-null animals curtailed vascular density and consequently increased infarct size compared to changes seen in WT mice; conversely intracerebroventricular lactate injection increased vascular density and diminished infarct size in WT but not in GPR81-null mice. Collectively, we show that lactate acting via GPR81 participates in developmental brain angiogenesis, and attenuates HI injury by restoring compromised microvasculature.
- Published
- 2022
- Full Text
- View/download PDF
41. Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib.
- Author
-
Owen S, Alken S, Alshami J, Guiot MC, Kavan P, Reardon DA, Muanza T, Gibson N, Pemberton K, Solca F, Cseh A, and Saran F
- Abstract
Glioblastoma is an aggressive form of central nervous system tumor. Recurrence rates following primary therapy are high, and few second-line treatment options provide durable clinical benefit. Aberrations of the epidermal growth factor receptor ( EGFR ) gene are observed in up to 57% of glioblastoma cases and EGFR overexpression has been identified in approximately 60% of primary glioblastomas. In preclinical studies, afatinib, a second-generation ErbB blocker, inhibited cell proliferation in cells harboring mutations commonly found in glioblastoma. In two previous Phase I/II studies of afatinib plus temozolomide in patients with glioblastoma, limited efficacy was observed; however, there was notable benefit in patients with the EGFR variant III ( EGFRvIII) mutation, EGFR amplification, and those with loss of phosphatase and tensin homolog (PTEN). This case series report details treatment histories of three long-term responders from these trials. Next-generation sequencing of tumor samples identified alterations in a number of cancer-related genes, including mutations in, and amplification of, EGFR . Tumor samples from all three patients shared favorable prognostic factors, eg O
6 -methylguanine-DNA methyl-transferase ( MGMT ) gene promoter methylation; however, negative prognostic factors were also observed, suggesting that these shared genetic features did not completely account for the favorable responses. The genetic profile of the tumor from Patient 1 showed clear differences from the other two tumors: lack of involvement of EGFR aberrations but with a mutation occurring in PTPN11 . Preclinical studies showed that single-agent afatinib and temozolomide both separately inhibit the growth of tumors with a C-terminal EGFR truncation, thus providing further rationale for combining these two agents in the treatment of glioblastomas harboring EGFR aberrations. These findings suggest that afatinib may provide treatment benefit in patients with glioblastomas that harbor ErbB family aberrations and, potentially, other genetic aberrations. Further studies are needed to establish which patients with newly diagnosed/recurrent glioblastomas may potentially benefit from treatment with afatinib., Competing Interests: Scott Owen reports being part of an advisory council or committee for Bayer, Bristol-Myers Squibb, Merck, Pfizer; and receiving honoraria from AstraZeneca, Bayer, Bristol-Myers Squibb, Merck, Pfizer, and Roche. David A Reardon reports research support (paid to Dana-Farber Cancer Institute) from Acerta Pharmaceuticals, Agenus, Celldex, EMD Serono, Incyte, Inovio, Omniox, Tragara; advisory/consultation (paid to Dr. Reardon) from AbbVie, Advantagene, Agenus, Agios, Amgen, AnHeart Therapeutics, Bayer, Boston Biomedical, Boehringer Ingelheim, Bristol-Myers Squibb, Celldex, Deciphera, Del Mar Pharma, DNAtrix, Ellipses Pharma, EMD Serono, Genenta, Genentech/Roche, Hoffman-LaRoche, Ltd, Imvax, Inovio, Kintara, Kiyatec, Medicenna Biopharma, Inc., Merck, Merck KGaA, Monteris, Neuvogen, Novartis, Novocure, Oncorus, Oxigene, Regeneron, Stemline, Sumitomo Dainippon Pharma, Pyramid, Taiho Oncology, Inc., Y-mabs Therapeutics; honoraria (paid to Dr. Reardon) from AbbVie, Advantagene, Agenus, Agios, Amgen, Bayer, Boston Biomedical, Boehringer Ingelheim, Bristol-Myers Squibb, Celldex, Deciphera, DelMar, Ellipses Pharma, EMD Serono, Genenta, Genentech/Roche, Imvax, Inovio, Kintara, Kiyatec, Medicenna Biopharma, Inc., Merck, Merck KGaA, Monteris, Neuvogen, Novartis, Novocure, Oncorus, Oxigene, Regeneron, Stemline, Sumitomo Dainippon Pharma, Taiho Oncology, Inc. Neil Gibson is an employee of Boehringer-Ingelheim GmbH & Co. KG. Karine Pemberton declares being a Global project Manager working for Boehringer Ingelheim. Flavio Solca reports employment from Boehringer Ingelheim RCV, during the conduct of the study; In addition, Flavio Solca is a co-inventor on Patent WO 02/50043 A1 describing afatinib. Agnieszka Cseh was an employee of Boehringer Ingelheim International. Current affiliation for Frank Saran is at the Department of Radiation Oncology, Auckland District Health Board, Auckland, New Zealand. The remaining authors report no potential conflicts of interest in this work., (© 2022 Owen et al.)- Published
- 2022
- Full Text
- View/download PDF
42. Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancer.
- Author
-
Tejera D, Rana M, Basik M, Boileau JF, Margolese R, Prakash I, Meguerditchian AN, Muanza T, Monette J, and Wong SM
- Subjects
- Aged, Aged, 80 and over, Axilla pathology, Female, Humans, Lymph Node Excision, Mastectomy, Mastectomy, Segmental, Neoplasm Staging, Receptors, Estrogen, Sentinel Lymph Node Biopsy, Breast Neoplasms epidemiology, Breast Neoplasms pathology, Breast Neoplasms therapy
- Abstract
Purpose: To examine the proportion of older women with ER + HER2- breast cancer receiving non-operative management versus surgery, and to evaluate the use of axillary staging and adjuvant radiation in this population., Methods: We queried the SEER database to identify all women aged 70 years or older with stage I-III ER + HER2- invasive breast cancer diagnosed between 2010 and 2016. We evaluated trends in non-operative management, breast surgery, axillary staging, and adjuvant radiation according to age at diagnosis., Results: We identified 57,351 older women with ER + HER2- disease. Overall, 3538 (6.2%) of the cohort underwent non-operative management, 38,452 (67.0%) underwent breast-conserving surgery (BCS), and 15,361 (26.8%) underwent mastectomy. The proportion of patients undergoing non-operative management increased from 2.8% among 70-74-year-old women to 30.1% in those ≥ 90 years old (p < 0.001). In 53,813 women who underwent surgery, 36,850 (68.5%) underwent sentinel lymph node biopsy, while 10,861 (20.2%) underwent axillary lymph node dissection. Subgroup analysis of 29,032 older women undergoing BCS for stage I ER + HER2- breast cancer revealed a 14.2% rate of omission of axillary staging, increasing from 5.3% in those 70-74 years to 67.6% in those ≥ 90 years old (p < 0.001). Receipt of adjuvant radiation occurred in 63.3% of older women following BCS and 18% post-mastectomy, with similar trends towards omission in older age groups., Conclusion: Primary breast surgery remains the dominant management strategy for the majority of older women with ER + HER2- breast cancer. Omission of axillary staging and adjuvant radiation are used in a minority of eligible women undergoing breast conservation for early-stage disease., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
43. Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer.
- Author
-
Wong SM, Basik M, Florianova L, Margolese R, Dumitra S, Muanza T, Carbonneau A, Ferrario C, and Boileau JF
- Subjects
- Axilla, Humans, Lymph Node Excision, Lymph Nodes surgery, Neoadjuvant Therapy, Neoplasm Recurrence, Local drug therapy, Prospective Studies, Retrospective Studies, Sentinel Lymph Node Biopsy, Breast Neoplasms drug therapy, Breast Neoplasms surgery, Sentinel Lymph Node surgery
- Abstract
Background: The oncologic safety of sentinel lymph node biopsy (SLNB) alone for clinically node-positive (cN1-2) patients who convert to pathologic node-negativity (ypN0) after neoadjuvant chemotherapy (NAC) is not well established., Methods: This study retrospectively identified 244 consecutive patients with a diagnosis of cT1-3cN0-2 breast cancer who underwent NAC followed by SLNB at the authors' institution between 2013 and 2018. The patients were categorized as clinically node-negative (cN0) or cN1-2 before the onset of NAC, and the Kaplan-Meier method was used to compare locoregional and distant recurrence rates after SLNB alone for ypN0 patients., Results: Among 244 patients who underwent NAC followed by surgery with SLNB for axillary staging, 112 (45.9%) were cN0 at presentation, whereas 132 (54.5%) had biopsy-proven cN1-2 disease and converted to cN0 after treatment. Of the patients presenting with cN0 disease, 102 (91.1%) were ypN0 on SLNB pathology compared with 60 cN1/2 patients (45.5%; p < 0.001). Regional nodal irradiation was administered to 5% of the cN0/ypN0 patients compared with 70.7% of the cN1-2/ypN0 patients (p < 0.001). Overall, 211 patients were treated with SLNB alone and had a median follow-up period of 36 months (interquartile range [IQR], 24-53 months). For 101 cN0/ypN0 patients who underwent SLNB alone, the 5-year local and regional recurrence rates were respectively 5.7% (95% confidence interval [CI], 2.4-13.8) and 1% (95% CI 0.1-7.0). For 58 cN1-2/ypN0 patients who underwent SLNB alone, the 5-year local and regional recurrence rates were respectively 4.1% (95% CI 1.0-15.5) and 0%, with no axillary recurrences noted., Conclusion: For ypN0 patients, SLNB alone after NAC is associated with low and acceptable short-term axillary recurrence rates. Additional follow-up data from prospective clinical trials are needed to confirm long-term oncologic safety and define optimal local therapy recommendations.
- Published
- 2021
- Full Text
- View/download PDF
44. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
- Author
-
Whelan TJ, Julian JA, Berrang TS, Kim DH, Germain I, Nichol AM, Akra M, Lavertu S, Germain F, Fyles A, Trotter T, Perera FE, Balkwill S, Chafe S, McGowan T, Muanza T, Beckham WA, Chua BH, Gu CS, Levine MN, and Olivotto IA
- Subjects
- Aged, Australia, Breast Neoplasms surgery, Canada, Carcinoma in Situ pathology, Carcinoma in Situ surgery, Carcinoma, Ductal, Breast surgery, Female, Humans, Mastectomy, Segmental, Middle Aged, Neoplasm Invasiveness, Neoplasm Recurrence, Local prevention & control, New Zealand, Prognosis, Survival Rate, Brachytherapy methods, Breast Neoplasms radiotherapy, Carcinoma in Situ radiotherapy, Carcinoma, Ductal, Breast radiotherapy
- Abstract
Background: Whole breast irradiation delivered once per day over 3-5 weeks after breast conserving surgery reduces local recurrence with good cosmetic results. Accelerated partial breast irradiation (APBI) delivered over 1 week to the tumour bed was developed to provide a more convenient treatment. In this trial, we investigated if external beam APBI was non-inferior to whole breast irradiation., Methods: We did this multicentre, randomised, non-inferiority trial in 33 cancer centres in Canada, Australia and New Zealand. Women aged 40 years or older with ductal carcinoma in situ or node-negative breast cancer treated by breast conserving surgery were randomly assigned (1:1) to receive either external beam APBI (38·5 Gy in ten fractions delivered twice per day over 5-8 days) or whole breast irradiation (42·5 Gy in 16 fractions once per day over 21 days, or 50 Gy in 25 fractions once per day over 35 days). Patients and clinicans were not masked to treatment assignment. The primary outcome was ipsilateral breast tumour recurrence (IBTR), analysed by intention to treat. The trial was designed on the basis of an expected 5 year IBTR rate of 1·5% in the whole breast irradiation group with 85% power to exclude a 1·5% increase in the APBI group; non-inferiority was shown if the upper limit of the two-sided 90% CI for the IBTR hazard ratio (HR) was less than 2·02. This trial is registered with ClinicalTrials.gov, NCT00282035., Findings: Between Feb 7, 2006, and July 15, 2011, we enrolled 2135 women. 1070 were randomly assigned to receive APBI and 1065 were assigned to receive whole breast irradiation. Six patients in the APBI group withdrew before treatment, four more did not receive radiotherapy, and 16 patients received whole breast irradiation. In the whole breast irradiation group, 16 patients withdrew, and two more did not receive radiotherapy. In the APBI group, a further 14 patients were lost to follow-up and nine patients withdrew during the follow-up period. In the whole breast irradiation group, 20 patients were lost to follow-up and 35 withdrew during follow-up. Median follow-up was 8·6 years (IQR 7·3-9·9). The 8-year cumulative rates of IBTR were 3·0% (95% CI 1·9-4·0) in the APBI group and 2·8% (1·8-3·9) in the whole breast irradiation group. The HR for APBI versus whole breast radiation was 1·27 (90% CI 0·84-1·91). Acute radiation toxicity (grade ≥2, within 3 months of radiotherapy start) occurred less frequently in patients treated with APBI (300 [28%] of 1070 patients) than whole breast irradiation (484 [45%] of 1065 patients, p<0·0001). Late radiation toxicity (grade ≥2, later than 3 months) was more common in patients treated with APBI (346 [32%] of 1070 patients) than whole breast irradiation (142 [13%] of 1065 patients; p<0·0001). Adverse cosmesis (defined as fair or poor) was more common in patients treated with APBI than in those treated by whole breast irradiation at 3 years (absolute difference, 11·3%, 95% CI 7·5-15·0), 5 years (16·5%, 12·5-20·4), and 7 years (17·7%, 12·9-22·3)., Interpretation: External beam APBI was non-inferior to whole breast irradiation in preventing IBTR. Although less acute toxicity was observed, the regimen used was associated with an increase in moderate late toxicity and adverse cosmesis, which might be related to the twice per day treatment. Other approaches, such as treatment once per day, might not adversely affect cosmesis and should be studied., Funding: Canadian Institutes for Health Research and Canadian Breast Cancer Research Alliance., (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
45. On Capturing Radiological Diagnoses of Brain Tumors to Provide Complete Population Data in Cancer Registries in Canada.
- Author
-
Yuan Y, Amjad S, Eckstrand A, Sevick R, Scott J, Devji S, Bertrand C, King MJ, Brunka V, Maplethorpe E, Walker E, Muanza T, and Davis F
- Abstract
Nonmalignant brain tumors are underreported by an estimated 60% in Canadian cancer registries. One explanation is that radiology facilities or their databases may not be adequately included in the cancer reporting infrastructure. A multidisciplinary stakeholder team met for 1 day, followed by teleconferences, to discuss the evidence for the importance of incorporating radiology diagnoses in brain tumor reports. A role for the neuroradiologist was delineated in brain tumor diagnosis and in ensuring that radiology report information is available to support cancer case ascertainment in the cancer surveillance system. It was noted that brain tumors identified through imaging are clinically managed depending on the diagnosis and prognosis of the disease, and that patient radiology reports become a part of a larger administrative information system. The proportion of nonmalignant brain tumors diagnosed using histology is lower in the United States (49.3%) than in Canada (59%), suggesting that a higher proportion of cases with nonhistologic (likely radiology) diagnosis are captured by the US system (eg, tumors of the sellar region, cranial and spinal tumors, and tumors of the meninges). Finding a way to use existing electronic radiology reports to identify nonmalignant brain tumors needs to be prioritized. This will require access to electronic radiology reports, as manual reporting is impractical. Once access is achieved, an electronic flag to identify new cases through a natural language processing algorithm could be pursued. As radiologists and cancer registrars become more familiar with each other's mandates and workflow demands, innovative and collaborative solutions to improve case ascertainment for brain and other cancers are likely to emerge.
- Published
- 2018
46. A Pilot Randomized Controlled Trial on the Effects of a Progressive Exercise Program on the Range of Motion and Upper Extremity Grip Strength in Young Adults With Breast Cancer.
- Author
-
Ibrahim M, Muanza T, Smirnow N, Sateren W, Fournier B, Kavan P, Palumbo M, Dalfen R, and Dalzell MA
- Subjects
- Adult, Axilla, Breast surgery, Female, Humans, Mastectomy adverse effects, Pilot Projects, Prospective Studies, Radiotherapy, Adjuvant adverse effects, Radiotherapy, Adjuvant methods, Shoulder Pain etiology, Treatment Outcome, Young Adult, Breast Neoplasms therapy, Exercise Therapy methods, Hand Strength physiology, Range of Motion, Articular, Shoulder Joint physiology, Shoulder Pain rehabilitation
- Abstract
Background: The diagnosis of breast cancer in young women (aged 18-45 years) has been increasing. Women are commonly left coping with treatment-related disabilities of the upper limb that can persist for > 2 years postoperatively., Patients and Methods: A total of 59 young breast cancer patients (29 in the intervention group and 30 in the control group) participated in a pilot prospective randomized controlled trial to determine whether a 12-week postradiation exercise program would improve long-term arm mobility, pain, and handgrip strength. During an 18-month period, range of motion, handgrip strength, and pain with shoulder movements were evaluated at 6 points., Results: Although the differences were not statistically significant, external rotation and horizontal abduction of the shoulder improved in the intervention group immediately after the exercise intervention (3 months) and showed a trend toward less pain on movement. However, at 18 months after radiation the control and intervention groups both retained a residual loss of range and persistent pain with movement. Radiation to the axilla and/or chest wall yielded long-term (18 months) limitations in flexion and horizontal abduction compared with hypofractionation, which resulted in greater flexion and external rotation at 18 months. The median grip strength of the study participants corresponded to the 10th percentile of healthy aged-matched white women., Conclusion: The exercise intervention timed shortly after radiation improved short-term shoulder mobility and pain; however, these gains were not sustained at 18 months after radiation., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
47. Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells.
- Author
-
Ghashghaei M, Niazi TM, Heravi M, Bekerat H, Trifiro M, Paliouras M, and Muanza T
- Subjects
- Antineoplastic Agents therapeutic use, Apoptosis drug effects, Benzamides, Cell Cycle Checkpoints drug effects, Cell Line, Tumor, Cellular Senescence drug effects, DNA Damage drug effects, Drug Administration Schedule, Humans, Male, Nitriles, Phenylthiohydantoin pharmacology, Phenylthiohydantoin therapeutic use, Prostatic Neoplasms drug therapy, Radiation-Sensitizing Agents therapeutic use, Antineoplastic Agents pharmacology, Cell Survival drug effects, Phenylthiohydantoin analogs & derivatives, Prostatic Neoplasms pathology, Radiation-Sensitizing Agents pharmacology
- Abstract
Background: Prostate cancer (PCa) is a progressive disease and the most diagnosed cancer in men. The current standard of care for high-risk localized PCa is a combination of androgen deprivation therapy (ADT) and radiation (XRT). The majority of these patients however become resistant due to incomplete responses to ADT as a result of selective cells maintaining androgen receptor (AR) activity. Improvement can be made if increasing radiosensitivity is realized. Therefore, the aim of this study is to investigate the efficacy of the next-generation PCa drug Enzalutamide (ENZA), as a radiosensitizer in XRT therapy., Methods: Using a number of androgen-dependent (LNCaP, PC3-T877A) and androgen-independent (C4-2, 22RV1, PC3, PC3-AR V7) cell lines, the effect of ENZA as a radiosensitizer was studied alone or in combination with ADT and/or XRT. Cell viability and cell survival were assessed, along with determination of cell cycle arrest, DNA damage response and repair, apoptosis and senescence., Results: Our results indicated that either ENZA alone (in AR positive, androgen-dependent PCa cells) or in combination with ADT (in AR positive, hormone-insensitive PCa cells) potentiates radiation response [Dose enhancement factor (DEF) of 1.75 in LNCAP and 1.35 in C4-2] stronger than ADT + XRT conditions. Additionally, ENZA sensitized androgen dependent PCa cells to XRT in a schedule-dependent manner, where concurrent administration of ENZA and radiation lead to a maximal radiosensitization when compared to either drug administration prior or after XRT. In LNCaP cells, ENZA treatment significantly prolonged the presence of XRT-induced phospho-γH2AX up to 24 h after treatment; suggesting enhanced DNA damage. It also significantly increased XRT-induced apoptosis and senescence., Conclusions: Our data indicates that ENZA acts as a much stronger radiosensitizer compared to ADT. We have also observed that its efficacy is schedule dependent and related to increased levels of DNA damage and a delay of DNA repair processes. Finally, the initial abrogation of DNA-PKcs activity by AR inhibition and its subsequent recovery might represent an important mechanism by which PCa cells acquire resistance to combined anti-androgen and XRT treatment. This work suggests a new use of ENZA in combination with XRT that could be applicable in clinical trial settings for patients with early and intermediate hormone responsive disease., (© 2017 Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
48. Time course of upper limb function and return-to-work post-radiotherapy in young adults with breast cancer: a pilot randomized control trial on effects of targeted exercise program.
- Author
-
Ibrahim M, Muanza T, Smirnow N, Sateren W, Fournier B, Kavan P, Palumbo M, Dalfen R, and Dalzell MA
- Subjects
- Adolescent, Adult, Breast Neoplasms mortality, Breast Neoplasms radiotherapy, Female, Humans, Middle Aged, Pilot Projects, Prospective Studies, Surveys and Questionnaires, Survivors, Young Adult, Breast Neoplasms rehabilitation, Exercise Therapy methods, Return to Work trends, Upper Extremity physiopathology
- Abstract
Purpose: Breast cancer (BC) diagnosis in young adults (YA) is rising, and both disease and treatments are aggressive in this population. Evidence supports the use of physical activity in reducing shoulder dysfunction, which is common among BC survivors. A pilot randomized clinical trial was performed to determine the effectiveness of a 12-week post-radiation exercise program in minimizing upper extremity dysfunction in YA with BC., Methods: Participants were randomized to either an exercise arm or a control arm receiving standard care. Data was collected over six time points using: the Disability of Arm, Shoulder, and Hand (DASH); the Metabolic Equivalent of Task-hours per week (MET-hours/week), and a post hoc questionnaire on return to work., Results: In total, 59 young women participated in the study (n = 29 exercise; n = 30 control). No statistically significant differences were found in overall DASH results between groups; however, those who underwent total mastectomy had residual upper limb dysfunction (p < 0.05). Both groups returned to pre-diagnosis activity levels by 18 months. Final evaluation showed that 86% of the women returned to work, and 89% resumed prior work activities with a decrease of 8.5 h/week., Conclusion: Although the short-term targeted exercise program had no effect on long-term upper limb function post-radiation, timing and program specificity may require consideration of tissue healing post-radiation and surgery type. The majority of participants returned to work, however not returning to pre-diagnosis work hours., Implications for Cancer Survivors: Exercise interventions alone may not reverse the long-term sequelae of breast cancer treatment and allow young adult patients to return to work.
- Published
- 2017
- Full Text
- View/download PDF
49. Radiation-Induced Oral Mucositis.
- Author
-
Maria OM, Eliopoulos N, and Muanza T
- Abstract
Radiation-induced oral mucositis (RIOM) is a major dose-limiting toxicity in head and neck cancer patients. It is a normal tissue injury caused by radiation/radiotherapy (RT), which has marked adverse effects on patient quality of life and cancer therapy continuity. It is a challenge for radiation oncologists since it leads to cancer therapy interruption, poor local tumor control, and changes in dose fractionation. RIOM occurs in 100% of altered fractionation radiotherapy head and neck cancer patients. In the United Sates, its economic cost was estimated to reach 17,000.00 USD per patient with head and neck cancers. This review will discuss RIOM definition, epidemiology, impact and side effects, pathogenesis, scoring scales, diagnosis, differential diagnosis, prevention, and treatment.
- Published
- 2017
- Full Text
- View/download PDF
50. Pattern of Local Recurrence and Distant Metastasis in Breast Cancer By Molecular Subtype.
- Author
-
Wu X, Baig A, Kasymjanova G, Kafi K, Holcroft C, Mekouar H, Carbonneau A, Bahoric B, Sultanem K, and Muanza T
- Abstract
Background and Purpose: No longer considered a single disease entity, breast cancer is being classified into several distinct molecular subtypes based on gene expression profiling. These subtypes appear to carry prognostic implications and have the potential to be incorporated into treatment decisions. In this study, we evaluated patterns of local recurrence (LR), distant metastasis (DM), and association of survival with molecular subtype in breast cancer patients in the post-adjuvant radiotherapy setting., Material and Methods: The medical records of 1,088 consecutive, non-metastatic breast cancer patients treated at a single institution between 2004 and 2012 were reviewed. Estrogen/progesterone receptors (ER/PR) and human epidermal growth factor receptor-2 (HER2) enrichment were evaluated by immunohistochemistry. Patients were categorized into one of four subtypes: luminal-A (LA; ER/PR+, HER2-, Grade 1-2), luminal-B (LB; ER/PR+, HER2-, Grade > 2), HER2 over-expression (HER2; ER/PR-, HER2+), and triple negative (TN; ER/PR-, HER2-). Results: The median follow-up time was 6.9 years. During the follow-up, 16% (174/1,088) of patients failed initial treatment and developed either LR (48) or DM (126). The prevalence of LR was the highest in TN (12%) and the lowest in LA (2%). Breast or chest wall relapse was the most frequent site (≈80%) of recurrence in LA, LB, and HER2 subtypes, whereas the regional lymph nodes and chest wall were the common sites of relapse in the TN group (50.0%). DM rates were 6.4% in LA, 12.1% in LB, 19.2% in HER2, and 27.4% in TN subgroups. Five-year survival rates were 84%, 83%, 84%, and 77% in the LA, LB, HER2 and TN subgroups, respectively. There was a statistically significant association between survival and molecular subtypes in an univariate analysis. In the adjusted multivariate analysis, the following variables were independent prognostic factors for survival: T stage, N stage, and molecular subtype., Conclusions: Of the four subtypes, the LA subtype tends to have the best prognosis, fairly high survival, and low recurrent or metastases rates. The TN and HER2 subtypes of breast cancer were associated with significantly poorer overall survival and prone to earlier recurrence and metastases. Our results demonstrate a significant association between molecular subtype and survival. The risk of death and relapse/metastases increases fewfold in TN compared to LA. Future prospective studies are warranted and could ultimately lead to the tailoring of adjuvant radiotherapy treatment fields based on both molecular subtype and the more conventional clinicopathologic characteristics., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.